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Maedi Visna virus (MVV) is the prototype lentivirus, capable of infecting cells
of the monocyte/macrophage series in sheep. Infection is associated with
pathological changes characterised by dysfunction of the cell mediated immune
system. The work described in this thesis was undertaken to study in vivo cell
mediated immune function in sheep infected with MVV using the tuberculin driven
delayed type hypersensitivity (DTH) reaction as the experimental system.
The gross and immunohistological characteristics of the DTH were firstly
evaluated in control sheep (CD4+, CD8+, y8, and B lymphocytes, macrophages and
MHC class II expression). Grossly, the reaction consisted of an indurative plaque,
maximal in size at 48-72 hours post challenge. Histologically, there was an early
infiltrate of polymorphonuclear neutrophils (PMNs), with a subsequent influx of
CD4+ and CD8+ T cells. Macrophages and MHC class II bearing cells left the lesion
at the later stages. In comparison, MVV infected sheep exhibited a reduction in the
size of the gross DTH which was significantly associated with a decreased density of
PMNs and CD4+ cells in the early reaction, but not with the degree of classical
pathological change evaluated at subsequent post mortem or the presence of viral
RNA in the skin.
Depletion of circulating PMNs using cytotoxic drugs in control sheep resulted
in the depression in the size of the DTH and a reduced influx of CD4+ cells,
confirming the importance of PMNs in the development of the DTH lesion.
The migratory ability of PMNs and CD4+ cells to the sites of dermally injected
proinflammatory mediators (IL-8, TNF-a, and zymosan activated plasma) was
subsequently shown to similar in control and MVV infected sheep.
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Evaluation of the levels of circulating anti-PPD antibodies in the MVV infected
and control groups provided evidence for a negative association between antibody
levels and DTH size suggesting a switch to a Th2 type response in the MVV infected
sheep.
Finally, the presence of cytokine mRNA (IL-10, TNF-a, IFN-y and IL2-R) in
the early lesions of both groups was assessed using reverse transcription polymerase
chain reaction (RT-PCR) technology. This indicated that the mRNA expression
pattern of these cytokines was not significantly different in control and MVV
infected sheep.
In conclusion, the work has shown a significant depression of the DTH
response in sheep infected with MVV. This depression is associated with decreased
density of PMNs and CD4+ cells in the early reaction, but is not associated with
abnormalities in the trafficking of these cells to dermally injected proinflammatory
mediators, the presence of antibody/antigen complexes, the presence of viral RNA,
or difference in the cytokine mRNA production profile. The importance of the PMN
in the DTH has been indicated, and a defect in the in vivo immune response of the
PMN in MVV infected sheep has been described.
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Maedi-visna describes a geographically widespread ovine disease of viral
aetiology. Infection is characterised by chronic, progressive lymphoid inflammatory
lesions primarily affecting lung tissue, but also occurring in central nervous tissue,
mammary gland tissue and synovial membranes. The clinical course of the disease is
prolonged, with a gradual increase in the severity of clinical signs, and commonly
results in the demise of the animal.
1.2 THE VIRUS
1.2.1 Classification
Maedi-Visna virus (MVV) is the a member of the Retroviridae family of
viruses, this family being characterised by the presence of a positive sense single
stranded RNA genome and the utilisation of a reverse transcriptase enzyme (Lin,
Thormar, 1970). It is further classified into the Lentivirinae subfamily, so named as
members of this family are characterised by a slow, yet predictable, disease
progression (Sigurdsson, 1954a). Other members of this subfamily are capable of
producing clinical disease in a range of animal species; bovine immunodeficiency
virus (BIV) (Van Der Maaten et al. 1972; Gonda et al. 1987), caprine arthritis-
encephalitis virus (CAEV) (Crawford et al. 1980), equine infectious anaemia virus
(EIAV) (Kobayashi, 1961), feline immunodeficiency virus (FIV) (Pedersen et al.
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1987), human immunodeficiency virus (HIV) (Barre-Sinoussi et al. 1983), and
simian immunodeficiency virus (SIV) (Daniel et al. 1985).
1.2.2 Structure and replication
Electron microscopic studies have shown the infective virion to consist of a
spherical or elliptical outer membrane of diameter of 65-110pm, with numerous
small projecting spikes and an electron dense nucleoid (Thormar, 1961; Thormar,
Cruickshank, 1965; Coward et al. 1970). The genome is composed of a 9-10 kilobase
positive sense single stranded (ss) RNA (Brahic et al. 1977; Sonigo et al. 1985;
Carey et al. 1993). At each end of the genome are replicated base sequences known
as long terminal repeats (LTRs) which are involved in the control of viral replication.
The majority of the remainder consists of three major gene regions gag, pol, and env,
which code for core proteins, reverse transcriptase, integrase and protease enzymes,
and envelope glycoprotein, respectively. The genome includes several short, multiply
spliced open reading frames (ORFs), of which tat, rev, and vif genes have been
characterised. These genes are considered to be involved in the control of replicative
events (Carey et al. 1993).
The viral replicative cycle is initiated by the binding of the virus to a cell
surface receptor molecule, putatively major histocompatability complex (MHC) class
II antigen (Dalziel et al. 1991). This is followed by fusion of the virus with the cell
membrane, which precedes viral entry and uncoating (Carey et al. 1993). The viral
reverse transcriptase subsequently converts the viral ssRNA into proviral double
stranded (ds) DNA (Haase, Varmus, 1973). This dsDNA then passes to the nucleus
where it is present predominantly in a linear form, but also exists in a circular form
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(Harris et al. 1981), and has been shown to integrate into the host genome via the
action of a viral integrase encoded in the pol region of the viral genome (Clements et
al. 1979; Katzman, Sudol, 1994). Integration into the host genome has not been
proven to be a necessary stage in the viral life cycle (Carey et al. 1993). In vivo, there
is control of viral protein expression at this stage of infection, with suppressed
translation of this dsDNA into viral messenger RNA (mRNA) (Brahic et al. 1981).
This contrasts with the in vitro cell culture models in which translation occurs rapidly
and is followed by cell lysis and death (Thormar, 1961).
Translation of the gag and pol gene regions produces a 150 kDa precursor
protein which cleaves to generate the reverse transcriptase and gag related proteins
(Vigne et al. 1982).
The translation of the gag gene produces a precursor protein of 55kDa that is
cleaved intracellularly to produce the three major internal structural proteins p30, pi6
and pi4 (Vigne et al. 1982).
Translation of the env component gives rise to the gpl35 envelope glycoprotein
and the gp46 transmembrane glycoprotein (Sonigo et al. 1985).
Translation of the characterised small ORFs leads to the production of the 10
kDa transactivator of viral transcription (tat) (Hess et al. 1985), a 19 kDa regulator of
expression of viral protein (rev) product connected with env expression (Tiley et al.
1990), and a 29kDa vifprotein of uncertain function (Audoly et al. 1992).
The ds DNA also acts as a template for the production of the viral ss RNA
genome.
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The mechanism of final viral particle assembly is not fully characterised, but is
associated with budding from the cell membrane (Thormar, 1961).
The control of the life cycle has largely been studied in vitro, with evidence
that there is a controlled sequence of transcription with smaller mRNAs expressed
within 24 hours post innoculation, followed by larger molecules at the 72 hour time
point (Sargan et al. 1994). The initial RNAs are postulated to code for the tat and rev
messages (Gourdou et al. 1989; Tiley et al. 1990). Tat acts both as an activator of
viral transcription via interaction with the LTR region (Neuveut et al. 1993), and has
been found to have direct pathogenic effects in rats and mice, with neurotoxicity
(Hayman et al. 1993) and multiorgan lymphoid hyperplasia (Vellutini et al. 1994)
having been reported. Rev is required for the productive infection of cells in culture
(Toohey, Haase, 1994), possibly acting to stabilise mRNA transcripts (Vigne et al.
1990). The combined action of these two factors facilitates active replication.
The relatively restricted level of replication occurring in vivo is not fully
understood, although the upregulation of virus replication with cell activation
(Gendelman et al. 1986) suggests the interaction of cellular factors with the virus
control region can exert regulatory effects on virus multiplication (Carey et al. 1993).
1.2.3 Viral tropism
The virus is infective to both sheep and goats (Banks et al. 1983), with no
evidence of other species acting as hosts (Carey et al. 1993).There is a suggestion of
a variable susceptibility to infection between different breeds of sheep (Houwers et
al. 1989).
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Within the host, cells of the macrophage/monocyte series appear the most
important target for the virus (Gorrell et al. 1992; Lujan et al. 1994), with the bone
marrow monocyte precursor cell possibly acting as a reservoir of latent infection
(Gendelman et al. 1985). Within the macrophage population, there is a selective
infection with macrophages of the lung, lymph node, synovium, mammary gland,
bone marrow, spinal cord, and spleen being particularly prone to infection(Kennedy
et al. 1985; Gendelman et al. 1985; Brodie et al. 1992; Brodie et al. 1995). This
phenomenon is possibly associated with the increased susceptibility to infection with
increased activational status of the cell (Gendelman et al. 1986). Viral RNA has been
located in macrophages, macrophage like cells and epithelium in vivo, although the
productive infection was found to be restricted to cells of the macrophage series, with
expression of viral proteins being further restricted to macrophages in the tissues
affected with pathological changes (Brodie et al. 1995). There has been a single
report of the productive infection of blood vessel smooth muscle cells in an in vitro
study (Leroux et al. 1995).
1.2.4 Relationship with other members of the subfamily
Maedi visna virus is closely related to the other members of the Lentivirinae
family genetically (particularly in the gag and pol regions of the genome),
morphologically, and antigenically (Gonda et al. 1985; Stephens et al. 1986; Gonda
et al. 1986; Maslak, Schmerr, 1993; Gonda et al. 1994).
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1.3 CLINICOPATHOLOGICAL ASPECTS OF THE DISEASE
1.3.1 Historical perspective and occurrence
Maedi-visna, although previously reported (Marsh, 1923), first became
prominent due to a severe epidemic of the disease in Iceland in the 1930s (Petursson,
1994). The disease was imported in a clinically inapparent form with Karakul sheep
imported from Germany, and was disseminated in an alarming fashion largely due to
the local sheep farming practices and the susceptibility of the local breed of sheep
(Petursson, 1994). Subsequently the MVV has been recorded infecting a considerable
proportion of the sheep population in many areas of the world (Rajya, Singh, 1964;
Ressang et al. 1968; Wandera, 1970; Suveges, Szeky, 1973; Gates et al. 1978; Lujan
et al. 1993; Bouljihad, Leipold, 1994)
The disease was first recognised serologically in the U.K. in 1979 (Dawson et
al. 1979), with the first pathologically confirmed case in Scotland in 1981 (Grimshaw
et al. 1981). A recent random serological survey of sheep flocks in England indicated
that 1.6% of flocks sampled were infected, although the author considered this to be
a gross underestimate when considering the limited percentage of the flock tested
(Dawson, 1994).
1.3.2 Epidemiology
There is conflicting evidence as to the main pathway of transmission ofMVV,
although there appears to be a consensus that lambs born to seropositive ewes are
more likely to seroconvert. Several authors have confirmed the prenatal infection of
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lambs in utero, indicating a vertical transmission of the virus, with speculated
mechanisms including viral genome integration into the germ cell line or the passage
of somatic cells across the placenta (Cross et al. 1975; Cutlip et al. 1981; Brodie et
al. 1994). This evidence has been challenged by other workers (De Boer et al. 1979;
Houwers et al. 1987) who concluded that there was limited evidence of vertical
transmission, and postulated that the epidemiologically significant method of
transmission was horizontal, either via suckling and ingesting infected macrophages
from the ewe's colostrum or inhalation of infected macrophages shed in respiratory
secretions. It is apparent that close contact is required for infection to spread between
individuals.
There is evidence that the coinfection of sheep with sheep pulmonary
adenomatosis (SPA) increases the likelihood of the horizontal transmission ofMVV
(Pritchard, Done, 1990; Gonzalez et al. 1993).
1.3.3 Clinical presentation
MVV infection is associated with a range of clinical presentations, which may
occur independently or in conjunction with each other, consisting of exercise
intolerance associated with pulmonary disease (Maedi), progressive limb paresis and
ataxia or vestibular disease (Visna), diffuse indurative mastitis, and swelling and
crepitus associated with arthritis primarily affecting both carpal joints (Dawson,
1980; Oliver et al. 1981; Cutlip et al. 1985; van der Molen et al. 1985; Watt et al.
1992a; DeMartini et al. 1993; Brodie et al. 1995). Clinical evidence of infection only
becomes apparent several years after infection, and as such sheep are generally 3 to 4
years of age before the onset of clinical symptoms (Sigurdsson, 1954b; Watt et al.
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1992a). All sheep clinically affected by MVV exhibit wasting in the latter stages of
the disease, but this is particularly evident when the disease sydrome Visna is
apparent, 'visna' being the Icelandic term for wasting.
Sheep may survive for a period of months to years after the onset of clinical
signs (Watt et al. 1992a).
Within the U.K., the respiratory form or Maedi is prevalent (Dawson, 1980;
Wattetal. 1992a).
1.3.4 Pathology
Pathologically, MVV infection is characterised by a diffuse lymphocytic
infdtrate in affected organs.
The affected lung fails to collapse, is heavier than normal, uniformly enlarged,
firm and rubbery in consistency, with small multifocal grey spots on cut surfaces.
The associated pulmonary lymph nodes are enlarged and exhibit hyperplasia.
Histologically, there is diffuse interstitial infiltration with lymphocytes and
monocyte/macrophages, a smooth muscle hyperplasia, and a predominantly
lympocytic alveolitis. Lymphocytic germinal centre type structures are also diffusely
present in the lung of many cases (Cutlip et al. 1979; Oliver et al. 1981; Lujan et al.
1991; Watt et al. 1992a; DeMartini et al. 1993; Lujan et al. 1993).The infiltrating
lymphocytes present in the lung interstitium are of the CD4+and CD8+ phenotype,
and have been found to be in the same ratio as control lung tissue (Watt et al. 1992b).
The alveolitis has been characterised as having an increased number of CD8+
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lymphocytes (Cordier et al. 1992; Lujan et al. 1993), with a decreased number of
CD4+ lymphocytes being recorded by one group (Lujan et al. 1993) with a resultant
inversion of the CD4+/CD8+ ratio. Expression ofMHC class II has been found to be
increased (Cordier et al. 1992; Lujan et al. 1993). The number of polymorphonuclear
neutrophils (PMNs) is also raised (Cordier et al. 1992; Lujan et al. 1993). The
hyperplastic regional lymphoid tissue exhibits an increase in the levels of CD8+ and
y§ T cells in the follicles of the cortex (Watt et al. 1992b).
Affected central nervous tissue (CNS) is usually grossly normal, although there
is a report of reddish streaking in the brain and spinal cord in some animals (Watt et
al. 1992b). The typical histological changes consist of lymphocytic meningitis,
lymphocytic infiltration of the neuroparenchyma with perivascular and choroid
plexus lymphocyte/macrophage aggregations. There is evidence of demyelination,
gliosis and astrocytic hypertrophy (Cutlip et al. 1979; Oliver et al. 1981; Watt et al.
1992b). The lymphocyte subsets involved in the CNS inflammation vary dependent
upon the site examined with the perivascular infiltrates being predominantly CD4+
and the diffuse neuroparenchymal response being predominantly CD8+
(Torsteinsdottir et al. 1992). The latter results in a reversed CD4+/CD8+ ratio in this
area. Many of these cells express MHC class II antigen (Torsteinsdottir et al. 1992).
Affected mammary gland is small and firm to cut, exhibiting a diffuse
lymphocytic infiltration and fibrosis, with germinal centre type structures being
found particularly periductally (Oliver et al. 1981; van der Molen et al. 1985; Lujan
et al. 1991; Watt et al. 1992b).
Finally, the affected joints exhibit swollen, oedematous and hyperaemic
synovial membranes with increased joint fluid and erosions of the joint cartilage.
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Histologically there is proliferation of the synovial lining cells with synovial villous
hypertrophy, and a diffuse cellular infiltrate consisting mainly of lymphocytes, but
also macrophage/monocytes and plasma cells(01iver et al. 1981; Cutlip et al. 1985;
Narayan et al. 1992; Watt et al. 1992b).The synovial fluid contains a raised level of
all lymphocyte subsets, although CD8+ cells predominate and there is a reversal of
the CD4+/CD8+ ratio (KennedyStoskopf, 1989; Harkiss et al. 1991). A similar
pattern is evident in the synovium of the affected joints, with a predominant CD8+
response (KennedyStoskopf, 1989; Anderson et al. 1994). An increased level of
MHC class II expression has been found in both the synovial fluid and synovial
membrane (KennedyStoskopf, 1989; Harkiss et al. 1991; Anderson et al. 1994).
The CD4+/CD8+ ratio was also considered to be reversed in the peripheral
blood of infected animals in one small study(KennedyStoskopf, 1989), a finding that
was challenged subsequently in a considerably larger study (Lujan et al. 1993) who
considered there to be no significant differences in the levels of circulating
lymphocytes using a range ofmonoclonal lymphocyte markers.
1.3.5 Diagnosis and control
The current methods of detection of in vivo infection with MVV rely on
serological testing for the presence of antibodies to MVV proteins, with both the agar
gel immunodiffusion test (AGIDT) and enzyme linked immunosorbent assay
(ELISA) in common use (Winward et al. 1979; Houwers, Gielkens, 1979). One
comparative study discovered little difference between the accuracy and sensitivity of
these methods (Dawson, 1982), although more recently several authors have claimed
a greater sensitivity for ELISA techniques, especially those relying upon whole virus
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preparations (Houwers et al. 1982; Kwang, Torres, 1994; Rosati et al. 1994; Zanoni
et al. 1994).All these methods are reliant on the presence of circulating antibodies,
which has been shown to underestimate the number of virally infected individuals as
determined by in-situ hybridisation (Johnson et al. 1992). Detection of individual
infected cells is possible using the polymerase chain reaction in the fixed cell,
followed by detection with in situ hybridisation (Haase et al. 1990). This markedly
improves sensitivity, but would prove difficult to operate as a true diagnostic test as
it is a costly and complicated technique.
*
A recent study has suggested the use of cerebrospinal fluid (CSF) for the
diagnosis of visna, relying on cellular and globulin changes that may be specific to
the disease (Lowenthal, Karcher, 1994).
Control of spread of the disease is complicated by the prolonged latent period
of clinically inapparent infection, during which time virus shedding and transmission
may occur, and the dependence on serological testing for identification of infected
individuals. Vaccination against MVV has been studied in detail, but the persistence
of infection as a DNA provirus, antigenic variation within the virus population,
transmission to neonates, and a poorly understood immune response to live viral
challenge all create practical difficulties that are unlikely to be overcome in the
foreseeable future (reviewed by Pearson et al. 1989). Current methods of control rely
on serological testing and the culling of either entire flocks or infected individuals
and their offspring (De Boer et al. 1979; Houwers et al. 1987). The removal of lambs
from infected dams at birth has also proved effective as a control measure, but is
difficult to achieve in commercial flocks (De Boer et al. 1979). Within the U.K., a
voluntary national Sheep and Goat Health Scheme is in operation which accredits
flocks that have been confirmed free from infection serologically.
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Currently there is no specific clinical treatment available.
1.3.6 Economic importance
The level of economic loss associated with MVV is difficult to assess due to
the difficulty in diagnosis and the insidious onset of clinical signs which tend to lead
to poor production, emaciation and premature culling. The occurrence of indurative
mastitis has been linked with poor growth rates in lambs (Pekelder et al. 1994), and
the economic loss associated with infection has been recently estimated at £5 per ewe
in a flock (Dawson, 1994).
1.4 INFECTION AND THE IMMUNE SYSTEM
1.4.1 Response to viral challenge
Due to the uncertainty surrounding the epidemiology of natural infection, the
response of the immune system to viral challenge has been largely studied using
experimental infection models. These have consisted of viral innoculation via the
respiratory route, directly into central nervous tissue, and via the subcutaneous route.
The immune response to the virus is composed of both cell mediated and
humoral components. The immune response to an acute viral challenge administered
into the respiratory system, mimicking the supposed method of natural disease
transmission, has been evaluated (Sihvonen, 1981; Larsen et al. 1982b; Lairmore et
al. 1986; Cordier et al. 1992; Begara, 1994). All these studies have reported an early
increase in lymphocyte numbers in bronchoalveolar lavage fluid (BALF), with
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phenotyping of lymphocyte subsets being performed in two studies (Cordier et al.
1992; Begara, 1994). These studies have provided conflicting results, with Cordier et
al reporting a significant increase in both the CD4+ and CD8+ lymphocytes,
significant increase in PMN numbers, and unchanged macrophage numbers in BALF
at three months post infection, and Begara reporting a decrease in CD4+ and increase
in CD8+ lymphocytes (with resultant inversion of the CD4+/CD8+ ratio), decreased
PMN numbers, and decreased macrophage numbers in BALF at 4-8 weeks post
innoculation. Seroconversion to MVV antigens has been found to occur in a majority
of innoculated sheep at 2-12 weeks post challenge, and to persist throughout the
study period (Larsen et al. 1982b; Lairmore et al. 1986; Begara, 1994). The induction
of a viral-specific lymphocyte response, as assessed by the lymphocyte
transformation test, was found to occur at 3 weeks post innoculation. but had
returned to baseline by 7 weeks post innoculation (Larsen et al. 1982a).
Other workers, particularly those interested in the pathogenesis of the
neurological form of the disease visna, have utilised direct viral innoculation
intracerebrally (Petursson et al. 1976; Griffin et al. 1978; Oliver et al. 1981). All
studies reported the finding of visna like pathological lesions in the brains of infected
sheep, although there was disparity in the results of leukocyte counts in the
cerebrospinal fluid (CSF); one study reports a slight increase in leukocyte count in a
small number of innoculated sheep (Oliver et al. 1981), whilst the other two report an
initial transitory marked elevation in leukocyte numbers in the CSF followed by a
prolonged marginal elevation throughout the period of study (Petursson et al. 1976;
Griffin et al. 1978). All three studies report the development of a serological antibody
response, usually detected at 1-2 months post infection.
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The intra-articular innoculation with virus is reported to produce a
mononuclear cell infiltrate into the synovial fluid, with a lymphocytic infiltration in
the synovial membrane (Oliver et al. 1981). A seroconversion was found to occur
between 14 and 42 days post innoculation.
Finally, intradermal viral innoculation has been undertaken (Bird et al. 1993;
Blacklaws et al. 1994; Blacklaws et al. 1995), allowing the investigators to study
changes in cell populations in the regional lymph node and efferent lymphatics
draining the site of the experimental infection. Viral challenge led to the initial
decrease in cell numbers in efferent lymph, with a subsequent return to baseline cell
output, but with an increase in CD8+ MVV specific cytotoxic cells, the presence in
draining lymph nodes and the peripheral circulation of MHC restricted cytotoxic
cells, and circulating anti-viral antibody production (Bird et al. 1993; Blacklaws et al.
1994; Blacklaws et al. 1995). Virus was only rarely isolated from affected tissues.
1.4.2 Persistence of the virus
The persistence of the virus in the face of both an antibody and cell-mediated
immune response is a phenomenon that is not fully understood, and accounts for the
continually progressive nature of the clinical course of disease. The favoured
explanation for this viral persistence is the restriction of viral gene expression by the
host cell, with the virus existing in a proviral from in the monocyte and only
becoming active when the cell is activated (Narayan et al. 1982; Gendelman et al.
1986). This leads to the situation where only a relatively small proportion of cells
that contain viral protein express any viral proteins on their cell surface (Brodie et al.
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1995), and hence the immune system is unable to recognise the vast majority of
infected cells.
Another possible mechanism involves the mutation of the virus under pressure
from circulating antibodies, leading to production of strains of virus that are no
longer neutralised (Zink et al. 1987).
1.4.3 Immunosuppression
In contrast to the profound immunosuppressive activity of the other members
of the Lentivirinae family, there has been little documented evidence of a similar
alteration in the immune response of sheep infected with MVV. There have been
suggestions that MVV infection is associated with increased infection with SPA
(Myer et al. 1988) and lungworms (Giangaspero et al. 1993), but the direct
association through immunosuppression is not clear and this may be a synergistic
relationship (Dawson et al. 1985; Gonzalez et al. 1993). More direct evidence of
immunosuppression was provided when it was discovered that there was a depression
of the gross dimensions of the delayed type hypersensitivity response in sheep
infected with MVV (Myer et al. 1988).
1.4.4 In-vivo testing of the cell mediated immune system
The cell mediated immune response in ruminants consists of complex
interactions between antigen presenting cells and antigen specific T lymphocyte
clones, particularly of the CD4+ phenotype (McKeever, 1994), and is particularly
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responsible for immune responses to certain agents such as viruses and fungi and
mycobacteria (Kniker et al. 1984). Although there have been many recent
developments of in vitro tests of the immune system, comparative studies have
indicated that the most readily undertaken and reliable indicator of the ability of the
cell mediated immune system to function in vivo is the delayed type hypersensitivity
(DTH) response (Spitler, 1980; Ahmed, Blose, 1983; Borleffs et al. 1991; Blatt et al.
1993; Otto et al. 1993; Rosentreich, 1993). This test consists of the intradermal
injection of a specific antigen into a previously sensitised individual.
The assessment of the cell mediated system is of particular importance in
lentiviral infection, where there is a dysregulation of this part of the immune
response, and the presence of virus in at least one of the component cell phenotypes.
As such, the gross size of the DTH has been used extensively in HIV infection as a
marker of the degree of immunosupression in individual patients, and is a component
of the widely utilised Walter Reed system of assessment of progression to acquired
immune deficiency syndrome (AIDS) (Redfield et al. 1986). A similar pattern has
been described in cats infected with FIV (Otto et al. 1993), and sheep infected with
MVV (Myer et al. 1988). There has been no histological or mechanistic assessment
of this reported decrease in the gross size of the DTH.
1.4.5 Maedi visna as an animal model for HIV infection
The thorough investigation of pathogenic mechanisms is reliant on both the
collection of biopsy material for further in vitro experiments, and direct invasive
experimentation in the living animal. The study of human subjects is obviously
highly restricted due to both ethical considerations and the danger of transmission of
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infection to the experimenter. For these reasons, the study of animal models of
human disease provides useful insights into pathogenesis, and helps direct the
investigation of the human condition. The sheep is inexpensive to purchase and
maintain, docile and readily handled, and presents little risk of zoonosis to the
handler. For these reasons, the sheep has become an important experimental animal
(Borrie, Mitchell, 1960).
Considering lentivirus infections in particular, the ovine lentivirus shares many
features of the human equivalent: genomic organisation, method of viral replication,
antigenic variation, restriction of replication the host cell, persistence of the virus in
the face of humoral and cell mediated immune responses, slow and progressive
development of disease, and similarities in the pathological lesions produced by the
disease (Narayan et al. 1988; Petursson et al. 1989; Petursson et al. 1991). The major
difference between the two viruses rests on the concurrent infection of CD4+
lymphocytes, as well as macrophages, in HIV. This difference appears to be the
important factor in producing the profound immunosuppression found in HIV, and is
only apparent at late stages when the development of secondary infections tends to
obscure primary pathology (Narayan et al. 1988; Petursson et al. 1989; Petursson et
al. 1991). Study of the pathogenesis ofMaedi-Visna, particularly in vivo, is therefore
of comparative interest in the understanding of the human HIV infection.
1.5 THE DELAYED-TYPE HYPERSENSITIVITY (DTH)
RESPONSE
The DTH response was first recognised by Koch, who discovered the now
classical response to the intradermal injection of tubercle bacilli extract, in which
human patients or guinea pig models infected with tuberculosis reacted with an
inflammatory lesion characteristic of the tuberculous inflammatory process which
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was maximal at 48-72 hours post injection. Further work established that this
reaction could take place in the absence of antibodies, and that the sensitivity could
be transferred by means of blood cells (reviewed by Spitler, 1980), leading to the
description of this reaction as 'cell-mediated immunity'. The reaction has now been
reproduced utilising a variety of antigenic materials ( Rosentreich, 1993).
In most instances, the DTH is evaluated purely at a gross level, with the
increase in skin thickness at the site of the indurative response being measured. In
this form the reaction is utilised in a variety of clinical situations; either as an aid to
the diagnosis of infectious disease such as tuberculosis, or as an assessment of the
functional ability of the cell mediated immune system in vivo (Spitler, 1980; Ahmed,
Blose, 1983; Otto et al. 1993; Rosentreich, 1993; Pesanti, 1994).
A large range ofDTH sensitisation and elicitation models have been previously
reported, leading to the possibility that there could be an equally wide range of
mechanisms involved in producing such a lesion. Indeed, a recent study comparing
the DTH responses to either tuberculin or human albumin in mice discovered that
there are two distinct cellular mechanisms operating; the tuberculin reaction being
macrophage dependent and the albumin reaction being mast cell dependent (Torii et
al. 1993). Many previous studies have concentrated on the chemically induced skin
contact hypersensitivity reaction (Nickoloff et al. 1990), and while this model was
considered for use in the present studies, the marked immunological involvement of
the epidermal cells in this response led to the consideration that it would be difficult
to evaluate the results terms of specific macrophage cell functions that were the basis
of this study into the effects of MVV infection on the DTH reaction. The tuberculin
reaction is also a commonly investigated example of the DTH response and appears
to operate in a macrophage dependent manner. After careful consideration, this
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model was selected to be the experimental system of choice, and this review will
concentrate on the tuberculin reaction.
In order for a hypersensitivity response to take place , the subject has to be first
sensitised to a particular antigen (Imamura et al. 1993; Ng et al. 1995). In the case of
the tuberculin response, sensitisation is commonly performed by vaccinating the
subject with a Mycobacterium vaccinal preparation (Davey, 1995). The response may
then be generated by the injection of bacterial proteins extracted from cultures of
Mycobacterium, most commonly into the dermis (Davey, 1995). The most frequently
used bacterial preparation is the purified protein derivative (PPD) of Mycobacterium
bovis, which is often referred to as tuberculin (although the term tuberculin appears
to be used somewhat indiscriminately). PPD is prepared from cultures of
Mycobacteria by initially heat killing the culture and then harvesting the cell free
supernatant. This supernatant is then precipitated with trichloroacetic acid (Klausen
et al. 1994). As such, PPD is a crude mixture of a large range of antigenic material
including heat shock proteins (Vordermeier et al. 1992). Attempts have been made to
identify the components of PPD responsible for the DTH, and one study found a
38kDa protein capable of eliciting a DTH response in immunised mice (Vordermeier
et al. 1992). There has been no such reported work undertaken in the sheep, and the
author obtained a supply of a number of pure proteins which were components of
PPD and had been shown to produce immunological responses in other animal
species (Hewinson, personal communication). Unfortunately, these proteins failed to
elicit any detectable DTH response when injected into sensitised sheep, and PPD as
opposed to a single protein, remained the sole choice for DTH induction in this
species.
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The histological nature of the DTH reaction has been the subject of study for
some number of years, with initial controversy regarding the cellular characteristics
of the reaction. One of the earliest studies (Dienes, Mallory, 1932) concluded that the
predominant infiltrative cell type was of mononuclear morphology, but was
challenged by two reports (Feldman, Fitch, 1937; Long 1937) which reported the
PMNs as the dominant cell type found in the early (up to 24 hour time point)
reaction, subsequently being replaced by the mononuclear cells. The main site of
accumulation of the PMN was found to be perivascularly and perineuronally. A
marked accumulation of oedema fluid, which has subsequently been shown to be
involved in the production of the induration in the lesion (Muller, 1995), was
consistently reported. Subsequent to the studies by Feldman and Fitch (1937) and
Long (1937), an attempt was made to recreate the initial work of Dienes (Follis,
1940). This provided a conflicting result to that initially reported by Dienes, and
confirmed the work of Feldman and Long in concluding that the predominant cell
type in the early (up to 24 hour) reaction was the PMN. The original work of Dienes
was again repeated (Gell, Hinde, 1951) and this time the presence of a significant
number of PMNs in the early reaction was recorded, although the authors considered
these to be a secondary and non specific response to epidermal necrosis and persisted
with the view that the mononuclear cells were of primary importance in the reaction.
Similar observations were made by Boughton and Spector (1963), with PMNs
considered the main cell type in the early reaction, located mainly in a perivascular
pattern, being superseded latterly by mononuclear cells. Another interesting finding
of this study was that non-sensitised animals differed from sensitised animals in their
lack ofmarked PMN migration in the early reaction.
The importance of the mononulcear cells to the DTH reaction was
subsequently demonstrated experimentally by the passive transfer of reactivity to
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tuberculin, from a sensitised to a naive animal using these cells (Turk, Oort, 1963).
The specificity of the cells present in the DTH lesion was further studied utilising
radioactive labelling techniques, but it was found that the origin (donor or recipient)
of the mononuclear cells migrating into the DTH lesion was not significantly
different from that of cells migrating into non specific control lesions (Turk, Oort,
1963). The same study also noted the presence of large numbers of PMNs in the
early lesion. The actively dividing nature of the invading mononuclear (described by
the authors as lymphocytes morphological grounds) was then confirmed by a study
of tritiated thymidine uptake by cells in a DTH lesion, with lymphocytes exhibiting a
marked uptake of the radioactive material indicative of active cellular division
(Kosunen at al. 1963). Several more recent studies have also indicated the presence
of large numbers of PMNs (Legendre et al. 1979; Piatt et al. 1983; Norris et al.
1991), although the most recent publication regarding PMN influx (Gao et al. 1994),
suggested that PMNs did not participate in the lesion. This work unfortunately was
confined to time points after 24 hours when most authors suggest PMN migration has
ceased.
Attempts were then made to differentiate the mononuclear cell types involved
in the lesion, initially using histochemical techniques. Differentiation of
macrophages from lymphocytes was performed using an acid phosphatase staining
method (Turk et al. 1966). This study indicated that macrophages and lymphocytes
were present in roughly equal numbers up until 24 hours, at which point there was a
marked lowering of macrophage numbers in the lesion with a corresponding increase
in the levels of lymphocytes. PMNs were also found to be present in the early lesion
in significant quantities. The advent of the use of antisera for the staining of
histological sections facilitated the discovery of a marked deposition of extravascular
fibrin in the reaction (Colvin et al. 1973). This was followed by the advent of the
31
monoclonal antibody, and its particular usage for the precise immunohistological
staining of specific cells as defined by their expression of certain cell surface
markers. Several workers reported the relative contribution of the T helper (CD4+)
and T suppressor (CD8+) T lymphocyte subsets, with the CD4+ being found to be
predominant in the lesion, although the ratios of the cell types was found to be of the
same order in the lesion as in the peripheral circulation which was interpreted as
indicating a non selective or random migration of the T cell subsets into the lesion
(Poulter et al. 1982; Konttinen al. 1983; Gibbs et al. 1984), with several of these
authors indicating a large influx ofmacrophage marker expressing cells into the later
lesion (Poulter et al. 1982; Konttinen et al. 1983; Piatt et al. 1983).
More detailed work has followed in an attempt to unravel the mechanisms
controlling the influx of cells into the lesion, with the discovery that the adhesion
molecules endothelial adhesion molecule-1 (ELAM-1) and vascular cell adhesion
molecule-1 (VCAM-1) are associated with the influx of both PMNs and lymphocytes
(Norris et al. 1991; Silber et al. 1994a; Silber et al. 1994b), and that the lymphocyte
associated adhesion molecules very late antigen-4 (VLA-4) and lymphocyte function
antigen-1 (LFA-1) are similarly involved in migration of mononuclear cells into the
lesion (Issekutz, 1993).
The levels of cytokine expression in the DTH lesion have been evaluated
indicating that in the early reaction interleukin-1 and TNF-a predominate, with
interferon-y and interleukin-2 expression (typical of the T-helper type 1 response)
being also upregulated at the 24 hour time point (Chu et al. 1992; Tsicopoulos et al.
1992; Tsicopoulos et al. 1994).
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In summary, there still remains controversy as to the cellular components of the
DTH reaction, with PMNs being commonly found in the early reaction, but with
many commentators considering the subsequent influx ofmononuclear cells to be of
more importance. The precise nature of the mononuclear cell influx is also a subject
of controversy, most experimenters discovering the presence of considerable
numbers of T lymphocytes, mainly of the CD4+ subset, in the later lesion. There is
discrepancy, however, in the reports of the numbers of macrophages in the later
lesions, some commentators considering them the predominant cell in the later
reaction, while others report a marked reduction in macrophage numbers at later time
points. It should be pointed out that none of these studies were performed in sheep,
and that there is no reference in published literature to the normal components of the
DTH in sheep.
1.6 AIMS OF THE THESIS
This thesis sets out to confirm sheep chronically infected with MVV (as
defined by persistent seropositivity) exhibit depressed DTH responses, and attempts
to characterise the altered response shown by these animals. This has both relevance
in furthering the study of the pathogenesis of a disease which is of economic
importance to the sheep breeding industry, and has implications for the
understanding of the immunopathogenesis of the depressed DTH that has been
recorded, but never histologically evaluated, in the human disease AIDS. The
primary step is the definition of the immunohistological characteristics of the normal
DTH reaction in sheep, followed by the examination of the reaction in sheep infected





Texel sheep were purchased from a commercial flock with a history of clinical
disease related to MVV and a high rate of MVV seroprevalence as previously
described (Watt et al. 1992a). All animals were seropositive at the time of purchase,
and were subsequently maintained in penned groups of approximately 30 sheep
within a 'polytunnel' sheep house. The pen sizes were such that sheep were
maintained in close contact with their peers at all times. They were managed in a
conventional manner, with a feeding regime of hay supplemented with a commercial
concentrate ration. Regular anthelmintic treatment was undertaken.
Sex and age matched control animals were purchased from pedigree Texel
flocks that were participants in the MAFF sheep and goat health scheme, indicating
that they had been serologically free from MVV infection for a considerable period
of time. They were separately housed, but maintained in an identical manner to the
infected sheep. These sheep were regularly serologically tested to confirm their
seronegativity.
2.2 SEROLOGICAL TESTING
Sheep were regularly tested for the presence of serum antibodies to MVV
antigen using an AGIDT supplied by The Central Veterinary Laboratory (Weybridge,
UK) , which is the standard test used by MAFF in the UK (Winward et al. 1979).
This test uses an antigen prepared from MVV ovine strain WLC-1 MVV. The kit
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includes a positive control of ovine antiserum to an MVV 135 kDa glycosylated
envelope protein, this being one of the main reactive viral antigens.
2.3 HAEMATOLOGY
Blood was collected by jugular venepuncture using a EDTA vacutainer tube
system (Becton Dickinson and Co., Rutherford, USA) at the time of PPD challenge.
The sample was haematologically analysed to provide total and differential white
blood cell counts in a routine manner in an automated analyser by the Clinical
Laboratory Service, Royal (Dick) School ofVeterinary Studies, Easter Bush, Roslin.
2.4 INITIATION OF THE DTH
The experimental sheep were first injected intradermally in the flank region
with five human doses (0.5ml) of a live attenuated Bacillus Calmette-Guerin vaccine
strain of Mycobacterium bovis (Intradermal BCG vaccine BP, Evans Medical
Limited ) as routinely performed (J. Hopkins, personal communication). After an
incubation period of 21 days, the DTH reaction was initiated by an intradermal
injection of a PPD of Mycobacterium bovis (Central Veterinary Laboratories,
Weybridge). A volume of 0.1 ml of PPD, equivalent to 0.01 mg of precipitable
tubercular protein or 2500 international units of activity (assessed against an
international in vivo assay utilising guinea pigs and cattle), was injected at selected
sites in the medial thigh of each sheep. Standardisation was achieved via the use of a
perspex template and spray marker to outline the injection areas; the precise point of
injection being marked with a spot of permanent black ink. Contralateral control
injections using an identical volume of sterile phosphate buffered saline (PBS) were
performed in the opposite limb.
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2.5 REACTION MEASUREMENT
The double skin thickness of the elevated lesion along with that of an adjacent
unaffected portion of skin was measured using a set of measuring calipers (Camlab
Ltd. ). The increase in skin thickness of the lesion was calculated as the difference
between the two values. The diameter of the lesion was measured using the calipers.
On occasions when there was more than one lesion present at a particular time point,
all lesions were measured and an average value for these two parameters recorded.
Lesions were measured at the standard times of 2, 7, 24, 48, 72, and 96 hours post
PPD injection.
2.6 SKIN BIOPSY TECHNIQUE
The skin area surrounding the lesion selected for biopsy was first aseptically
prepared using Hibitane concentrate 5% (ICI pic, Cheshire, UK) at a dilution of 1 in
200 in 70% alcohol. The area around the lesion was then injected subcutaneously
with the local anaesthetic agent Xylocaine 1% (Astra Pharmaceuticals, Kings
Langley, UK) in order to produce a perilesional local anaesthetic 'ring-block'. An
elliptical piece of skin including the DTH reaction was then removed with standard
surgical instruments and the wound closed with stainless steel surgical staples
(Ethicon Proximate PYW35, Ethicon Ltd.).
Biopsies obtained in this manner were processed according to the particular use
to which they would be put.
Biopsies intended for standard histological investigations were placed in 4%
buffered formaldehyde solution to fix for a minimum of 48 hours. They were then
embedded into paraffin blocks in a Tissue Tek 3 embedding console, before being
sectioned at a thickness of 4 microns and placed onto standard glass slides.
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Biopsies intended for immunohistochemical staining were embedded in O.C.T
and snap frozen in a slurry of dry ice and isopentane (Tissue Tek ltd., UK). They
were maintained at -80°C in a freezer prior to being sectioned in a cryostat at -20°C
at a thickness of 6 microns and placed on slides coated with 'Biobond' tissue adhesive
(British Biocell International Ltd., UK).
Biopsies intended for RNA extraction were wrapped in aluminium foil and
snap frozen in liquid nitrogen. They were maintained in a freezer at -80°C until used
for extraction.
2.7 HISTOCHEMICAL STAINING
2.7.1 Haematoxylin and Eosin staining
Sections were initially dewaxed in a graded series of decreasing percentage
alcohols. They were then immersed in haematoxylin for one minute, washed for one
minute in running tap water, immersed in eosin for 30 seconds, washed in tap water
for one minute, and then dehydrated through a graded series of increasing percentage
alcohols before being finally cleared in xylene. The stained sections were mounted in
DPX mountant (BDH Ltd., UK) and covered with glass coverslips. This staining was
performed on a Shandon Linistainer automated staining device (Shandon Ltd., UK).
2.7.2 Martius scarlet blue stain
Sections were initially dewaxed in a graded series of decreasing percentage
alcohols and rinsed for several minutes in tap water. Subsequently, they were
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immersed in celestine blue for 10 minutes, immersed in haematoxylin for 10 minutes,
rinsed briefly in tap water, immersed in Scott's tap water substitute for 3 minutes,
rinsed in tap water for 5 minutes, rinsed briefly in 95% ethanol, immersed in 0.5%
Martius yellow in 95% ethanol with 2% phosphotungstic acid for 2 minutes, rinsed
briefly in tap water, immersed for 15 minutes in 1% brilliant crystal scarlet 6R in
2.5% acetic acid, rinsed briefly in tap water, immersed in 2% phosphotungstic acid
for 2 minutes, rinsed briefly in tap water, immersed in 0.5% soluble blue in 1% acetic
acid for 4 minutes, rinsed briefly in tap water, and finally dehydrated through a
graded series of increasing percentage alcohols, cleared in xylene and mounted in
DPX mountant with a glass coverslip placed on top.
2.7.3 Toluidine blue staining
Sections were initially dewaxed in a graded series of increasing percentage
alcohols and rinsed in tap water. They were subsequently immersed overnight in a
0.5% toluidine blue in 0.5N HC1 solution, rinsed briefly in distilled water, rinsed
briefly in 0.125N HC1, immersed briefly in isopropanol, cleared in xylene and finally
mounted in DPX mountant with a glass coverslip.
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2.8 IMMUNOHISTOCHEMICAL STAINING
2.8.1 Monoclonal antibodies utilised
The monoclonal antibodies utilised and their specificities are incorporated in
the following table.
Code name Specificity Dilution Reference
SBU-T4 Ovine CD4 1:1000 (Maddox et al. 1985)
SBU-T8 Ovine CD8 1:1000 (Maddox et al 1985)
86D Ovine yd T cell 1:1000 (Mackay et al 1989)
receptor
SW73.2 Ovine pan MHC 1:100 (Hopkins et al.
class II 1986)
VPM63 Ovine Fey receptor 2 1:100 Gupta (personal
(macrophage) communication)
VPM65 Ovine CD 14 1:100 Gupta (personal
(macrophage) communication)
OM1 Ovine CD1 lc 1:100 (Gupta etal. 1993)
(macrophage)
DU2.87 Ovine B cells 1:100 (Gupta et al. 1994)
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2.8.2 Stain development
A 'Vectastain Elite ABC Kit' (Vector Laboratories Inc., Burlinghame, USA)
immunohistochemical stain development kit was used to demonstrate the monoclonal
antibody staining of the tissue sections, and all the reagents (with the exceptions of
the antibodies and phosphate buffered saline) used were supplied as part of the kit.
Firstly, the cryostat sections were air dried for 2 hours at ambient room
temperature, immersed in acetone for 5 minutes at 4°C in order to fix the tissue, air
dried at ambient room temperature for 5 minutes, and then washed three times for 5
minutes in 5 mis of pH7.3 PBS at room temperature. Subsequently, lOOpl of 1.5%
normal horse serum was placed on the section for 15 minutes at room temperature. A
lOOpl volume of the appropriate monoclonal antibody at the appropriate dilution was
then added to the section, and the slides were incubated for 12 hours at 4°C. The
slides were subsequently washed three times for 5 minutes in 5 mis of PBS at room
temperature, before lOOpl of biotinylated link antibody (of suitable species
specificity for the primary monoclonal antibody) was added for 30 minutes at room
temperature. This was followed by a further three washes for 5 minutes in 5 mis of
PBS at room temperature, before the addition of lOOpl of a 0.3% solution of
hydrogen peroxide in methanol for 30 minutes at room temperature. Three further
washes for 5 minutes with 5 mis of PBS at room temperature followed, with the
subsequent addition of 100 pi of ABC (avidin-biotin complex) enzyme linked
reagent for 30 minutes at room temperature. A final three washes for 5 minutes with
5 mis of PBS were then performed, with lOOpl of the enzyme reagent 3-amino 9-
ethylcarbazole (AEC) being added for 10 minutes at room temperature. The slides
were then washed with copious volumes of tap water, counterstained with
haematoxylin for 45 seconds, washed again in tap water, immersed in Scott's tap
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water substitute for 1 minute and finally rinsed in tap water. The slides were mounted
in Immumount reagent (Shandon Ltd.) with standard glass cover slips. Relevant
control sections with either no antibody or irrelevant antibody added were
simultaneously developed.
2.9 FLOURESCENCE ACTIVATED CELL SORTING (FACS)
ANALYSIS OF CIRCULATING LYMPHOCYTES
2.9.1 Collection of peripheral blood
Peripheral blood was collected from the jugular vein using a 'vacutainer' system
into a tube containing lithium heparin anticoagulant (Becton Dickinson and Co.,
Rutherford, USA).
2.9.2 Preparation and staining of cells
Ten mis of the heparinised blood were mixed with a red blood cell lysis buffer
(Appendix 2.9.2) that had been prewarmed to 37 °C. This was incubated for 5
minutes at RT, and then centrifuged at 450x g for 5 minutes at RT. The lysed red
blood cells in the supernatant were decanted, and the cell pellet resuspended in 50mls
of an ice cold solution of a wash buffer solution containing PBS, bovine serum
albumin, heparin and sodium azide (Appendix 2.9.2). The cell suspension was then
recentrifuged at 450x g for 5 minutes to repellet the cells. This last step was then
repeated, before the cells were finally resuspended in 10 mis of the buffer solution.
The concentration of cells in the resultant suspension was measured in a
haemacytometer, and adjusted to be in the range of 2-4x10^ ml"L
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A 50(_tl aliquot of this cell suspension (equivalent to lxl 0^ cells) was added to
a microcentrifuge tube, and 25pl of the monoclonal antibody at a dilution of 1:250 in
PBS was added. A single tube was left without any monoclonal stain as a negative
control, and to provide samples for 'gating' the FACS machine. This mixture was
incubated at 4°C for 15 minutes, and then centrifuged at 450x g for 5 minutes. The
supernatant liquid was decanted, and the cells resuspended in 400pl of the wash
buffer solution, before being recentrifuged at 450x g for 5 minutes. This latter
washing stage was repeated, before 25pl of a 1:1500 dilution of FITC conjugated
anti-mouse IgG, A and M (The Binding Site, Birmingham, UK), was added to the
tube and the cells resuspended. This cell suspension was incubated for a further 15
minutes at 4°C, before undergoing a further two washes as before. The cells were
finally resuspended in 400pl of wash buffer and analysed in the FACScan
instrumentation.
2.9.3 FACS analysis
FACS analysis was performed using a Becton Dickinson FACScan apparatus,
running Consort 30 software (Becton Dickinson Immunocytometry system, Oxford,
UK). Initially, a control unstained sample of cells was run through the machine in
order to visualise the forward and side scatter characteristics of the total cell
population. From this total profile, the cell population corresponding to the
lymphocyte population was selected , and a 'gate' manually set surrounding this
population. The details of the gate setting were recorded, and used for all analyses.
Once the gate was set, samples were run through the machine with an appropriate
fluorescence detector in operation to detect the population of cells that exhibited
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positive staining with the monoclonal antibody. Data was analysed using the Consort
30 software package.
2.10 LUNG PATHOLOGY
2.10.1 Post mortem technique
Animals which were used for postmortem studies were euthanased with an
intravenous injection of pentobarbitone sodium BP (Lethobarb, Solvay-Duphar
Veterinary, Southampton, UK) and immediately exsanguinated by sectioning the
axillary blood vessels. A full routine post mortem examination was performed, and
the lungs removed from the carcase, ensuring that the pleural membranes were left
intact. The heart was dissected free from the pluck, and the isolated trachea and lungs
were weighed. The left lung was then routinely fixed by the positive pressure airway
instillation of phosphate buffered 4% paraformaldehyde, with a head pressure of 30
cm of paraformaldehyde applied until the tissue was completely fixed.
2.10.2 Sample selection
In order to provide standardised samples for the microscopic evaluation of the
degree of lung pathology, a system of routine sampling was utilised. The
diaphragmatic lobe of the fixed lung tissue was sectioned in the mid caudal area to
produce an approximately 1cm thick slice. Four lcm^ sections were then dissected
from this slice in four anatomically distinct areas - 1. the dorsolateral parenchyma, 2.
the ventral parenchyma, 3. the mediodorsal parenchyma, 4. the peribronchial region
(Figure 1)
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Figure 1. Indication of the standard sampling sites of the fixed lung
These samples were then embedded in wax, sectioned and
haematoxylin and eosin in an identical manner to that described for the
(sections 2.6 and 2.7).
2.10.3 Quantification of lung pathology
The degree of pathological change present in the lungs of both MVV infected
and control sheep was independently assessed subjectively by two experienced
pathologists, with the slides being read in an observer blinded manner. The degree of
interstitial reaction and smooth muscle hyperplasia were graded subjectively, being
assigned a numerical value between 1 and 5, with the number of follicle like





2.11 ANTI-PPD ANTIBODY EVALUATION
2.11.1 Production of hyperimmune ovine anti-PPD serum
A control Texel sheep, that was normal on clinical examination, was used to
produce hyperimmune anti-PPD serum. Firstly, a mixture of lmg (equivalent to 1ml)
of PPD and 1ml of complete Freund's adjuvant (Sigma-Aldrich Company Ltd.,
Dorset, England) were thoroughly mixed by repeated passage through a fine bore 23
gauge hypodermic needle attached to a syringe. The resultant homogenate was
halved, and each half being injected into a separate site on the dorsal subcutis of the
sheep. After a period of 4 weeks, a similar homogenate of 1ml of PPD in 1ml of
incomplete Freund's adjuvant (Sigma-Aldrich Company Ltd., Dorset, England) was
prepared and injected in two equal injections into distinct sites in the dorsal subcutis
of the sheep. After a period of 2 weeks blood was collected from the sheep into
sterile plain vacutainer tubes (Becton Dickinson and Co., Rutherford, USA). This
blood was allowed to clot and then centrifuged at 2000rpm for 10 minutes to separate
the serum, the resultant supernatant serum being harvested using a pipette and stored
at -20°C prior to usage.
2.11.2 Negative control serum
As there are cross reactive epitopes between many Mycobacteria that sheep are
normally exposed to in the environment and the BCG vaccine strain, negative control
serum had to be obtained from an immunologically naive animal. Serum was




Firstly, lOOpl per well of PPD antigen at a concentration of lOpg/ml of protein
in PBS (equivalent to a dilution of 1 part PPD to 100 parts PBS/0.01% azide ) was
added to the wells of a 96 well, flat-bottomed, 'Immulon 1' ELISA plate (Dynatech
Laboratories Inc., Chantilly, USA). The loaded plate was then wrapped tightly in
aluminium foil and incubated for 12 hours at 4°C. The plate was subsequently
washed vigorously three times in 4 litres of PBS containing 0.1% of tween 20. The
test serum was then sequentially diluted with PBS containing 2% crystalline grade
bovine serum albumin (BSA) (Sigma-Aldrich Company Ltd., Dorset, England) to
produce a serum dilution series of 1/50, 1/100, 1/200, 1/400, 1/800, 1/1600, 1/3200,
triplicate 75pl aliquots of each dilution added to the wells of the plate, with positive
and negative controls. The plate was subsequently wrapped tightly in foil and left at
room temperature for 30 minutes. This was followed by a further three vigorous
washes in the PBS/0.1% tween mixture. Next, lOOpl of alkaline phosphatase labelled
anti-sheep IgG conjugate (Sigma-Aldrich Company Ltd., Dorset, England) diluted at
1:1000 in PBS/BSA2% was added to the test wells and incubated for 30 minutes at
room temperature. The plate was then washed vigorously thrice in the PBS/0.1%
tween solution. The enzyme substrate for the conjugated alkaline phosphatase was
then freshly prepared immediately before use (Appendix 2.11.3). A 1 OOjul quantity of
this mixture was added to the test wells, and the plate was incubated at 37°c for 30
minutes and subsequently at room temperature until a noticeable colour change was
apparent. The colour change was then quantified using an ELISA plate reader with a
405 nm filter in place.
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2.11.4 Western blotting protocol
The initial stage of the western blotting technique was the separation of the
PPD antigen into its protein constituents using a gradient SDS polyacrylamide gel
electrophoresis (SDS-PAGE). This was performed using a Mini protean II
electrophoresis apparatus in the following manner.
Firstly, all the glass plates and spacers were wiped with ethanol to remove all
traces of grease and dirt. The plates, with interposed spacers, were located into the
casting clamp and the gel solutions were freshly prepared (Appendix 2.11.4). A
gradient gel pourer was then used to produce a continuous gradient gel, with the
concentration of the gel passing from 5 to 20 %. Water was then gently overlaid over
the gels using a pipette to fill the plates. The gels were left to set, at which point the
overlay water was removed by inversion and blotting with filter paper. The freshly
prepared stacking gel was then layered over the gradient gels with a pipette and an
appropriate gel comb placed in position and left until the gel was set.
The PPD and a protein molecular weight marker were then prepared for
running in this gel by mixing 1:1 with SDS dissolving buffer (Appendix 2.11.4). The
resultant mix was then placed in a boiling water bath for 3 minutes.
The set gels were placed in a tris/EDTA/glycine/SDS running buffer (Appendix
2.11.4). The samples were loaded onto the gel using a Hamilton syringe, and the gel
was run at 200V / 90mA until the dye had passed down the entire length of the gel
The gel was then removed from the apparatus in order that the proteins could
be blotted onto a 'Hybond C' nitrocellulose membrane
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First, the Tris/glycine/methanol blotting buffer was freshly prepared (Appendix
2.11.4), Four sheets of 'Whatman no.3' filter paper were soaked in this buffer and
layered on the lower plate of a semi-dry electrophoresis apparatus (Anchos Ltd.,
UK), with a buffer soaked piece of nitrocellulose membrane placed on top. The
stacking component of the gel was removed using a scalpel blade, and the gel was
placed on top of the membrane, with the lane in which the marker was run clearly
marked. A further four pieces of soaked 'Whatman no. 3' filter paper were placed on
top of this gel. The upper plate of the apparatus was fitted, and an electric current of
120mA / 30V was applied for 2 hours. The nitrocellulose membrane was then
removed from the apparatus. The marker lane cut off the membrane and stained with
amido black stain for several minutes until clear bands were obvious, and
subsequently destained in 50% methanol / 5% acetic acid to clear the background
stain.
The remaining section of the membrane was placed in a PBS / 3% BSA
solution, and agitated for one hour on an orbital shaker in order to block all protein
binding sites. The membrane was then sectioned into strips, suitably sized to fit into
a multichannel dish. The strips were appropriately marked, and then placed in a
channel of the dish which contained the corresponding sheep serum which had been
diluted 1:200 in PBS / 3% BSA. The dish was sealed with cling film and agitated for
12 hours at room temperature on an orbital shaker. The strips were subsequently
washed thrice in situ with a PBS / 0.5% tween solution and then placed together into
a staining jar.
A 1:1000 dilution of alkaline phosphatase conjugated anti-sheepIgG antisera
(Sigma-Aldrich Company Ltd., Dorset, England) added, and were placed on an
orbital shaker for 1 hour at room temperature. The strips were then washed three
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times in PBS / 0.5% tween for 10 minutes on an orbital shaker at room temperature,
and then immersed in 1M Tris pH9.5 for 10 minutes on an orbital shaker at room
temperature.
The antibody binding was visualised by adding an alkaline phosphatase
substrate ('sigma fast' tablets, Sigma-Aldrich Company Ltd., Dorset, England) to the
strips until the colour reaction had developed At this point the reaction was stopped
by flushing with copious amounts of tap water. The strips were dried with tissue
paper and preserved in a darkened environment.
2.12 TISSUE RNA EXTRACTION
2.12.1 General handling procedures
The isolation of RNA suitable for reverse transcription and subsequent
polymerase chain reaction (RT-PCR) is complicated by the fact that RNA is a
relatively unstable molecule which is irreversibly degraded by the enzyme RNAase
that is ubiquitously present on human skin, and by the fact that PCR is an extremely
sensitive technique which detects such small quantities of nucleic acids that
contamination and false positive results are major risks.
To combat these potential problems, all manipulations involving RNA were
performed in a laminar flow hood, whilst wearing rubber gloves that were frequently
changed, using new filtered pipette tips (Biorad Laboratories, Hercules, USA) for
each sample, with disposable plastic labware or thoroughly cleaned and sterilised
equipment, and with reagents specially prepared to be free from RNA and DNA
degrading enzymes. To further prevent cross contamination, the isolation of RNA
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and conversion of this into copy DNA (cDNA) were performed in a geographically
distant laboratory from that in which the PCR of the copy DNA was performed, with
no PCR product material being transferred back into the isolation and transcription
laboratory.
2.12.2 RNEasy extraction
RNA was extracted from the tissue samples using an 'RNEasy' commercial
RNA isolation kit (Qiagen Inc., Chatsworth, USA) according to the protocol supplied
with the kit. Firstly, lOpl of P-mercaptoethanol was added per ml of the lysis buffer
to prepare the buffer for use. A 600pl aliquot of this buffer mixture was placed in a
sterilised tissue homogeniser which had been maintained at 0°C in ice, the tissue
sample was removed from -70°C storage, and the tissue was immediately placed into
the lysis buffer and homogenisation undertaken until the sample had been completely
macerated. The resultant lysate was decanted into a microcentrifuge tube and
centrifuged at 8000 x g for three minutes to remove tissue fragments. The
supernatant was collected and mixed with an equal volume of 70% ethanol. This
mixture was pipetted onto the RNEasy spin column, which was subsequently
centrifuged for 15 seconds at 8000 x g. The flow through was discarded, 700pl of the
wash buffer was pipetted onto the column, and the column was recentrifuged at 8000
x g for 15 seconds. A new 2 ml collection was fitted to the column, before 500pl of a
working solution of 1 part wash buffer to 4 parts 100% ethanol was pipetted onto the
column, which was recentrifuged at 8000 x g for 15 second. This wash was repeated,
with the centrifugation prolonged to 2 minutes in order to dry the column. A new
collection tube was then fitted and 15pl of RNA-ase free, sterile, distilled, tissue
culture water (Sigma-Aldrich Company Ltd., Dorset, England) was pipetted onto the
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column, before centrifugation at 8000 x g for 60 seconds. The flow through solution




A reverse transcription mix was freshly prepared, taking care to maintain the
temperature of the RT superscript below 0°C (Appendix 2.13.1).The isolated RNA
was added to this mix in an eppendorf tube, mixed thoroughly and maintained at
room temperature for 10 minutes. The tubes were then incubated for 60 minutes in a
water bath maintained at 42'C. The RT reaction was then terminated by incubating
the tubes for 5 minutes in a dry heating block maintained at 95°C. The tubes were
then immediately plunged into ice and the cDNA stored at 4°C until required for the
PCR reaction.
2.13.2 PCR protocol
The PCR reaction mix was prepared (Appendix 2.13.2). A 36.5pl volume of
this mixture was then aliquoted into 0.5ml tubes and a drop of mineral oil (Sigma-
Aldrich Company Ltd., Dorset, England) added as an overlay. A 3pl volume of the
cDNA was subsequently pipetted into the reaction mix beneath the oil layer.
These reaction tubes were then transferred to a separate laboratory in order to
minimise future contamination risks. The tubes were placed in a dry heating block
(Techne PHC 1) where they were heated at 95°C for 5 minutes, after which the
temperature was rapidly reduced and maintained at 80°C. A 0.3pl volume of TAQ
polymerase (Gibco BRL, UK) was then added to each sample beneath the oil layer.
The samples were then thermally cycled in a PCR thermal cycler (Techne
PHC1) on a programme that had been temperature optimised for the particular cDNA
molecule and primers being amplified. The cycle consisted of 35 cycles of a cycle
consisting of: 95°C for 1 minute, 55°C for 1 minute, 72°C for 2 minutes, with a final
extension phase of 72°C for 5 minutes.
2.13.3 Gel electrophoresis of PCR products
The PCR products were separated by an ethidium bromide/agarose gel
electrophoresis method.
The gel was run in a TAE buffer, which was mixed as a 50 x concentrate
(Appendix 2.12.3). Ten mis of this stock solution was diluted in 500 mis of distilled
water immediately prior to use.
A 50 ml aliquot of this buffer was placed in a vessel with lg of agarose and
heated in a microwave oven to produce a clear solution. This was allowed to cool to
approximately 50°C, and then 2.5pl of ethidium bromide was mixed into the solution
before pouring into a adhesive tape sealed, ethanol cleaned gel trough, which was
then left until the gel had cooled and hardened. Meanwhile, 22.5 microlitres of
ethidium bromide were added to the remainder of the diluted running buffer.
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Seven pi of the PCR product were then mixed with a loading buffer, taking
care to that mineral oil was not included in the sample. A DNA ladder marker was
simultaneously mixed with the loading buffer.
The samples were then added to the wells in the submerged gel and the gel run
at 50mA for about 30 mins, at which point the coloured sample front had migrated
approximately half way along the gel. The gel was then viewed with ultraviolet
illumination and photographed, before undergoing southern blotting.
2.14 SOUTHERN BLOTTING AND DNA PROBING
2.14.1 Southern blotting protocol
The run gel was first washed in a 0.4M NaOH solution for 30 minutes on an
orbital shaker. A gel sized piece of 'gene screen plus' nylon membrane (DuPont,
Massachusetts, USA) was placed in distilled water, to which was added a small
quantity of the NaOH solution, and the membrane was left to soak for 15 minutes at
room temperature.
The blotting was performed in the minigel apparatus that had been used to run
the gel, and 'Whatman no.4' filter paper was cut to provide one piece that had ends
dipping into the gel tank troughs and 6 pieces that were the size of the gel. The larger
piece and one or the other pieces of filter paper were soaked in 0.4M NaOH and
placed in the gel tank. The washed gel was placed upside down on this filter paper,
and the membrane placed on the upturned gel. Three further pieces of 0.4M NaOH
soaked filter paper and two pieces of dry filter paper were added, followed by a large
quantity of folded tissue paper. To complete the system, a flat glass plate was placed
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on top of the entire apparatus and a large weight positioned on top of this plate. The
gel tank troughs were then filled with 0.4M NaOH the apparatus was left for 12
hours at room temperature.
The membrane was then removed from the apparatus, and washed twice in an
2xSSPE buffer diluted 1:10 from a stock solution (Appendix2.14.1): The membrane
was then placed on filter paper and crosslinked using an automatic programme in an
ultraviolet crosslinking machine. The membrane was subsequently dried at room
temperature, and stored in the dark in folded filter paper.
2.14.2 Radiolabeled oligonucleotide probing
The oligonucleotide specific for the internal sequence of the PCR product
being probed was firstly radiolabeled with 32p isotope using a polynucleotide kinase
(PNK) enzyme to transfer this molecule from an ATP molecule to the
oligonucleotide (Appendix 2.14.2). The unbound radioactive ATP molecules were
then removed from the reaction mix using a sephadex column (Nick column,
Pharmacia LKB Biotechnology, Uppsala, Sweden). The column was first primed
with TRIS-EDTA (TE) buffer at pH 7.4 (Appendix 2.14.2), before the PNK reaction
mix was added and the radiolabelled oligonucleotide eluted by the addition of a
further 400pl aliquot of TE buffer. The purified probe was then used in the
hybridisation mix.
The hybridisation buffer solution required for probing were freshly prepared
(Appendix 2.14.2).
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The southern blotted membrane was placed in the chamber of a hybridisation
machine (Techne hybridiser HB-1) with 50mls of 2xSSPE and revolved to remove
bubbles. This solution was decanted and 20mls of hybridisation buffer was added
and rotated for 30 minutes at 65°C. This solution was then decanted and a further
lOmls of hybridisation solution was added to the chamber before lOOpl of the
radiolabeled probe was added to this solution. The chamber was then left to rotate
for 12 hours at 65°C. The membrane was then washed twice with 20 mis of 2xSSPE
for 5 minutes at room temperature, before being washed twice with 30 mis of
2xSSPE+l%SDS for 20 minutes at 60°C. Finally the membrane was washed in
O.lxSSPE at room temperature for 20 minutes before being wrapped in PVC film and
left next to an X ray film in an X ray cassette for a variable period dependent upon
the level of radioactivity present on the membrane as detected by a Geiger-Muller




CHARACTERISATION OF THE NORMAL OVINE DTH
REACTION
3.1 INTRODUCTION
There are relatively few previously published studies of the immunohistological
characteristics of the PPD driven DTH reaction in any species, and no previously
published work of this type in the sheep, although the reaction has been generated in
sheep experimentally (Myer et al. 1988; Emery, Davey, 1995).
The purpose of this initial experiment, therefore, was to characterise the normal
immunohistological characteristics of a classical tuberculin induced DTH using an
ovine model. These data will provide the normal baseline for the studies into
abnormal DTH responses that have been reported to occur in sheep infected with
MVV (Myeret al. 1988).
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3.2 MATERIALS AND METHODS
3.2.1 Animals
Six adult female sheep were used in this preliminary study (table 1). They were
obtained from commercial sources, and were clinically normal. They were tested as
serologically free from MVV infection using the AGIDT described previously (2.2).
Table 1
Sheep Number Breed Age (years) Sex
111 Finn x 2 Female
114 Finn x 2 Female
142 Greyface Aged (>5) Female
143 Greyface Aged (>5) Female
144 Greyface Aged (>5) Female
145 Greyface Aged (>5) Female
3.2.2 DTH initiation, measurement, and biopsy
The DTH was initiated, measured, and biopsied in the standard manner
described in 2.4 - 2.6.
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3.2.3 Immunohistopathological staining
Routine paraffin embedded sections were processed and stained with
haematoxylin and eosin and toluidine blue as described in chapter 2.
Frozen sections were processed as described in chapter 2 and stained with
monoclonal antibodies SBU-T4 (CD4), SBU-T8 (CD8), 86D (y8 T cell), DU2.87 (B
cell) and OM-1 (CD1 lc, macrophage) (chapter 2).
3.2.4 Quantification of the sections
Initially, a histopathological assessment of the H&E sections was undertaken.
This indicated that the infiltrating cells were concentrated in the periadnexal areas,
with a diffuse infiltration of the superficial dermis. In order to successfully quantify
this infiltration, a wholly random pattern of counting was not suitable, as there were
distinct areas of concentrated cellular accumulation. It was therefore decided to count
the two distinct areas of accumulation separately for each section, in a modification of
a previously described method (Bos et al. 1987). This was achieved using a 10x10
square graticule (Graticules Ltd., Tonbridge, Kent) fitted to the eyepiece of a
microscope, with the sections appraised at x200 magnification. The first stage in this
process was the selection of an adnexal structure, which was then centred in the field
of view of the microscope. Ten randomly chosen squares located at the periphery of
the adnexal structure were then selected and the total number of cells of interest
within or with borders touching the lower and right hand grid line of these ten squares
was then counted. This count was repeated four times, which commonly constituted
the maximum number of adnexal structures present on each section. The second stage
of this counting was the counting of cells in the superficial dermis. In order to achieve
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this, an area of superficial dermis was selected and the total number of cells of interest
within or with borders touching the lower and right hand grid line of ten randomly
chosen squares was then counted. This count was repeated four times (Figures 3.1 and
3.2).
Figure 3.1 The periadnexal count was performed by moving the slide to
centralise the grid over an adnexal structure, Ten of the squares which were judged to
be adjacent to the adnexal structure (as indicated) were selected using a random
number table, and the total number of cells of interest within these squares were
counted.
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Figure 3.2 The superficial dermal cell count was performed by placing the grid over
this area and selecting 10 squares using a random number table, The number of cells
in these squares was counted, and the process repeated for a total of four counts.
A consistent finding for all types of cells counted in this manner was a
significant correlation (using a Spearman ranking statistic) between the superficial




There was a marked reddened indurative swelling associated with the PPD
injection site. This was maximal at 48-72 hours post injection, and was remarkably
consistent between the sheep (Figure 3.3 and Appendix 3.3.1).
Figure 3.3
Increase in skin thickness at time points
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3.3.2 Histopathological assessment
Considering firstly the biopsies taken of the PPD antigen injected sites, the early
2 hour biopsy exhibited a mild dermal oedema with few PMNs marginating in the
superficial dermal blood vessels of some animals (Figure 3.4). By seven hours, the
marginated PMNs were present in all the biopsies examined, and there was migration
of some of these PMNs into the perivascular spaces. Superficial dermal oedema was
less marked (Figure 3.5). At the 24 hour time point, the reaction had become much
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more florid, with a marked increase in cell density. The cells were primarily PMNs,
but there was a significant increase in the number of lymphohistiocytic and fibroblast
type cells. The reaction was mainly centred on the periadnexal structures, with a more
diffuse superficial dermal infiltration. Superficial dermal oedema was evident, and
fibrin was present in between the dermal collagen bundles (Figure 3.6). At the 48 hour
time point, the number ofPMN cells was markedly reduced, with an apparent increase
in the number of cells of lymphoid morphology. Fibrin was present in the superficial
dermis at high levels, and tissue oedema was marked, with dermal lymphatics
becoming dilated with proteinaceous fluid. In several biopsies at this time point, there
were large numbers of PMNs packed into the luminae of hypertrophic sweat glands.
The cellular reaction remained centred on the periadnexal areas. The overlying
epidermis frequently exhibited mild inter and intracellular oedema, although there
were very few inflammatory cells present in this compartment (Figure 3.7). The
reaction remained largely unaltered at the 72 hour time point (Figures 3.8 & 3.9). By
the 96 hour biopsy, the reaction was becoming less cellular, with a decrease in
oedema and fibrin levels. The cellular components remained at the same relative
levels, with a mainly lymphoid cell component (Figure 3.10).
Biopsies taken from the control (PBS injected) sites, exhibited an early mild
dermal oedema. There was no apparent cellular infiltrate present in any of the time
course biopsies.
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Figure 3.4: Photomicrograph of a 2 hour biopsy of the PPD lesion.. There are
few cells in the dermis, with no evidence of infiltration. There is slight
separation of the dermal fibres indicating a mild oedema associated with the
injection of PPD (H&E, xlOO).
Figure 3.5: Photomicrograph of a 7 hour biopsy of the PPD lesion. There is
still no widespread infiltration of the dermis, although blood vessels are
more prominent and contain large numbers of marginating PMNs that are
clearly visible on the inset photograph (H&E, xlOO with inset x400).
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Figure 3.6: Photomicrograph of a 24 hour biopsy of the PPD lesion. A
marked dermal cell infiltration is apparent, especially concentrated around
the adnexal structures. Most of these cells are PMNs. Dermal oedema and
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Figure 3.7: Photomicrograph of a 48 hour biopsy of the PPD lesion. There is
a more marked dermal infiltration. These cells are of lymphoid morphology.
Dermal oedema, proteinaceous fluid accumulation and swollen lymphatics
are present. (H&E, xlOO).
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Figure 3.8: Photomicrograph of a 72 hour biopsy of the PPD lesion. At low
power the concentration of infiltrating cells in a periadnexal position is
clearly apparent. (H&E, x40).
Figure 3.9: Photomicrograph of a 72 hour biopsy of the PPD lesion. At
higher power, cells are seen at a similar density to that in the 48 hour biopsy.
A majority of these cells are of lymphoid type. Swollen lymphatics and
dermal oedema are also apparent. (H&E, xlOO).
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Figure 3.10: Photomicrograph of a 96 hour biopsy of the PPD lesion. Cell
numbers and dermal oedema are beginning to subside by this time point. A
majority of these cells are of lymphoid morphology (H&E, xlOO).
3.3.3 Polymorphonuclear neutrophil cell counts
In the antigen injected sites, the number of PMNs increased markedly in the
early part of the reaction, reaching a maximal level at 24 hours post injection. This
peak was followed by a dramatic decline in numbers to a figure of approximately
half of this peak level by 48 hours post challenge. The numbers remained almost
constant at the 72 hour time point, before declining to almost baseline levels by 96
hours post injection (Figures 3.17 and 3.18, Appendix 3.3.3).
The number of PMN cells in the control (PBS injected) remained unchanged
throughout the time course of the study period (Figures 3.17 and 3.18, Appendix
3.3.3). Occasionally, small congregations of PMNs were seen surrounding a linear
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track of tissue disruption. This was considered to be a non specific reaction to a
'needle-track' injury.
3.3.4 CD4+ cell counts
In the antigen injected sites, the number of CD4+ cells increased marginally at
24 hours post injection, before rising to an almost maximal level at 48 hours post
challenge. This level increased slightly to become maximal at the 72 hour time point,
before declining marginally at 96 hours post challenge. The maximal number of
CD4+ cells in the lesion was approximately half that of the maximal number of PMN
cells (Figures 3.11, 3.12, 3.19, and 3.20, Appendix 3.3.4).
There were no significant changes in the CD4+ cell counts in the control (PBS
injected) biopsies (Figures 3.19 and 3.20, Appendix 3.3.4).
Figure 3.11: Photomicrograph of a 24 hour biopsy of the PPD lesion stained
with a monoclonal antibody to CD4+ (SBU-T4). A moderate number of
positively cells are present, concentrated in the periadnexal area (AEC,
x250).
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Figure 3.12: Photomicrograph of a 48 hour biopsy of the PPD lesion stained
with a monoclonal antibody to CD4+ (SBU-T4). A much greater number of
cells are present in the dermis, and a majority of these are positively stained.
The cells are concentrated in the periadnexal area (AEC, x250).
3.3.5 CD8+ cell counts
In the antigen injected sites, the kinetics of appearance of CD8+ cells was very
similar to those of the CD4+ cells, although the number of CD8+ cells was
approximately half that of the CD4+ cells. The CD8+ cell numbers rose slightly at 24
hours, and then markedly to reach maximal levels at 48 hours post challenge. The
numbers then remained relatively constant throughout the rest of the time course
(Figures 3.13, 3.14, 3.21 and 3.22, Appendix 3.3.5).
The control (PBS injected) biopsies exhibited no significant change in CD8+
cell numbers (Figures 3.21 and 3.22, Appendix 3.3.5).
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Figure 3.13: Photomicrograph of a 24 hour biopsy of the PPD lesion stained
with a monoclonal antibody to CD8+ (SBU-T8). There are relatively few
positively staining cells, and these are concentrated perivascularly. (AEC,
x250).
Figure 3.14: Photomicrograph of a 48 hour biopsy of the PPD lesion stained
with a monoclonal antibody to CD8+ (SBU-T8). There is an increased
number of positively staining cells, and these are concentrated in the
periadnexal area. (AEC, x250).
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3.3.6 Gamma delta cell counts
Gamma delta T cells were present at relatively low levels in the skin biopsies of
both antigen and control (PBS) injected sites. A marginal rise in the gamma delta cells
was noted in the biopsies taken from the sites injected with PPD antigen, with levels
peaking at 72 hours post injection (Figures 3.23 and 3.24, Appendix 3.3.6).
No alteration in gamma delta cell counts were apparent in the control (PBS
injected) biopsy material (Figures 3.23 and 3.24, Appendix 3.3.6).
3.3.7 Macrophage cell counts
Macrophages were present at relatively low levels in the normal skin. In the
antigen injected sites, numbers remained static until the 7 hour time point, after which
point numbers were reduced markedly to a level at which macrophages were not
evident in several sections, with numbers remaining at this low level throughout the
time course (Figures 3.15, 3.16, 3.25 and 3.26, Appendix 3.3.7).
The numbers of macrophages counted in the control (PBS injected) biopsies
remained relatively constant throughout the time course (Figures 3.15, 3.16, 3.25 and
3.26, Appendix 3.3.7).
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Figure 3.15: Photomicrograph of a 24 hour biopsy of the PPD lesion stained
with a monoclonal antibody defining macrophages (OM1). There are a small
number of cells positively stained in the periadnexal region (AEC, x250).
Figure 3.16: Photomicrograph of a 48 hour biopsy of the PPD lesion stained
with a monoclonal antibody defining macrophages (OM1). There are no
positively stained visible in the section (AEC, x250).
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3.3.8 MHC class II expression
The pattern of MHC class II expressing cell counts was very similar to the
pattern of macrophage cell counts, with the number of cells expressing MHC class II
constituting a relatively low proportion of cells in the reaction. Numbers were similar
to control biopsies in the early reaction, and then declined at 24 hours becoming, and
remaining, almost negligible by the 48 hour time point (Figures 3.27 and 3.28,
Appendix 3.3.8).
There were no apparent alterations in the number of MHC class II expressing
cells in the control (PBS injected) biopsies (Figures 3.27 and 3.28, Appendix 3.3.8).
3.3.9 Mast cells and basophils
Mast cells and basophils were only rarely noted in the biopsies examined.
3.3.10 B cells
B cells were only rarely noted in the biopsy material.
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Figure 3.17: Comparison of the periadnexal PMN
cell count following i/d injection of PPD and PBS
in sensitised sheep (median and interquartile
range indicated)
Figure 3.18: Comparison of the dermal PMN
cell count following i/d injection of PPD and
PBS in sensitised sheep (median and
interquartile range indicated)
Time post challenge (hours)
24 48 72
Time post challenge (hours)
Figure 3.19: Comparison of the periadnexal CD4+
cell count following i/d injection of PPD and PBS
in sensitised sheep (median and interquartile
range indicated)
Figure 3.20: Comparison of the dermal CD4+
cell count following i/d injection of PPD and
PBS in sensitised sheep (median and
interquartile range indicated)
Time post challenge (hours) Time post challenge (hours)
Figure 3.21: Comparison of the periadnexal CD8+
cell count following i/d injection of PPD and PBS
in sensitised sheep (median and interquartile
range indicated)
Figure 3.22: Comparison of the dermal CD8+
cell count following i/d injection of PPD and
PBS in sensitised sheep (median and
interquartile range indicated)




Figure 3.23: Comparison of the periadnexal yd
cell count following i/d injection of PPD and PBS
in sensitised sheep (median and interquartile
range indicated)
Figure 3.24: Comparison of the dermal yd cell
count following i/d injection of PPD and PBS in
sensitised sheep (median and interquartile
range indicated)
Time post challenge (hours) Time post challenge (hours)
Figure 3.25: Comparison of the periadnexal OMl +
cell count following i/d injection of PPD and PBS
in sensitised sheep (median and interquartile
range indicated)
Time post challenge (hours)
Figure 3.26: Comparison of the dermal OMl +
cell count following i/d injection of PPD and
PBS in sensitised sheep (median and
interquartile range indicated)
Time post challenge (hours)
Figure 3.27: Comparison of the periadnexal
SW73.2 cell count following i/d injection of
PPD and PBS in sensitised sheep (median
and interquartile range indicated)
Figure 3.28: Comparison of the dermal
SW73.2 cell count following i/d injection of
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3.4 DISCUSSION
The gross appearance of this particular sheep DTH reaction, consisting of an
indurative plaque of maximal size at 48-72 hours post challenge, is consistent with
that described in other species. Histopathologically, the cell type found to
predominate in the early reaction was the PMN. Previous studies have provided
controversy as to whether PMNs are present at all in DTH lesions, with some workers
reporting a high number of these cells in the early reaction (Feldman, Fitch, 1937;
Long, 1937; Follis, 1940; Dienes, Mallory, 1932; Gell, Hinde, 1951; Boughton,
Spector, 1963; Legendre et al. 1979; Piatt et al. 1983; Norris et al. 1991), and many
others failing to note the presence of PMNs at all. Many authors that describe the
presence of PMNs in the early lesion have considered them to be a non specific
reaction to tissue damage, and not a specific component of the DTH (Dienes, Mallory,
1932; Gell, Hinde, 1951; Boughton, Spector, 1963). A recent study, concentrating
specifically on PMN migration into DTH lesions, indicated that these cells were not
present in a dermal DTH reaction, although this study only evaluated biopsies at post
24 hour time points when it would appear that the PMN has become less predominant
in the lesion (Gao et al. 1994). The active contribution of the PMN to the DTH
response has been evaluated via the use of PMN depleting monoclonal antibodies in
the rat model (Kudo et al. 1993a; Kudo et al. 1993b), where it has been shown that the
depletion of PMNs at either the priming or initiation phase of a DTH type model
resulted in the markedly reduced size of the DTH and lowering of mononuclear cell
infiltration into the lesion.
The consistent finding of a relatively large number of PMNs in the early lesion
in this study would suggest that they have an important role to play in the
development of a DTH, presumably through the release of one or several of the
proinflammatory mediators which they contain. There is some evidence indicating
that PMN degranulation is indeed involved in the swelling associated with a DTH like
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response, with the level of degranulation controlled by the lymphocytes in the
reaction. There may also be a possibility that the PMNs are attracted to the site by a
mechanism that is not antigen specific, and it would have been of value to investigate
the histopathological characteristics of a PPD injection site in a non sensitised animal.
Another interesting finding of this work is the relatively low levels of
macrophages found in the reaction at the later time points. A majority of the
previously published work has not defined macrophages using monoclonal antibodies,
and in fact in most instances they are defined purely on their morphological
appearance or loosely grouped as lymphohistiocytic cells. Several studies utilising
monoclonal antibodies to study the kinetics of macrophage appearance have indicated
a considerable presence in the later lesion (Poulter et al. 1982; Konttinen et al. 1983;
Piatt et al. 1983) This has led to a situation where macrophages are commonly
considered as part of the DTH reaction. Only one previous report, using histochemical
markers for differentiating the macrophage, has indicated that macrophages decline in
numbers in the later lesion (Turk et al. 1966). This led to the consideration in this
study that the particular macrophage cellular marker against which the monoclonal
antibody was directed, was lost upon cell activation, and hence two other monoclonal
antibodies (VPM63 and VPM65) were used to stain representative biopsy samples.
The staining pattern was similar to that obtained with the OM1 monoclonal antibody.
The role of the macrophage in the initiation of the response has been previously
indicated (Torii et al. 1993), and their low levels in the later reaction would suggest
that they have trafficked away from the lesion. The most likely pathway for this traffic
would be to the local lymph node via the lymphatics, where a subsequent immune
reaction to the antigen could be stimulated. Indeed a study of the lymph node draining
the site of a DTH in the cat (Legendre et al. 1979), indicated a strong macrophage
response, and, although the source of the macrophages was not investigated, it would
seem likely that they originated from the DTH reaction.
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The relatively large contribution of the CD4+ and CD8+ cells was expected, as
these cells constitute a major part of the cell mediated immune system, and have
previously been consistently reported as being involved in the DTH response (Poulter
et al. 1982; Konttinen et al. 1983; Piatt et al. 1983; Gibbs et al. 1984). Their presence
in a ratio roughly equivalent to that reportedly found in peripheral blood (Lujan, 1994)
would suggest that the attraction of lymphocytes into the lesion is not selective to one
individual subtype. The attraction of these lymphocytes may be directed by a range of
chemoattractants, and it could be speculated that these have been released, at least in
part, by the PMNs present in the earlier lesion.
The contribution of gamma-delta cells to the classical DTH lesion has not been
previously reported, although one study of a similar contact allergy type DTH reaction
in human patients indicated that these cells were involved in the resolution rather than
the initiation of the reaction (Fujita et al. 1993). The facts, however, that gamma-delta
cells constitute a much larger proportion of circulating lymphocytes in sheep
compared to man (Hein, Mackay, 1991),and that gamma-delta cells have been
reported to be closely associated with immune responses to mycobacteria (Janis et al.
1989), suggested that they may have an important role in the ovine tuberculin DTH
reaction. The results of this study indicate that gamma-delta cells do not migrate into
the DTH lesion in any significant numbers, and suggests that they do not contribute to
the development of the lesion. The circulating levels of gamma-delta cells in sheep do
however decline with increasing age, which may have contributed to the findings.
The relatively low numbers ofmast cells and basophils is in accordance with the
work of Torii et al (1993), who indicated that the classical tuberculin response was
macrophage dependent and not reliant on mast cells or basophils.
The presence of marked levels of fibrin and oedema fluid in the reaction was
expected, and was largely responsible for the induration associated with the reaction.
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The absence of B cells was expected in a reaction that is associated with a cell
mediated immune response, and classically independent of the humoral immune
system.
In conclusion, this work has outlined the relative contributions of the major
immune cell types to the classical tuberculin reaction in the sheep. The significant
presence of the PMN in the early lesion has been shown, this clarifying the previously
disputed role of this cell in the DTH reaction. The disappearance of the macrophage in
the later lesion again clarifies an area of previous dispute, and suggests that these cells
migrate out of the later lesion, most probably to the local regional lymph node. The
low levels of gamma-delta cells in the DTH reaction has been shown, suggesting that
these cells have a relatively low contribution to the reaction. The high levels of CD4+
and CD8+ lymphocytes confirms their importance in this reaction, as would be
expected in a cell mediated immune response. A study of the levels of cell replication
occurring in these lymphocyte populations utilising a proliferation marker such as
PCNA, would have been of interest, reflecting the degree of activation and antigen
specificity of these cell populations.
Subsequent to the submission of this thesis, a similar study of the bovine
tuberculin reaction has been published, with results largely in accordance with the
above findings. The notable differences are in the findings that the bovine DTH
response has an initial significant presence of gamma-delta T cells and a subsequent
significant presence ofmacrophages. The difference in gamma-delta response may be
related to the age of the animals as discussed earlier, although the authors only
indicate the age of half the animals studied. The difference in macrophage counts may
reflect a real species difference, or may be related to the monoclonal antibody used in
the bovine study, which was not specific for the macrophage (Doherty et al. 1996).
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CHAPTER FOTJR
INVESTIGATION OF THE GROSS
CHARACTERISTICS OF THE DTH IN SHEEP
INFECTEDWITH MVV AND ITS RELATIONSHIP
WITH LUNG PATHOLOGY
4.1 INTRODUCTION
MVV is the prototype (ovine) lentivirus being closely related to the lentiviruses
infecting other species, most notably HIV (Gonda et al. 1985). MVV differs from
most related viruses in that infection is not associated with clinically recognised
immunosuppression or clear patterns of secondary opportunistic infection, although
some workers have suggested an increased susceptibility to certain ovine lung
pathogens (Myer et al. 1988; Giangaspero et al. 1993). This is suprising and contrasts
with the well recognised progressive immunosuppression and pattern of secondary
infection documented in HIV infection (Redfield et al. 1986), associated with a
declining capacity of the cell mediated immune system to respond to pathogens. This
different pattern of clinical infection may result from the fact that MVV primarily
infects cells of the monocyte/macrophage series (Gorrell et al. 1992; Lujan et al.
1994), whereas HIV also infects CD4+ cells, resulting in a declining number of these
cells in the later stages of the disease process (Redfield et al. 1986; Embretson et al.
1993).
The DTH response involves the interaction of antigen presenting cells with
antigen specific T lymphocytes (McKeever, 1994). It is commonly utilised to test the
in vivo activity of the cell mediated immune system, and has been shown to provide
an accurate indication of the capacity of this arm of the immune system to respond to
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an in vivo antigen challenge (Otto et al. 1993). It has been used extensively in the
evaluation of the immunosuppression produced by HIV infection, and is a
component of the standard Walter Reed staging classification of the progression of
HIV infection to AIDS (Redfield et al. 1986). The use of the DTH as an assessment
of the in vivo cell mediated immune response in sheep infected with MVV has been
reported previously by two groups, both of which studied the response in sheep
experimentally infected with the virus and at an early time point after infection. The
first study (Larsen et al. 1982b), found no difference in the size of the DTH response
in the sheep infected with MVV when compared to a control group, although both
groups showed variable responses. The second study (Myer et al. 1988), concentrated
on the experimental coinfection of lambs with MVV and SPA virus, and provided
limited evidence that MVV infection alone resulted in a decline in the DTH response.
This latter study remains the only documented evidence for altered in vivo immune
responses in sheep infected with MVV.
In HIV infection, the degree of depression of the DTH has been correlated with
the progression of the infection to AIDS (Redfield et al. 1986) and the decline in
number of CD4+ cells (Borleffs et al. 1991; Blatt et al. 1993). There is no equivalent
progression to a recognised immunodeficiency stage or decline in CD4+ cell
numbers (Lujan et al. 1993) in MVV infection, and the main assessment of the stage
of disease progression in infected individuals is the post mortem investigation of the
degree of pathological change present in target organs. This pathological change has
been shown to be associated with the expression of viral protein (Brodie et al. 1995),
and the degree of pathological change is therefore correlated with the level of viral
replication and viral protein expression in the individual.
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This study was undertaken to investigate the DTH response in sheep naturally
infected with MVV, in particular sheep which had been seropositive for several
years, in order to clarify whether there is a decline in DTH response in sheep
naturally infected with MVV; and, further, to investigate if there was any link
between the strength of the DTH and the level of viral multiplication as assessed by
the degree of classical MVV associated pathological changes in the lung.
4.2 MATERIALS AND METHODS
4.2.1 Animals
Five adult female sheep were used in this study (Table 4.1). They were selected
from the flock of naturally infected sheep maintained at the University of Edinburgh
Veterinary School (2.1). The sheep had all been serologically positive for MVV
infection for a considerable period of time (Table 4.1), as defined using the AGIDT
described previously (2.2).
Table 4.1: Details of the sheep used in this experiment
Sheep Number Breed Age (years) Sex Years of
seropositivity
004 Texel 4 F 2
10 Texel 9 F 4
20 Texel 7 F 4
27 Bleu de Maine 5 F 4
57 Texel 9 F 4
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4.2.2 DTH initiation and measurement
The DTH was initiated and measured in the standard manner described in 2.4 -
2.5.
4.2.3 Post mortem technique and lung sample preparation
At the conclusion of the of the DTH experiment, the sheep were euthanased
and examined at post mortem in the manner described in 2.10.1, and the lung
samples selected and prepared as described in 2.10.2. The lung specimens obtained
from these MVV infected sheep were pooled with identically treated specimens
obtained from the clinically healthy sheep used in the previous experiment (Chapter
3).
4.2.4 Lung pathology assessment
The four sections (from both the MVV infected and clinically healthy sheep)
were assessed by two independent pathologists in an observer blinded subjective
assessment (2.10.3). The total score of each parameter for the four sections was




The gross reactions in the MVV infected sheep were similar in appearance to
those produced in the control animals, consisting of a raised, reddened indurative
plaque, which was maximal at 48-72 hours post injection. There was, however, a
marked variability in the increase in skin thickness recorded in the different sheep
(Figure 4.1, Appendix 4.3.1), with a significant depression in the size of the reaction
at 24, 72 and 96 hours post injection when compared to the values obtained from the
clinically healthy sheep in the previous chapter (Figure 4.2).
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Figure 4.1
Indication of the increase in skin thickness with time
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4.3.2 Lung pathology quantification
The numerical values obtained from the subjective assessment of lung
pathology by the two independent observers were not identical. When the values
were ranked, however, there was a very strong correlation between the two
assessments for all the parameters graded (Table 4.2, Figures 4.3-4.5, Appendix
4.3.2). Classical Maedi lesions were present in several sheep, consisting of interstitial
pneumonitis, smooth muscle hyperplasia, and lymphoid follicle development
(Figures 4.6 and 4.7). There were no significant differences between the MVV and
control animals in terms of the parameter scores assessed by either pathologist,
suggesting that most of the MVV group, although seropositive, were not suffering
from advanced Maedi lesions at the time of euthanasia.
Table 4.2: Table indicating the degree of correlation between the lung
parameter assessments of the two independent pathologists (Spearman correlation
statistic)
Parameter assessed
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Figure 4.4
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4.3.4 Correlation between DTH response and degree of lung pathology
There were no significant correlations found between the scores of the three
parameters of lung pathology indicated by either pathologist, and the size of the gross
DTH response (Appendix 4.3.4).
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Figure 4.6: Photomicrograph of a representative lung section from sheep
exhibiting the classical features of Maedi pathology: interstitial pneumonitis,
smooth muscle hyperplasia, and lymphoid follicle presence. Several alveoli
contain activated macrophages (H&E, x40).
Figure 4.7: Photomicrograph of a section of lung taken from a control sheep
in an anatomically matched area to the above figure 4.6. Note the complete




This study has shown that a majority of sheep naturally exposed, and
seropositive, to MYV exhibit grossly depressed DTH responses to PPD. There is no
previously published investigation of the gross DTH in sheep naturally infected with
MVV, although these results concur with the previous work of Myer et al (1988),
who indicated a depression in DTH response size in sheep experimentally infected
with MVV. Such a depression in DTH size was not indicated in a similar
experimental infection study by Larsen et al (1982), although response size in both
the infected and control groups was variable. The finding of a depression in DTH
response size correlates with the well documented decrease in DTH response size
seen in the latter stages of HIV infection, considered indicative of progression to
AIDS (Redfield et al. 1986; Colebunders et al. 1989; Borleffs et al. 1991; Blatt et al.
1993; Birx et al. 1993; Pesanti, 1994), and a similar decrease in DTH response size
that has been reported in FIV infection (Otto et al. 1993). There is no previously
published study indicating the mechanisms responsible the depression of the DTH in
lentivirally infected individuals, although in HIV infection the relative size of the
DTH has been shown to correlate with the decline in CD4+ cell numbers that occurs
in the latter stages of the clinical disease (Borleffs et al. 1991; Blatt et al. 1993). Such
a decline in CD4+ cells is not associated with MVV infection(Lujan et al. 1993), and
therefore is not available as an explanation for the depressed DTH response.
The association of the depression in DTH response with the advanced stage of
disease is well established in HIV infection (Redfield et al. 1986; Colebunders et al.
1989; Borleffs et al. 1991; Blatt et al. 1993; Birx et al. 1993; Pesanti, 1994), and has
been indicated in FIV infection (Otto et al. 1993). The assessment of stage of disease
progression is more difficult in MVV infection as there is no recognised pattern of
secondary infection or recognised change in circulating CD4+ cell numbers. In this
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study, this assessment of stage of disease progression was made using a subjective
quantification of the degree of classical MVV pathology, this having been shown
previously to be associated with the level of viral protein expression and replication
(Brodie et al. 1995). There was no association between the scores of lung pathology
and the degree of depression of the DTH response, suggesting that the alteration in
DTH responsiveness is independent of the viral load in the host. This finding is in
agreement with an extensive study of the depression of DTH response in HIV
infected people, which investigated the depressed DTH response in conjunction with
an assessment of proviral DNA load, lymphocyte abnormality, and antiviral antihody
status indicated that the suppression in DTH response was associated with HTLV-1
infection per se, and not with viral replication or load (Welles et al. 1994). This result
is surprising considering the reported association between the depression of DTH
response and progression of HIV infection to AIDS, although the study by Welles et
al (1994) also reported that the depression of DTH was associated with changes in
the number of lymphocytes and monocytes, and hypothesised that the depression of
DTH was caused by altered cytokine production in viral carriers that leads to an
alteration in the cell populations involved in the DTH.
In conclusion, this study has shown that sheep naturally exposed to and
seropositive for MVV have significantly depressed DTH reactions when compared to
uninfected control sheep. This depression in DTH response size is independent of the
degree of classical MVV-associated pathology in the lungs of the infected sheep, and
may therefore be independent of the viral load in the infected animals. It would have




IMMUNOHISTOLOGICAL ANALYSIS OF THE
DEPRESSED DTH IN MVV INFECTED SHEEP
5.1 INTRODUCTION
The previous chapter has described the finding of a depressed DTH response in
sheep that were seropositive for MVV following natural exposure to the virus, and
indicated that the degree of depression of the DTH is variable. Furthermore, it has
shown that the degree of depression of the DTH is not associated with the degree of
pathological change in the lung.
In order to investigate this deficiency in development of the DTH further, there
is a need to characterise the immunohistological nature of the MVV associated
reduction in DTH response size, relating the decreased MVV response to that of
clinically normal control animals. The previous study of the normal ovine DTH
response (Chapter 3), indicated that the reaction was maximal at 48-72 hours post
injection, and was characterised by two main types of cellular infiltration: an initial
PMN infiltrate at 24 hours, and a subsequent CD4+/CD8+ influx at 48-72 hours post
PPD injection. The time points of 24 and 72 hours post injection were therefore
selected for evaluation of the MVV response in comparison to similar control
biopsies, with a full range of cell types being investigated using histochemical and
immunohistochemical techniques. There have been no reported equivalent studies
performed in HIV infected humans, although the depression in DTH associated with
HIV infection is a well recognised phenomenon.
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5.2 MATERIALS AND METHODS
5.2.1 Animals
Six adult female Texel sheep were selected from the MVV infected flock (2.1,
Table 5.1). All of these sheep had exhibited a persistent serological response to MVV,
as defined using a standard agar gel immunodiffusion test (2.2, Appendix 5.2.1).
Clinical examination, particularly of the respiratory and nervous systems, of these
sheep revealed no detectable abnormality, and routine haematological samples
revealed a mild neutrophilia in sheep 076 to be the sole abnormal finding (Appendix
5.2.1). Five sex and breed matched control sheep of similar age to the infected ewes
were obtained from accredited flocks (2.1, Table 5.1). These control sheep were
clinically and haematologically normal, and serologically free from MVV infection at
the time of challenge (Appendix 5.2.1).
Table 5.1
Sheep Number Status Breed Age (years) Sex
Oil MVV +ve Texel 9 Female
025 MVV +ve Texel 9 Female
035 MVV +ve Texel 8 Female
071 MVV +ve Texel 9 Female
076 MVV +ve Texel 8 Female
118 MVV +ve Texel 8 Female
183 Control Texel 8 Female
184 Control Texel 9 Female
245 Control Texel 8 Female
246 Control Texel 7 Female
247 Control Texel 9 Female
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5.2.2 Blood sampling
Blood was collected from the sheep at the time of initiation of the DTH and
analysed for white blood cell parameters as described previously (2.3).
5.2.3 DTH initiation, measurement, and biopsy
The DTH was initiated, measured, and biopsied in the standard manner
described in 2.4 - 2.6. In this particular experiment, biopsies were taken at 0 hours, 24
hours and 72 hours post injection, these being the time points which the investigation
of the normal DTH had shown to be time points associated with the significant
infiltration of the lesion with PMNs and CD4+ cells respectively.
5.2.4 Immunohistopathological staining
Routine paraffin embedded sections were processed and stained with
haematoxylin and eosin as described in chapter 2.
Frozen sections were processed as described in chapter 2 and stained with
monoclonal antibodies SBU-T4 (CD4+ T cells), SBU-T8 (CD8+ T cells), 86D
(gamma delta T cells), DU2.87 (B cells), VPM63 (macrophages), VPM 65
(macrophages) and OM-1 (macrophages) (chapter 2).
93
5.2.5 Quantification
An initial subjective appraisal of the sections revealed that the reactions in both
groups exhibited very similar patterns of cellular infiltration, consistent with the
pattern of infiltration found in the study of the normal DTH reaction (3.2.4). As before
the periadnexal structures and superficial dermal areas of the histological sections
were noted as areas of cellular accumulation, and these areas were once again selected
for cell counting.
The method utilised for counting the cellular infiltrate in Chapter 3 was an
adaptation of the most comprehensive previously published method for the evaluation
of cellular infiltrates in the skin, with a separation of the counting into the distinct
areas of cellular accumulation. After careful consideration of this method of counting,
the author considered that there was a potential for error and subjective interference in
the method of counting the periadnexal regions, with the selection of grid squares that
were considered to be periadnexal being reliant upon the subjective appraisal of the
observer. In order to rectify this problem, use was made of a computer assisted image
analysis system (Quantimet 500C image analysis system, Leica Instruments,
Cambridge, UK), which allowed standardisation between different sections,
eliminating the possibility of subjective operator interference and therefore
maximising the accuracy of the cell counting. The method was developed and then
stored in the computer as a specific routine that could then used on every section
counted (Appendix 5.2.4). The routine followed a similar pattern to the previous
manual method of counting, beginning with the periadnexal area count. To begin
with, the adnexal structure of interest was first outlined manually using the cursor.
The computer then expanded this outline by a specific distance which had been judged
to be the area of accumulation of cells around the adnexae, and produced a binary
image counting window in which the cells of interest were then manually selected
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using the cursor. The computer then counted the number of cells indicated, and
measured the area of the counting window, producing a figure for the number of
positive cells per mm^ of tissue section. An initial pilot study of several sections was
undertaken to ascertain the reproducibility of individual counts and variability
between different sections in order to ascertain the number of counting fields required
to produce an average final figure that was a true representation of the cell density in
each specimen (Aherne, Dunnill, 1982). This study indicated that this computerised
method produced a consistent result within each area counted, and also that there was
relatively little variation between different fields on an individual section. The number
of fields to be counted for each section was decided by evaluating the number of fields
required to produce a result whereby the standard error of the counts was less than 5%
of the their mean, which may be considered as a statistically valid representation of
the true figure (Aherne, Dunnill, 1982), the mean being the figure that would be
recorded as the result. This trial indicated that an evaluation of six individual fields
would satisfy this statistical requirement, and this number of repetitions was included
in the counting routine. In the case of the superficial dermal area, the area to be
counted was manually outlined to avoid extraneous structures such as hair follicles.
The computer then outlined the area with a binary overlay image, and produced a
counting area window. The cells of interest were indicated manually, and the
computer produced a figure of cells per mm^. As above, a trial was undertaken to
ascertain the number of fields required to be examined in order to produce a
statistically significant result, and a figure of six fields was produced. This number of
fields was incorporated into the computer routine.




MVV infected animals had significantly lower increases in skin thickness
compared to the control animals at all measurement points after 7 hours (Figure 5.1,
Appendix 5.3.1), the significance being p<0.05 using a Mann-Whitney test. There
was, however, a marked variation in results within the MVV group. No change in skin
thickness was seen in the control PBS injected sites.
Figure 5.1
Comparison of the increase in skin thickness with time
following the i/d injection of PPD into sensitised control
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5.3.2 Histopathological assessment
Within the control group of animals, the histological characteristics of the
reaction were indistinguishable from those of the previous control animals (3.3.2),
consisting of a predominantly PMN infiltrate at 24 hours post injection followed by a
predominantly mononuclear cell infiltrate at 72 hours post injection. The biopsies
from the MVV infected sheep exhibited a subjectively lower level of cellular infiltrate
into the lesion at the 24 hour time point, with a subjectively similar reaction at the 72
hour time point.
The control biopsies of both groups exhibited no apparent change from the
normal skin.
5.3.3 Polymorphonuclear neutrophils
PMNs were relatively sparse in normal skin of both groups, but were the
predominant infiltrating cell in the PPD induced lesion at the 24 hour time point
biopsy (Appendix 5.3.3). There was a significant depression in the PMN density in the
MVV infected sheep (p<0.01) at this time point (Figures 5.2, 5.4 and 5.5). MVV
lesions exhibited a marked variability in the numbers of cells in the lesion, contrasting
with the consistent levels found in the control animal reactions. Highly significant
correlations between the numbers of cells in the periadnexal area in the 24 hour
biopsy and the eventual thickness of the gross lesion (Figure 5.3, Table 1) were
present. By the 72 hour time point, PMNs were present at reduced densities and there
were no significant differences between the groups. There were no significant
alterations in the PMN numbers in the control biopsies.
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Figure 5.2
Comparison of the periadnexal PMN cell count at
time points following the i/d injection of PPD into
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Figure 5.3
Correlation between periadnexal PMN cell count at
24 hours and increase in skin thickness at 72
hours following the i/d injection of PPD into
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Table 5.2 Correlations between the periadnexal 24 hour cell count of PMNs and
the increase in skin thicknesses at 48, 72 and 96 hours post the i/d injection of PPD
into sensitised control and MVV infected animals (Spearmann ranking correlation
statistic)
Increase in skin thickness (mm)
48 hours post 72 hours post 96 hours post
challenge challenge challenge
Periadnexal PMN rs = 0.828 rs = 0.806 rs = 0.838
cell count at 24 hours (p<0.005) (p<0.005) (p<0.005)
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Figure 5.4: Photomicrograph of a 24 hour biopsy of a PPD lesion from a
control sheep. Note the marked density of cells in the section, particularly
periadnexally. These cells are primarily PMNs as shown in the inset. (H&E,
x40, with inset x 250).
Figure 5.5: Photomicrograph of a 24 hour biopsy of a PPD lesion from an
MVV infected sheep that exhibited a depressed DTH response(071). Note
the much reduced density of cells in the reaction at this point, although the
inset shows that these are still predominantly PMNs (H&E, x250).
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5.3.4 CD4+ cells
CD4+ cells were found at low levels perivascularly in normal skin. In the PPD
reaction, the CD4+ cells were markedly increased in the 24 hour biopsy, reaching
maximal levels at the 72 hour time point (Appendix 5.3.4). The levels in the MVV
animals were significantly lower at the 24 hour time point, with a significance of
p<0.05 (Figure 5.6). There were no significant differences at 72 hours post challenge,
with levels of CD4+ cells similar in both groups. There were significant correlations
(p<0.05) between the periadnexal CD4+ cell densities at 24 hours and the later skin
thickness (Table 5.3). There were no significant alterations in the numbers of CD4+
cells in the control biopsies.
Figure 5.6
Comparison of the periadnexal CD4 count at time
points following the i/d injection of PPD into
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Table 5.3 Correlations between the periadnexal 24 hour cell count of CD4+
cells and the increase in skin thicknesses at 48, 72 and 96 hours post challenge,
incorporating the counts for both infected and control groups (Spearmann ranking
correlation statistic)
Increase in skin thickness (mm)
48 hours post 72 hours post 96 hours post
challenge challenge challenge
Periadnexal CD4 cell rs = 0.642 rs = 0.628 rs = 0.691
count at 24 hours (p<0.05) (p<0.05) (p<0.05)
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5.3.5 CD8+ cells
In normal and control (PBS injected) biopsies, CD8+ cells were distributed in a
similar pattern to the CD4+, being concentrated in the perivascular area, although they
were present at a lower level (Appendix 5.3.5). In the PPD lesion biopsy, cell numbers
were increased at 24 hours, but rose to a maximal level at 72 hours post challenge,
achieving counts that were approximately half those of the CD4+ cells (Figure 5.7).
There was no significant difference in CD8+ cell counts between the MVV and
control group, and no correlation between CD8+ numbers and skin thickness was
present. The CD4+/CD8+ cell ratio was not significantly different between the groups
of sheep
Figure 5.7
Comparison of the periadnexal CD8 cell count at
time points following the i/d injection of PPD into
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5.3.6 Gamma delta cells
Gamma/delta T cells were found at low levels, predominantly in the
perivascular area, in the untreated and control (PBS injected) biopsies(Appendix
5.3.6). They remained present only at low levels in the DTH lesions, and no consistent
pattern of alteration in gamma/delta cell numbers was present in these biopsies,
although there was a marginal rise at 24 hours evident in some animals (Figure 5.8,
Appendix 5.3.6). No significant differences between the MVV and control groups of
animals, or correlations between cell count and skin thickness, were present.
Figure 5.8
Comparison of the periadnexal gamma delta cell
count at time points following the i/d injection
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5.3.7 Macrophages
Macrophages were found at relatively low levels in normal and control (PBS
injected) biopsies, with levels remaining unchanged after PBS injection in the control
biopsies (Appendix 5.3.7). Macrophages constituted the smallest population of cells in
the DTH lesion, with a slight rise in cell numbers at 24 hours, followed by a marked
decrease reaching minimal levels at the 72 hour time point (Figure 5.9, Appendix
5.3.7). There were no significant differences in macrophage cell count between MVV
and control groups, nor correlations between macrophage cell count and DTFI
response size present.
Figure 5.9
Comparison of the periadnexal macrophage cell
count at time points following the i/d injection of
PPD into sensitised control and MVV infected
animals
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5.3.8 MHC class II expression
MHC class II expression, as defined by the number of cells staining positive for
MHC class II, followed a very similar pattern to the macrophage cell staining, with
cells expressing MHC class II at low levels in normal skin, and remaining unchanged
in the control (PBS) injection sites (Appendix 5.3.8). In the DTH lesions, the number
of MHC class II expressing cells increased slightly at the 24 hour time point, before
decreasing dramatically to almost negligible levels by 72 hours (Figure 5.10,
Appendix 5.3.8). There were no significant differences in the number of MHC class II
expressing cells between the MVV and control groups, nor correlations between MHC
class II expression and DTH skin thickness noted.
Figure 5.10
Comparison of the periadnexal MHC class II
expressing cell count at time points following
the i/d injection of PPD into sensitised control
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5.4 DISCUSSION
The results from this study have confirmed the findings of the previous chapter,
with a significant and variable depression of the size of the DTH response in the sheep
infected with MVV. This depression in the gross reaction was significantly associated
with a depression in the levels of PMNs and CD4+ cells in the reaction biopsies of the
MVV sheep, particularly evident in the early time point biopsy of 24 hours post
injection. The PMN cell count was the most significantly depressed at this point, and
exhibited the strongest correlation with the size of the DTH. Counts of CD8+ cells,
gamma delta cells, macrophages, and MHC class II expressing cells were not
statistically different between the two groups.
This depression in DTH response size has been previously recorded in sheep
experimentally infected with MVV (Myer et al. 1988), although this contradicted the
findings of a previous study which could find no difference in the size of a DTH
reaction between experimentally infected and control animals (Larsen et al. 1982a). A
depressed DTH response is a common finding in the latter stages of HIV infection,
being utilised as a predictor of the progression of infection to the AIDS syndrome
(Redfield et al. 1986; Colebunders et al. 1989; Borleffs et al. 1991; Johnson et al.
1992; Blatt et al. 1993; Birx et al. 1993; Pesanti, 1994), and has also been reported to
occur in cats infected with FIV (Otto et al. 1993). It is surprising, therefore, that there
has been no corresponding published study of the immunohistological characteristics
of this depression associated either with MVV or any of the related lentiviral
infections. Several studies of the response in HIV infected individuals have linked this
depression in DTH with a depression in the circulating CD4+ cells and associated
progression of infection to the AIDS complex (Borleffs et al. 1991; Blatt et al. 1993;
Birx et al. 1993). This reduction in circulating CD4+ cells is not a recognised feature
of MVV infection (Lujan et al. 1993), and therefore cannot provide a direct
explanation for the reduced DTH. This leads to the speculation that the deficiency in
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the DTH response size is related either to the mechanism of attraction of the PMN and
CD4+ cell into the early lesion, or the ability of these cells to enter and/or function in
the lesion.
The complex nature of the PPD initiated DTH response, combined with a lack
of information regarding the specific cellular interactions involved in the normal
response in sheep, leads to difficulties in defining the basis of the depressed cellular
infiltration into the early lesion. The fact that the reaction is already significantly
different by the 24 hour time point suggests that the mechanism involved in the
alteration of the response is one occurring during the initiation of the response, at a
time point before there has been significant infiltration with cells.
The basis of the DTH response is the presentation of the initiating antigen, in
association with MHC class II, by an antigen presenting cell to an antigen specific
CD4+ T helper cell. The interaction of these two cell types leads to the release of
proinflammatory mediators that initiate the subsequent cellular infiltration
(McKeever, 1994). There is some dispute in previous publications as to the
histopathological character of the tuberculin DTH, but the present study suggests that
the PMN is of crucial significance in the establishment of the gross characteristics of
the DTH response, a finding that is supported by the work of Kudo et al (1993), who
used monoclonal antibodies to deplete PMNs in a murine model and discovered that
PMNs were essential in both the priming and initiation phase of the DTH response.
The author is unaware of any work investigating the role of the PMN in the human
DTH response, and the involvement of this cell type in the HIV associated DTH
deficiency is unknown. The evident correlation of early PMN infiltration with the
eventual maximal gross size of the DTH could be explained by the fact that they
contain and produce a large range of proinflammatory mediators (Buchta, 1990), and
it may be speculated that they are attracted into the lesion in a non specific manner as
a result of mediators released following the initial reaction between the antigen
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presenting cells and antigen specific CD4+ cells, and subsequently release their
mediators in situ, augmenting the inflammatory response. The decrease in PMN cells
involved in the reaction at the 24 hour time point in the MVV infected sheep may be
either associated with a lack of inflammatory signal, or an inability of these cells to
respond to a normal signal. The fact that both the PMN and CD4+ cell infiltration is
decreased suggests that the deficiency is associated with a depressed or altered
proinflammatory signal.
The CD4+ T helper cell population is commonly accepted to be a major
component of the DTH response (Poulter et al. 1982; Konttinen et al. 1983; Piatt et al.
1983; Gibbs et al. 1984), with the role of release of cytokines responsible for the
further mediation of the immune response (McKeever, 1994). The CD4+ cell
population has been studied extensively in mouse and man, where it has been found
that this lymphocyte subset may be divided into two distinct groups, designated Thl
and Th2, which have been separated on the basis of their cytokine production profile.
The Thl subset is predominantly associated with DTH response, and the Th2 subset is
primarily associated with the control of a humoral and/or allergic response (Mosmann.
Coffman, 1989; Del Prete et al. 1991). This separation ofCD4+ cells into functionally
distinct populations has not yet been reported in the sheep, although one study has
recorded a reduction in the gross size of the tuberculin DTH response in sheep
pretreated with a monoclonal antibody to interferon-y, this cytokine being one of the
main cytokines produced by Thl type cells (Emery, Davey, 1995). Evidence from
studies of the CD4+ population of cells in HIV infection has revealed that, as the
infection progresses to AIDS, there is a dysregulation in the function of antigen
presenting cells that leads to a decrease in Thl type cells and an increase in Th2 type
cells in the circulation (Meyaard et al. 1993). This change in proportion of population
of CD4+ cells, as well as the overall decline in CD4+ cell numbers, may explain a
decrease in the ability of the individual to develop a DTH reaction. One could
speculate that this mechanism may be operating in the sheep, although the existence
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of the Th subtypes is not proven in this species. A shift from a predominantly Thl
type response to a Th2 type response would result in the increased production of
antibody, a phenomenon which is investigated later. Lowering of Thl cell
numbers/proportions would also be linked with a decline in PMN attraction to the
DTH site since interferon-y, a Thl associated cytokine, is one of the more important
mediators of PMN infiltration(Colditz, Watson, 1992).
The macrophage is also a key component of the DTH response (McKeever,
1994), and the finding of no significant difference in macrophage cell numbers
between the infected and control group does not indicate whether there are any
functional alterations in this cell type as may be expected as this is the main target cell
for MVV infection (Gorrell et al. 1992; Lujan et al. 1994; Brodie et al. 1995).
However, only one in one million macrophages are considered to be infected
(Brownlee, personal communication). There are various studies relating macrophage
association with HIV or HIV peptides with altered cytokine production in vitro, of
which the constitutive overexpression of IL-10 by infected macrophages (Akridge et
al. 1994; Emilie et al. 1994; Haraguchi et al. 1995) would provide a plausible solution
to the puzzle of the declining DTH, since IL-10 is both involved in the switch between
Thl and Th2 subsets and has been shown to inhibit DTH reactions (Powric et al.
1993; Li et al. 1994). The DTH defect, however, may be associated with the altered
production of a large range of inflammatory mediators by the macrophage, as they are
responseible for the production ofmany such products.
The lack of significant difference in the CD8+ cell counts, and gamma delta cell
counts correlates with the lower number of these cells found in the lesion, and
suggests that they have a lesser part to play in the release of mediators responsible for
the development of the gross DTH lesion, although absolute numbers once again do
not give an indication of possible functional differences.
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In conclusion, these experiments have indicated that the depression in the gross
size of the DTH response in sheep infected with MVV is significantly associated with
the level of PMN and CD4+ cells present in the early DTH lesion. This leads to
speculation that there is either a deficit in the mechanism of attraction of these cells




THE EFFECT OF SELECTIVE PMN DEPLETION ON
THE DTH REACTION
6.1 INTRODUCTION
Previous chapters have described the finding of depression in the gross size of a
DTH response in sheep seropositive to MVV, and significantly associated this
alteration in gross characteristics with a decreased density of PMNs and CD4+ cells in
the reaction at an early time point. The presence of considerable numbers of PMNs in
the early DTH reaction has never been previously reported in sheep, although there
have been variable reports of PMNs in the early DTH reaction of other species. The
association of PMNs with the failure of development of the gross characteristics of a
DTH response has been previously investigated in the rat, using monoclonal
antibodies to deplete circulating PMNs at both the priming and initiation phase of a
DTH model (Kudo et al. 1993a; Kudo et al. 1993b). This work indicated that the PMN
was a crucial cell in the establishment of a grossly visible DTH response, although the
DTH model used in these experiments was markedly different from the classical
tuberculin response in sheep used by the author in the previous experiments.
In order to confirm that the PMN was indeed an integral component of the
classical tuberculin DTH reaction in sheep, and to correlate the findings of lowered
levels of PMNs in the early reaction being associated with the reduction in size of the
DTH response seen in MVV seropositive animals, it was important to establish a
direct link between the PMN cell and the development of a typical tuberculin
response. The most direct method of investigating this link was the specific depletion
of circulating PMNs immediately prior to the induction of a standard DTH response.
The most specific method of achieving depletion would be the use of a PMN specific
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monoclonal antibody which has been used in other species, but unfortunately there is
no such ovine reagent available. Previous authors had reported achieving a PMN
depletion in sheep through the use of the cytotoxic drug hydroxyurea, which had been
shown to mainly reduce the number of circulating PMNs, with a relatively minor
depletion of the level of circulating lymphocytes (Heflin, Brigham, 1981; Raj et al.
1985; Kubo et al. 1992; Pearse, Sylvester, 1992).
The following experiment was therefore undertaken utilising hydroxyurea to
deplete circulating PMNs in a group of control sheep, previously primed with BCG
vaccine, at the time of initiation of the DTH response with a PPD challenge. In order
to confirm the specificity of the hydroxyurea induced changes, the level of circulating
blood cells was closely monitored during the depletion and subsequent DTH using
routine haematology and FACScan flow cytometry techniques.
6.2 MATERIALS AND METHODS
6.2.1 Animals
Six adult female Texel sheep (Table 6.1) were obtained from a flock that was a
participant in the UK sheep health scheme, and had therefore been seronegative for
MVV for a number of years. The sheep were seronegative for MVV when tested
immediately prior to the commencement of the experiment.
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Table 6.1 Details of the sheep used in this experiment
Sheep Number Breed Age (years) Sex
RT 33 Texel 7 Female
RT 34 Texel 5 Female
RT 35 Texel 6 Female
RT 36 Texel 7 Female
RT 37 Texel 5 Female
RT 38 Texel 5 Female
The control sheep detailed in chapter 5 (sheep 183, 184, 245, 246, 247) were
used as a control group in this experiment.
6.2.2 DTH initiation, measurement and biopsy
The DTH was initiated, measured, and biopsied in the standard manner
described in 2.4 - 2.6.
6.2.3 Immunohistopathological staining and quantification
Routine paraffin embedded sections were processed and stained with
haematoxylin and eosin and toluidine blue as described in chapter 2.
Frozen sections were processed routinely and stained with monoclonal
antibodies SBU-T4 (CD4), SBU-T8 (CD8), 86D (yd T cell), SW73.2 (pan MHC class
II) and OM-1 (CD1 lc, macrophage) (chapter 2).
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Quantification of cellular infiltration was performed utilising the computerised
image analysis system previously described in 5.2.5.
6.2.4 FACS analysis of peripheral lymphocytes
Peripheral blood was collected from the sheep for FACS analysis at the
commencement of the PMN depletion therapy, and immediately prior to the initiation
of the DTH with PPD as described in 2.9.1. The cells were stained with monoclonal
antibodies SBU-T4 (CD4) and SBU-T8 (CD8), as well as normal mouse serum and an
irrelevant monoclonal antibody of identical isotype (VPM53, an anti-campylobacter
like organism monoclonal antibody (McOrist et al. 1987)) in the manner described in
2.9.2. Cells were analysed using a FACScan automated cell counter as described in
2.9.3.
6.2.5 PMN depletion
Circulating PMNs were selectively depleted from the circulation in the manner
previously described by other workers. Hydroxyurea (Hydrea capsules, Bristol-Myers
Squibb Pharmaceuticals Ltd., Dublin, Ireland) was dissolved in a 0.9% w/v sterile
saline solution (Aquapharm, Animalcare Ltd., York, UK) at a rate of 4g of
hydroxyurea to 60 ml of saline solution. A 60 ml (4g) aliquot of the solution was then
administered to the sheep intravenously daily for a period of six days, commencing
six days prior to the challenge of the sheep with PPD, such that maximal depletion of
PMNs had occurred at the time of challenge.
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6.2.6 Routine haematological monitoring
The level of circulating blood cells was monitored daily throughout the
depletion period and subsequent DTH response, with peripheral venous blood
collected and analysed in a standard manner (2.3).
6.3 RESULTS
6.3.1 Haematological changes following hydroxyurea treatment
Considering firstly the total white blood cell counts, at the start of the depletion
experiment sheep 35 and 36 had cell counts above the laboratory normal range with
the others having counts within the normal range. In response to hydroxyurea
treatment, there was initially a steady fall in the number of white blood cells in all the
sheep, although sheep 36 had a count that was very high and remained so throughout
the experiment. After four days of treatment, sheep 35 and 38 exhibited a rapid
increase in the cell count, and subsequently remained at levels above normal for the
rest of the experiment. The cell counts of sheep 33, 34 and 37 remained steadily
declining throughout the treatment, although sheep 37 was the only sheep to have a




















Change in the total white blood cell count of the sheep during
the 6 day treatment with hydroxyurea and subsequent DTH
reaction
Hydroxyurea
24/7/95 26/7/95 28/7/95 30/7/95 1/8/95
Date of blood sample
3/8/95
Although there was a trend towards a lower total white blood cell count in the
depleted group, there was no significant difference between the treated and control
groups at the time of initiation of the DTH, or correlation between the cell count and
increase in skin thickness.
The segmented PMN cell count followed similar trends to the total white blood
cell count. Sheep 36 had a very high cell count at the commencement of hydroxyurea
treatment which gradually declined, but with a marked increase after 5 days of
treatment and remaining above normal levels throughout the experiment. Sheep 35
and 38 once again showed a gradual decline in cell numbers for the first four days of
hydroxyurea treatment, but then exhibited a sudden rise in cell numbers, which then
fell slightly once more at the time of DTH initiation, but then rose once more during
the early stages of the DTH. Sheep 33, 34 and 37 exhibited a gradual decline in PMN
numbers, and the counts of sheep 33 and 37 were subnormal at the time of DTH
initiation (Figure 6.2 and Appendix 6.3.1).
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Figure 6.2
Change in the segmented PMN cell count of the sheep during


























Date of blood sample
There was no significant difference between the PMN cell counts in the depleted
group and the control group at the time of initiation of the DTH, or correlation
between the cell counts and increases in skin thickness.
The lymphocyte cell counts appeared to be relatively unaffected by the
hydroxyurea, but once again sheep 36 had levels above normal throughout the
experiment. Sheep 35 and 38 exhibited also exhibited a sharp rise in lymphocyte




Change in the lymphocyte cell count of the sheep during the 6



















24/7/95 26/7/95 28/7/95 30/7/95 1/8/95
Date of blood sample
3/8/95
Once again, there was no significant difference in the lymphocyte cell counts
between the depleted and control groups, with no correlations between the cell counts
and increases in skin thickness.
The eosinophil cell counts of all sheep except 36 were relatively low and
appeared to be unaffected by hydroxyurea treatment. Sheep 36 had a very high
eosinophil cell count that, although declining, remained above normal levels
throughout the majority of the experiment (Appendix 6.3.1). There was no significant
difference in the eosinophil cell counts between the depleted and control groups, with
no correlations between the cell counts and increases in skin thickness.
Monocyte counts were also relatively unaffected by the hydroxyurea treatment
(Appendix 6.3.1).
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The FACScan data produced figures for the relative proportion of lymphocytes
that were CD4+ or CD8+ at the start of hydroxyurea treatment and at the initiation of
the DTH. There was a general increase in the level of CD4+ cells and a general
decrease in the levels of CD8+ cells following the hydroxyurea treatment, although
this was found to be not significant using a Wilcoxon statistic. The ratio of
CD4+/CD8+ lymphocytes was significantly increased (p<0.05, Wilcoxon statistic)
after the hydroxyurea treatment (Appendix 6.3.1). No FACScan data was available for
the control group.
6.3.2 Increase in skin thickness of the DTH lesion
The increases in skin thicknesses were variable within the group, with the
increases in skin thicknesses for the treated group being significantly lower than the
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6.3.3 Histopathological characterisation of the DTH lesion
Qualitatively, the DTH reaction was similar in the PMN depleted sheep to the
previously described normal DTH reaction, although there was an apparent decrease
in the density ofPMNs in the early DTH reaction in this treated group.
The PBS injected control skin biopsies were once again unremarkable, with no
apparent alteration from the skin biopsies taken from non-injected sites.
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Figure 6.5: Photomicrograph of a 24 hour biopsy taken from the PPD lesion
of a control sheep. Note the marked accumulation of infiltrating cells in the
periadnexal region (H&E, x40).
mmm
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Figure 6.6: Photomicrograph of a 24 hour biopsy taken from the PPD lesion
of a PMN depleted sheep (34). Note the marked reduction in the density of
infiltrating cells. The reduction is associated with a lower count of PMNs in
the lesion (H&E, x40).
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6.3.4 PMN cell count
Considering the DTH reaction, PMNs were present in the biopsies at low levels
initially, rose to a maximal level at 24 hours at which point they were the predominant
cell, before the numbers fell again at 72 hours. The sheep in the hydroxyurea treated
(PMN depletion) group exhibited markedly variable PMN cell counts, which were
usually below the more consistent PMN cell count in the control group, although this
reduction in PMN cell numbers was only significant in the periadnexal compartment
at 72 hours (Figure 6.5, 6.6, and 6.7 and Appendix 6.3.4). When the data for both
groups was combined, there were significant correlations between the PMN cell
counts and increases in skin thicknesses (Table 6.1). There were also significant
correlations (p<0.05, Spearman statistic) between the circulating PMN cell count and
the density of PMNs in the superficial dermis of the DTH reaction at both 24 and 72
hours.
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Table 6.1 indicating the significant correlations between PMN cell counts and
increases in skin thicknesses with data from both the PMN depleted and control
groups combined (Spearmann statistic).
Increase in skin thickness (mm)
48 hours post 72 hours post 96 hours post
challenge challenge challenge
Periadnexal PMN rs = 0.729 rs = 0.653 NS
cell count at 24 hours p<0.02 p<0.05
Dermal PMN cell rs = 0.679 rs = 0.621 NS
count at 24 hours p<0.05 p<0.05
Periadnexal PMN ND rs = 0.694 NS
cell count at 72 hours p<0.05
The PBS injected control biopsies exhibited little alteration from the non
injected skin, although there was a significantly higher PMN cell count in the 24 hour
periadnexal biopsies taken from the PMN depleted group (Appendix 6.3.4).
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Figure 6.7
Comparison of the periadnexal PMN cell count at time
points following the i/d injection of PPD into sensitised
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6.3.5 CD4+ cell count
Considering the DTH reaction, the CD4+ cell counts were at low levels in the
control skin biopsies of both groups, rising at 24 hours, and becoming maximal at 72
hours. The CD4+ cell counts were significantly depressed in the animals that had been
hydroxyurea treated at both 24 and 72 hours (Figure 6.8 and Appendix 6.3.5). When
the data for both groups was combined, there was a significant correlation between the
periadnexal CD4+ cell counts at 24 hours and the increase in skin thicknesses at 24
hours (p<0.05, Spearmann statistic).
The CD4+ cell counts in the PBS injected sites remained at low levels with no
significant differences between the groups (Appendix 6.3.5).
Figure 6.8
Comparison of the periadnexal CD4 cell count at time
points following the i/d injection of PPD into sensitised
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6.3.6 CD8+ cell count
The counts of CD8+ cells in the DTH reaction were very similar between the
two groups, with the cell numbers increasing at 24 hours and becoming maximal at 72
hours (Figure 6.9 and Appendix 6.3.6). Cell numbers remained relatively unchanged
in the PBS injected sites (Appendix 6.3.6). There were no significant differences in
counts in the DTH reaction or PBS injected sites. There were no correlations between
the CD8+ cell counts and the increases in skin thicknesses in the DTH lesion.
Figure 6.9
Comparison of the periadnexal CD8 cell count at time
points following the i/d injection of PPD into sensitised













, „ . 2. 800
0 20 40 60 80
Time post challenge (hrs)
127
6.3.7 Gamma-delta cell count
Considering the DTH reaction, the counts of gamma/delta cells were initially
very similar between the groups, although by 72 hours the cell count in the depleted
group had risen to be significantly higher than the control group (Figure 6.10 and
Appendix 6.3.7). When the data for both groups was combined, there was a significant
negative correlation between the periadnexal gamma/delta cell counts at 72 hours and
increases in skin thickness at 72 hours (p<0.05, Spearmann statistic).
Within the PBS injected sites, there was relatively little change in cell numbers,
although there were significantly higher gamma/delta cell counts at 24 hours in the
depleted group.
Figure 6.10
Comparison of the periadnexal gamma/delta cell count
at time points following the i/d injection of PPD into
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6.3.8 OM1 positive cell count
Considering the DTH reaction, the levels of OM1 positive cells was relatively
low in both groups in the non injected skin and at 24 hours, falling to almost
negligible levels by 72 hours. The depleted group had significantly higher counts
(p<0.05, Mann-Whitney U statistic) of OM1 positive cells at 24 hours (Figure 6.11
and Appendix 6.3.8).
There was relatively little change in OM1 cell counts in the PBS injected sites,
with no significant differences present.
Figure 6.11
Comparison of the periadnexal OM1 cell count at time
points following the i/d injection of PPD into sensitised
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6.3.9 MHC class II expressing cell count
Considering the DTH reaction, there were relatively low levels of SW73.2
expressing cells in the early biopsies, falling to very low levels at 72 hours. The
depleted group had significantly lower counts (p<0.05, Mann-Whitney U statistic) of
SW73.2 positive cells at 24 hours (Figure 6.12 and Appendix 6.3.9). There were no
significant correlations between the SW73.2 cell counts and increases in skin
thickness.
There was relatively little change in SW73.2 cell counts in the PBS injected
sites, with no significant differences present.
Figure 6.12
Comparison of the periadnexal SW73.2 cell count at
time points following the i/d injection of PPD into
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6.4 DISCUSSION
The results of this experiment suggest that the use of hydroxyurea to selectively
deplete the level of circulating PMNs in sheep is not as reliable as previously reported
(Heflin, Brigham, 1981; Raj et al. 1985; Kubo et al. 1992; Pearse, Sylvester, 1992),
with three sheep exhibiting a marked increase in the circulating level of both white
blood cells and PMNs after 4 days (sheep 35 and 38) and 5 days (sheep 36)
respectively. This is indicative of the development of an acute inflammatory response,
and would suggest that the depletion of PMNs in the early part of the experiment has
allowed the evolution of a subclinical infective process. Although the precise nature of
this infection was not evident on clinical inspection, several of the sheep had
undergone recent treatment for infections in the feet and it is possible that there had
been a resurgence of this infection following PMN depletion. This finding also
indicates that there are mechanisms present in the sheep that are capable of
overcoming the cytotoxic effects of hydroxyurea and causing an increase in
circulating PMNs. Ideally, gnotobiotic animals could have been employed to reduce
these problems of subclinical infection, but such animals could not have been
considered true controls for the MVV seropositive animals in terms of their previous
management and possible previous exposure to mycobacterial and other pathogens.
The other three sheep, however, did exhibit a fall in circulating PMN numbers in
response to the hydroxyurea, with one sheep becoming subnormal at the time of DTH
initiation.
The hydroxyurea did appear to be somewhat selective in its depletion of
peripheral PMNs, with the level of circulating lymphocytes, eosinophils and
monocytes remaining relatively static during the treatment. The levels of CD4+ and
CD8+ cells were statistically unchanged by the treatment, although the trend towards
higher levels of CD4+ and lower levels of CD8+ cells was manifest as a significant
increase in the CD4+/CD8+ cell ratio.
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The failure of the hydroxyurea to deplete the level of circulating PMNs in all the
experimental sheep led to a situation where there was no significant difference in the
PMN cell count between the depleted and control groups, although the statistics were
particularly skewed by the very high cell count of sheep 36. When the statistic was
repeated excluding the three sheep that had experienced a rise in circulating PMN
cells, again there was no significant difference. This reflects the low numbers of sheep
in the groups, with significance difficult to attain even with marked differences
between the groups.
There was, however, a significant depression in the later increases in skin
thickness in the treated group, with a trend towards lower increases in skin thicknesses
being associated with lower levels of circulating PMNs, although there was no
statistically significant correlation present between these two parameters. This
depression in the later increase in skin thickness was significantly associated with a
depression in the density of PMNs in the early lesion, a result identical to that found
in the depressed DTH response of the MVV seropositive sheep. The lower density of
PMNs in the DTH lesion was also significantly associated with the level of circulating
PMNs. These latter two significant associations indicate a circuitous relationship
between the circulating PMN cell count and the increase in skin thickness in the
sheep, providing further evidence for a link between the circulating PMN and the
DTH reaction. The finding of a link between the circulating PMN and the DTH
reaction size is concordant with the previous experiments in the rat DTH model (Kudo
et al. 1993a; Kudo et al. 1993b), and indicates that the early migration of PMNs into a
DTH lesion is crucially involved in the development of the later cell influx and also
the development of the gross swelling associated with this reaction. Since the PMN is
considered to operate in a non antigen-specific manner, this finding suggests that an
earlier antigen specific interaction is involved in the attraction of PMNs to the site of
antigen deposition, these PMNs then being involved in the non antigen specific
augmentation of the reaction. The association with the density of the early PMN cell
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infiltrate with the gross size of the DTH response reflects the wide range of
proinflammatory mediators released by these cells (Buchta, 1990), particularly those
associated with the control of vascular permeability (Wedmore, Williams, 1981; Abe
etal. 1990; Yi, Ulich, 1992).
The depleted sheep also exhibited a depression in the density of CD4+ cells in
the reaction, both at 24 and 72 hours, which occurred even though treatment caused
no decrease in the circulating lymphocyte count and a relative increase in the
percentage of CD4+ lymphocytes. There was no significant association between the
reaction CD4+ cell density and the circulating levels of either lymphocytes or PMNs,
but the hydroxyurea treatment produces it's main effect on the level of circulating
PMNs, and this depression in CD4+ cell density in the DTH reaction is apparently
linked to alterations in the PMN cell count. The decreased density of CD4+ cells in
the DTH lesion is analogous to the situation found in the MVV seropositive sheep,
where a similar phenomenon occurred. The previous work investigating the
association between the level of circulating PMNs and the characteristics of a DTH
type response (Kudo et al. 1993a; Kudo et al. 1993b) did not use immunohistological
techniques to identify particular cell types, but grouped cells morphologically as
mononuclear type cells. This work did, however, indicate a depression in the
mononuclear cell infiltration into DTH sites following depletion of circulating PMNs.
The authors considered that this depression was linked to the fact that PMNs in the
lesion are capable of releasing cytokines that are potent attractants for lymphocytes,
citing IFNa as a prime candidate in this role. This hypothesis that PMNs in the lesion
are responsible for the release of mediators and subsequent attraction of mononuclear
cells is also suggested by the results of this experiment, with a circulating PMN
suppression being linked with a decline in CD4+ cells in the lesion. The specific
nature of the mediators released by the PMNs and involved in this CD4+ attraction are
not immediately obvious, with a wide range of putative candidates being available.
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The level of circulating CD8+ cells appeared to be relatively lowered following
the treatment with hydroxyurea when compared to the CD4+ levels. There was,
however, no difference between the density of these cells in the DTH lesion between
the depleted and control groups. Again, this is a situation analogous with the
depression in DTH response found in the MVV seropositive group. The density of
gamma delta cells in the DTH reaction was slightly, but significantly, increased in the
treated group. This increase was not seen in the MVV seropositive group, although the
relatively low level of gamma-delta cell involvement was a common feature. The
apparent lack of alteration in the level of infiltration of CD8+ lymphocytes and
increase in gamma-delta cell infiltration into the DTH following PMN depletion
suggests that the mediators released by the PMN that are responsible for the control of
CD4+ cell infiltration are specific for this cell type. It also supports a hypothesis that
the CD8+ and gamma-delta T cells are not involved in the development of the gross
characteristics of the DTH response.
The data regarding the OM1 positive cells and the SW73.2 positive cells is a
little confusing, as there is an apparent reciprocal relationship between the cell
densities in the control and treated groups. It would be expected that the two
monoclonal antibodies would be defining the same cell populations, namely
macrophage type antigen presenting cells (APCs), as the only non APC cell
population that expresses MHC class II is the B lymphocyte subset which was not
found in the DTH response. The actual numerical values of the cell counts, as opposed
to the non-parametric rank, are very similar in the control and depleted group
suggesting that the statistical difference is possibly a quirk of the results.
In conclusion, the treatment of sheep with hydroxyurea did not produce a
consistent reduction in the circulating levels of PMNs. It did, however, produce
evidence that the circulating level of PMNs is associated with the size of a DTH
response and the level of PMNs and CD4+ cell infiltration into the histological DTH
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reaction. In MVV infected sheep, however, the depression in DTH response was not
associated with lowered levels of circulating PMNs. This depression in DTH size
following hydroxyurea treatment was not associated with a reduced influx of CD8+ or
gamma delta T cells into the lesion. The reduction in DTH response achieved by the
treatment with hydroxyurea was remarkably similar to the reduction in DTH response
associated with MVV seropositivity.
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CHAPTER SEVEN
ASSESSMENT OF IN VIVO PMN AND CD4+ CELL
FUNCTION
7.1 INTRODUCTION
The previous chapters have indicated that PMNs are present in high numbers in
the early DTH reaction, and that the depletion of neutrophils in vivo is associated with
a diminished ability of the sheep to establish a DTH response. The association of
PMNs with the establishment of a DTH response reflects the involvement of this cell
type in the control of increased vascular permeability (Wedmore, Williams, 1981; Abe
et al. 1990; Yi, Ulich, 1992), and the ability of the PMN to release a broad range of
proinflammatory mediators (Buchta, 1990). The CD4+ T cell was also found to be
present at significant levels in the early DTH lesion, this cell being both a direct
source of proinflammatory mediators, and responsible for the stimulation of the
release of such mediators by other cells (Scott, Kaufmann, 1991). This corresponds
with the finding that the depressed DTH response in animals chronically infected with
MVV is associated with a decreased level ofmigration of PMNs and CD4+ cells into
the early reaction. This reduced migration could be associated with either a decline in
the level of proinflammatory signal attracting the PMNs and CD4+ cells into the
lesion, or a decline in the ability of these cells to respond to a normal level of signal.
There has been no previously published investigation into the function of PMNs
in sheep infected with MVV, although studies ofHIV infected individuals have found
reductions in the in vitro performance of PMNs particularly in patients progressing
rapidly to AIDS (Gabrilovich et al. 1994), and dysregulated L selectin shedding after
cytokine stimulation by PMNs in AIDS patients (Elbim et al. 1994). A study
investigating the PMN function in HIV infected chimpanzees also discovered a
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decline in in vitro PMN function in these animals (Lafrado et al. 1989). There are also
reports of lentivirally associated neutropenias, particularly marked in FIV infection
(Mandell et al. 1992; Linenberger et al. 1995).
Similarly, there are no published reports ofCD4+ cell trafficking dysfunction in
MVV infected sheep, although they are present at relatively low levels in the
predominant pathological lesions in the lung tissue (Cordier et al. 1992; Lujan et al.
1993).
It was important, therefore, to assess the migratory ability of PMNs and CD4+
cells in the MVV infected sheep in order to ascertain whether the decrease in PMN
and CD4+ cell numbers in the early DTH in these animals was associated with a
decreased ability of these cells to migrate into the lesion. Previous publications had
shown that the dermal injection of a range of mediators were capable of recruiting
PMNs and/or CD4+ cells to the site of injection in sheep (Colditz, Movat, 1984;
Colditz, Watson, 1992; Mulder, Colditz, 1993; Colditz et al. 1994; Seow et al. 1994).
Three of these were selected for use in this trial, based on the results of these previous
publications that had shown these particular mediators to predominantly attract
PMNs, but also to attract smaller numbers of CD4+ cells. These mediators should,
therefore, mimic the cell traffic present in the early DTH lesion, where the MVV
associated abnormality in cell traffic was occurring. Three distinct mediators were
used to provide comparative data, as the mode of action of these three mediators has
been shown to be different.
The first of these mediators was zymosan activated plasma (ZAP), which is
prepared from sheep plasma, and contains activated complement components. This
agent acts as a direct chemoattractant, not requiring an intermediate protein synthesis
stage, and acts as an extremely potent chemoattractant of PMNs, but also attracts a
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small number of CD4+ cells (Colditz, Movat, 1984; Colditz, Watson, 1992; Mulder,
Colditz, 1993; Colditz etal. 1994).
The second mediator used was recombinant human IL-8 (rh-IL8). This again has
been shown to be a potent chemoattractant for PMNs and CD4+ cells in vivo (Colditz,
Watson, 1992; Mulder, Colditz, 1993; Colditz et al. 1994; Seow et al. 1994), with a
similar potency to recombinant ovine IL-8 (roIL8) (Seow et al. 1994). Again the
mechanism of attraction appears to be independent of de novo protein synthesis.
The final mediator chosen was tumour necrosis factor a (TNFa), which again is
a powerful chemoattractant for PMNs and CD4+ cells in vivo (Colditz, Watson, 1992;
Mulder, Colditz, 1993; Colditz et al. 1994), but is considered to require an
intermediate stage of protein synthesis for it's activity (Cybulsky et al. 1989), possibly
via the production of other cytokines such as IL-8 (Mulder, Colditz, 1993). This
mediator attracts relatively more CD4+ cells than the other mediators used.
The same sheep were subsequently examined for the degree of attenuation of the
DTH response.
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7.2 MATERIALS AND METHODS
7.2.1 Animals
Six adult female Texel sheep were chosen from the MVV infected flock (2.1,
Table 7.1). All of these sheep had been persistently seropositive for MVV, as defined
using a standard agar gel immunodiffusion test (2.2). Clinical examination of these
sheep revealed no detectable clinical abnormality, and routine haematological samples
indicated no abnormality in white blood cell count. Six sex and breed matched control
sheep of similar age to the infected ewes were obtained from accredited flocks (2.1,
Table 7.1). These control sheep were clinically normal and differential white blood
cell counts (2.3) revealed a slight elevation in total white blood cell count in sheep
148 to be the sole abnormality detectable. They were all found to be seronegative for
MVV infection at the time of challenge (Appendix 7.2.1).
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Table 7.1: Details of the breed, age, sex and serological status of the sheep used
in this study
Sheep Number Status Breed Age (years) Sex
006 MVV +ve Texel 8 Female
045 MVV +ve Texel 7 Female
065 MVV +ve Texel 8 Female
075 MVV +ve Texel 8 Female
101 MVV +ve Texel 8 Female
115 MVV +ve Texel 8 Female
RT05 Control Texel 5 Female
RT135 Control Texel 5 Female
RT151 Control Texel 5 Female
147 Control Texel 6 Female
148 Control Texel 5 Female
149 Control Texel 6 Female
7.2.2 Preparation and source of mediators
ZAP was prepared from plasma extracted from one of the control sheep (149). It
was prepared in the manner previously described (Colditz, Movat, 1984; Colditz,
Watson, 1992; Mulder, Colditz, 1993; Colditz et al. 1994). Firstly, heparinised blood
was collected from the sheep via jugular venepuncture into a sterile container
containing endotoxin free heparin (Sigma-Aldrich Company Ltd., Dorset, England).
The heparin and blood mixture were then centrifuged at 1500g for 5 minutes, and the
resultant supernatant plasma was aseptically decanted. Zymosan extract (Sigma-
Aldrich Company Ltd., Dorset, England) was hydrated by boiling in sterile pyrogen
free saline for 60 minutes with occasional agitation. The hydrated zymosan was added
to the plasma at a rate of 5mg of hydrated zymosan per ml of plasma. This was
140
incubated for 30 minutes at 37°C, with occasional agitation. The mixture was
subsequently centrifuged at 1500g for 5 minutes, and the supernatant was harvested
and either used immediately or snap frozen and stored at -70°C until required. The
activated plasma was arbitrarily considered to have a concentration of 5x10"^ mo1/1 of
activated complement component C5a as was assumed by previous authors (Damerau,
1987; Colditz, Watson, 1992; Mulder, Colditz, 1993; Colditz et al. 1994). The ZAP
was used at this concentration, and a 0.2ml volume of mediator was injected
intradermally into the skin of the medial thigh, equivalent to 1x10"^ mols of C5a,
this quantity having been shown to produce significant accumulation of PMNs and
CD4+ cells (Colditz, Watson, 1992; Mulder, Colditz, 1993; Colditz et al. 1994).
Recombinant human interleukin-8 was kindly supplied by Roche Products Ltd.,
Hertfordshire, U.K.. This was dissolved in pyrogen free phosphate buffered saline
(Sigma-Aldrich Company Ltd., Dorset, England) to a dilution such that a 0.2ml
injection dose contained 1x10"^ mols of rh IL8, this quantity having been shown to
cause the significant accumulation of PMNs and CD4+ cells (Colditz, Watson, 1992;
Mulder, Colditz, 1993; Colditz et al. 1994).
Recombinant ovine tumour necrosis factor a (ro-TNFa) was kindly provided by
Mr. Bahram Ebrahimi, Department of Veterinary Pathology, University of Edinburgh,
Edinburgh, UK. This was diluted in pyrogen free phosphate buffered saline (Sigma-
Aldrich Company Ltd., Dorset, England) such that a 0.2ml injection aliquot contained
0.2ng of ro-TNFa, the quantity that has been shown to attract a significant influx of
PMNs and CD4+ cells (Colditz, Watson, 1992; Mulder, Colditz, 1993; Colditz et al.
1994).
Sterile, pyrogen free saline was used as a control injection.
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7.2.3 Injection and biopsy technique
The three mediators and control sterile saline were injected into the medial thigh
of the sheep, with the precise point of injection marked with black ink (2.4). Biopsies
were taken at four hours post injection, this being the time indicated by the previous
studies as a time at which a significant infiltration with PMNs and CD4+ cells would
have occurred (Colditz, Movat, 1984; Colditz, Watson, 1992; Colditz et al. 1994;
Seow et al. 1994). Biopsies were performed in a standard manner (2.6), although an
8mm punch biopsy (Steifel Laboratories Ltd, Buckinghamshire, UK.) was used to
collect the skin specimens. The biopsies were bisected and processed in a routine
manner (2.6).
7.2.4 Histopathological staining




Frozen specimens were sectioned in a cryostat at 6pm, and subsequently stained
with SBU-T4 (CD4) monoclonal antibody in a standard fashion as described in
chapter 2.
7.2.6 Quantification
Sections were quantified in the manner described by the previous investigators
of PMN infiltration (Colditz, Watson, 1992; Mulder, Colditz, 1993; Colditz et al.
1994). This method consisted of the blind counting of the sections using a calibrated
eyepiece graticule at x250. Four adjacent fields in the superficial dermis and four
adjacent fields in the deep dermis were evaluated, and the total number of PMNs
(defined by their morphology) in the four fields of each of these sites was recorded.
The four fields counted represented a total counting area of 0.6724mm2.
7.2.7 DTH response
The sheep were subjected to an assessment of their DTH response in the




Grossly, injection with these mediators produced a relatively small reaction. A
reddened firm area of approximately 5mm diameter was visible, although no increase
in skin thickness was apparent.
7.3.2 PMN count
PMNs were found at relatively low levels in the control skin biopsies of all the
sheep (Appendix 7.3.2). Intradermal injection of all the mediators produced a
considerable influx of PMNs, with most of the cells recruited to the deep dermal areas
as opposed to the superficial dermal areas (Appendix 7.3.2, Figures 7.1 and 7.2). With
all mediators, there was a marked variation in the numbers of cells attracted to the
injection sites of the same mediator in different animals (Appendix 7.3.2). The level
of PMN cell infiltration was similar in all three mediators. Sites injected with sterile
saline as a control exhibited a relatively slight accumulation of PMNs in a small
number of the sheep (Appendix 7.3.2).
In all of the biopsies examined, including the control skin and the sterile saline
injection site, there were no significant differences in the PMN cell count (i.e. in the
superficial dermis, the deep dermis and in the total number counted in both areas)
between the MVV seropositive and control sheep (Figures 7.3-7.8), nor were there
any significant correlations between the level of PMNs in the mediator injected sites
and the size of the subsequently induced DTH reactions.
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Figure 7.1
Graph indicating the superficial dermal PMN cell count in skin
biopsies at 0 hours and 4 hours post intradermal injection of
chemoattractant agents and saline control material in MW
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Figure 7.2
Graph indicating the deep dermal PMN cell count in skin
biopsies at 0 hours and 4 hours post intradermal injection of
chemoattractant agents and saline control material in MW
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Figure 7.3: Photomicrograph of a biopsy taken from the IL-8 injected site of
a control animal. Note the widespread distribution of the infiltrating cells
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Figure 7.4: Photomicrograph of a biopsy taken from the IL-8 injected site of
an MVV infected animal. The distribution and phenotype of the infiltrating
cells is very similar to the control specimen (H&E, x250).
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Figure 7.5: Photomicrograph of a biopsy taken from a TNF-a injected site of
a control animal. Again, there is a widespread distribution of the infiltrating
cells. A majority of the infiltrating cells are PMNs (FI&E, x250).
Figure 7.6: Photomicrograph of a biopsy taken from a TNF-a injected site of
an MVV infected animal. There is no appreciable difference in the
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Figure 7.7: Photomicrograph of a biopsy taken from a ZAP injected site of a
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Figure 7.8: Photomicrograph of a biopsy taken from a ZAP injected site of
an MVV infected animal. The degree and nature of the infiltrate is
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7.3.3 CD4+ cell count
CD4+ cells were present in the control skin biopsies taken from all the sheep.
Intradermal injection of all mediators produced a relatively low level of migration of
CD4+ cells to the site of injection, with TNF-a acting as the most potent attractor of
CD4+ cells (Appendix 7.3.3 and Figures 7.9 and 7.10) There was no apparent pattern
of distribution between the superficial and deep dermis. Injection of the sterile saline
control also produced a marginal influx of CD4+ cells (Appendix 7.3.3 and Figures
7.9 and 7.10).
There were no significant differences in the level of CD4+ (i.e. in the superficial
dermis, the deep dermis and in the total number counted in both areas) cells in the
control skin or level of CD4+ cell migration produced by any of the injections
between the MVV positive and control groups, nor were there any significant
correlations between the level of CD4+ cells in the biopsies and the size of the
subsequently produced DTH response.
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Figure 7.9
Graph indicating the superficial dermal CD4 cell count in skin
biopsies at 0 hours and 4 hours post intradermal injection of
chemoattractant agents and saline control material in MW
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Figure 7.10
Graph indicating the superficial dermal CD4 cell count in skin
biopsies at 0 hours and 4 hours post intradermal injection of
chemoattractant agents and saline control material in MW
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7.3.4 Increase in skin thickness of a DTH response
The DTH responses produced in these sheep were consistent with those
previously seen, consisting of a reddened indurative plaque that was maximal at 48-72
hours post injection. The size of the response was significantly depressed in the MVV
seropositive animals at 7, 24 and 72 hours post injection (Appendix 7.3.4 and Figure
7.11).
Figure 7.11
Comparison of the increase in skin thickness with time
following the i/d injection of PPD into sensitised control
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The mediators used in this study produced a predominantly PMN dermal
infiltration, with a smaller number of CD4+ cells entering the injection site. All
mediators produced a similar level of PMN infiltrate, but TNF-a produced a higher
level of CD4+ cell infiltrate compared to the other mediators. These findings
correspond to the previously published findings (Colditz, Watson, 1992; Colditz et al.
1994; Seow et al. 1994). In this particular study there was a variability in the degree of
cell influx induced by the same mediator between individual animals, the previous
studies not having presented enough detailed data to allow direct comparison,
although the relatively large size of the graphically indicated standard errors of the
mean suggest that a marked degree of variability in cell response was present. The
results of this study were unable to confirm the previously described preferential
accumulation of CD4+ cells in the superficial dermis following TNF-a injection
(Colditz et al. 1994), but found individual sheep to have attracted cells preferentially
to either the deep or superficial dermis, probably reflecting differences in the depth of
the initial dermal injection. This study also produced a more marked degree of cellular
accumulation in the control PBS injected sites when compared to the biopsies
previously examined in the DTH studies. Since the material and method of injection
was identical to the previous experiments, this cellular influx is probably associated
with the increased volume of material injected (0.2ml compared to the previous
0.1ml) causing a higher level of tissue damage.
This study found no significant difference in the level of PMN and CD4+ cell
influx in response to the intradermal injection of a range of mediators. This provides
strong evidence that the lower level of these cells seen in the early DTH response in
MVV seropositive sheep is not associated with a decreased ability of these cells to
traffic to a site of inflammation. The only comparable studies of PMN migration into
induced inflammatory skin sites have centred on the investigation of critically ill
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anergic human subjects, where it was found that there was an increased intravascular
activation of PMNs associated with a decreased PMN migration into skin blister
windows (Tellado, Christou, 1991; Tellado et al. 1993). There is no previously
published investigation of the in vivo ability of these cell types to traffic to
inflammatory foci in any of the related lentiviral infection, although several studies
have discovered decreased in vitro levels of performance of PMNs from HIV infected
individuals (Elbim et al. 1994; Gabrilovich et al. 1994) and SIV infected chimpanzees
(Lafrado et al. 1989). Neutropaenia is also recorded in FIV infection (Mandell et al.
1992; Linenberger et al. 1995). The results of the DTH studies indicated that the
reduction in size of the DTH response is associated directly with a decreased number
of cells in the early response, which suggests that the defect in response is not in the
ability of these cells to promote an inflammatory response, but rather in the trafficking
of these cells into the lesion. This may be as a result of abnormalities in the
endothelial binding, cell chemotaxis into the lesion, or cell retention in the lesion
(Nickoloff et al. 1990). The studies of Tellado et al (1991 and 1993) have indicated
such a deficiency in PMN traffic in critically ill patients and associated this deficiency
with skin test anergy, although the suggestion is that this is due to an abnormality in
the PMN cell.
The results obtained by this study indicate that the MVV associated defect in
DTH response is not connected with an altered degree of PMN and CD4+ cell traffic
to these particular inflammatory signals. This provides evidence that the depression in
DTH is associated with a lowered proinflammatory stimulus produced in the early
stages of the DTH response, with a lower number of normal cells migrating to this
reduced level of signal.
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CHAPTER EIGHT
COMPARISON OF ANTI-PPD ANTIBODY
PRODUCTION IN CONTROL AND MVV INFECTED
ANIMALS
8.1 INTRODUCTION
The previous chapter has shown that the lower density of PMNs and CD4+ cells
found in the early DTH lesion of sheep that are seropositive to MVV is not associated
with a reduced ability of these cells to migrate to a standard inflammatory stimulus.
This finding leads to the suggestion that this deficiency in cell traffic is associated
with a relatively lower level of proinflammatory signal produced in the early DTH
lesion in the sheep seropositive for MVV.
One of the most potent stimulators of PMN migration is antibody/antigen
complex, which causes both the 'classical' activation of complement components and
the stimulation of certain cells to produce proinflammatory mediators following the
interaction with cell surface Fc receptors, as classically demonstrated in the Arthus
reaction (Sylvestre, Ravetch, 1994). The potency of activated complement in
attracting PMNs to dermal sites was confirmed in the previous chapter, where it was
shown that the intradermal injection of such activated complement components in the
sheep induces a marked cellular infiltrate, predominantly PMNs and similar to the
infiltrate seen in the early ovine DTH lesion. Indeed, a reaction considered similar in
appearance to a classical DTH response has been reported to occur in certain
circumstances following the intradermal injection of antigen/antibody complex
(Raffel, Newel, 1958). The role of the humoral immune system in the response to both
mycobacterial infection and following BCG vaccination has been extensively studied,
largely in connection with the development of a diagnostic serological test. This work
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has indicated that mycobacterial infection induces an antibody response, although at
relatively low levels (reviewed by (Grange, 1984)). There is dispute as to whether
BCG vaccination induces a similar antibody response, although one in depth study has
suggested that there is an early transitory antibody response following vaccination that
appeared at three weeks and declined at seven weeks post vaccination (Diena et al.
1968). This response was primarily of a IgM isotype.
HIV infection has been associated with the increased susceptibility to
mycobacterial infections, and it has been shown that in the later stages of the AIDS
complex that there is a decrease in the humoral response to mycobacterial PPD
components (Barrera et al. 1992).
It was therefore considered conceivable that there may be an antibody
involvement in the development of the early DTH response in the experimental BCG
vaccination system used, and that the diminished DTH response seen in the sheep
seropositive for MVV may be associated with a reduced humoral response to PPD
components leading to a reduced influx of PMNs into the early lesion. In order to
investigate this possibility, the anti-PPD antibody status in sheep prior to and
following BCG vaccination was evaluated in a group of MVV seropositive and
matched control sheep.
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8.2 MATERIALS AND METHODS
8.2.1 Source of hyperimmune and non immune serum
In order to produce hyperimmune sheep serum to PPD components, a Texel
control sheep was hyperimmunised to PPD as described in 2.11.1. Control serum was
obtained from blood samples collected from neonatal presuckling lambs as described
in 2.11.2.
8.2.2 Animals evaluated
Blood taken from sheep used in a previous DTH experiment (Chapter 5) were
assessed for the presence of circulating antibodies (Table 8.1).
Table 8.1: Details of the breed, age, sex and serological status of the sheep used
in this study
Sheep Number Status Breed Age (years) Sex
Oil MVV +ve Texel 9 Female
025 MVV +ve Texel 9 Female
035 MVV +ve Texel 8 Female
071 MVV +ve Texel 9 Female
076 MVV +ve Texel 8 Female
118 MVV +ve Texel 8 Female
183 Control Texel 8 Female
184 Control Texel 9 Female
245 Control Texel 8 Female
246 Control Texel 7 Female
247 Control Texel 9 Female
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8.2.3 ELISA technique
A standard ELISA technique as described in 2.11.3 was employed.
8.2.4 Western blotting technique
A standard Western blotting technique described in 2.11.4 was employed.
8.3 RESULTS
8.3.1 Optical density readings from the ELISA study
The ELISA technique was first validated using serum samples from the sheep
hyperimmunised to PPD. The enzyme reaction was seen to proceed rapidly, and the
optical density readings were therefore evaluated following an incubation of 20
minutes at room temperature. A standard serum dilution curve was obtained from this
study which enabled the definition of the range of serum dilutions at which there was




Mean optical density reading of quadruplet serum anti-
PPD antibody ELISA tests pre and post
hyperimmunisation of a sheep with PPD
Serial doubling dilutions of serum from 1:40 to 1:25600
It was discovered that the hyperimmune serum produced a much more intense
reaction than the test sera, and that when the test serum was incorporated into the
standard ELISA test plates at the concentrations which had been shown to be within
the linear area for the hyperimmune serum, there was no apparent reaction in the test
wells. The test serum was therefore incorporated into the test ELISAs at higher
concentrations such that the serial dilution gave results which were apparent in the
optical density readings. The test sera dilutions at which there was a linear
relationship between relative dilution and optical density reading were then evaluated
and the mean optical density of the duplicate readings at a standard dilution in the
centre of this linear area was selected as representative of the quantitative level of
anti-PPD antibody and used in the statistical analysis. This standard reading was at a
serum dilution of 1 in 40.
The results of this ELISA study indicated a trend of a slight increase in levels of
serum anti-PPD antibodies following BCG vaccination, although this was found to be
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not significant using a non-parametric Wilcoxon rank test (Figure 8.2 and Appendix
8.3.1).
Figure 8.2
Comparison of the mean optical density reading
of anti-PPD antibody levels in an ELISA assay











There was a significant negative correlation (p<0.05, Spearman ranking
correlation) between the optical density reading of the pre vaccinal level of circulating
antibodies and the size of the DTH reaction at 72 and 96 hours post challenge
following vaccination (Figures 8.3 and 8.4). There were no significant differences
between the levels of antibody in the MVV seropositive group and control group
either before or after BCG vaccination, and no correlations between the optical
density readings and the degree of PMN influx into the DTH lesion. However, there
appeared to be a trend towards higher levels of serum anti-PPD antibodies in the
MVV seropositive group of animals.
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Figure 8.3
Correlation between the pre BCG vaccine optical density
estimation of anti-PPD antibody level and the increase in skin
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Figure 8.4
Correlation between the pre BCG vaccine optical density
estimation of anti-PPD antibody level and the increase in skin
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8.3.2 Western blotting results
Western blotting of PPD and subsequent staining with amido black protein stain
produced a broad smear of staining throughout the length of the blot, with no distinct
bands visible, confirming the diverse and complex protein composition of PPD.
Development of the blotted PPD strips with both PBS and prenatal lamb serum
produced a faint banding pattern, indicating the non-specific binding of the secondary
anti-sheep IgG antiserum to components of the PPD. The sheep hyperimmunised to
PPD exhibited a marked increase in antibody binding, although the pattern was one of
an intense broad band of reactivity throughout the whole protein spectrum, with no
distinct banding patterns visible. In comparison, the pre and post vaccinal serum
samples from both the MVV seropositive and control group of animals exhibited
relatively low levels of antibody binding, with many animals having apparently
similar levels of reaction as the negative controls, suggesting that the level of
circulating anti-PPD antibody was negligible in these animals. In the sera which did
have an apparent increase in antibody levels following BCG vaccination, the increase
in antibody binding occurred in the area of the lower molecular weight markers of
approximately 14-20 kilodaltons (Figure 8.5), with the binding occurring as a smear in
most instances, although in some situations specific bands were noticeable.
Subjectively, there was no apparent difference in antibody binding between the two
groups of sheep, either before or after BCG vaccination, and there was no apparent
difference in the response to BCG vaccination. There appeared to be a trend towards
more marked banding patterns in the MVV seropositive group of sheep (Figure 8.5).
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Figure 8.5: Photograph of the developed Western blot strips illustrating the relatively
weak banding pattern in the samples when compared to the positive and negative
controls. A slight increase in band intensity is noticeable following vaccination in
some samples. There is a trend towards stronger bands in the MVV infected sheep
samples.
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When comparing the results obtained using the different methods of quantifying
antibody levels, there were similarities noted between the relative change in optical
density reading in the ELISA and the subjective alteration in density of the antibody
bands in the Western blots in the same animal assessed pre and post BCG vaccination,
although there appeared to be much less correlation between the ELISA readings and
the density of the Western blot bands between individual animals.
8.4 DISCUSSION
The results of this experiment have shown that there is no demonstrable
difference in the levels of circulating anti-PPD antibodies between the group of sheep
seropositive to MVV and the control sheep when assayed quantitatively in an ELISA
assay, with all levels being relatively low when compared to the serum of a sheep
hyperimmunised to PPD. There appeared to be a trend towards higher levels of serum
antibodies in the MVV seropositive group of animals both prior to and following
BCG vaccination. There was a significant negative correlation between the pre
vaccinal antibody optical density readings and the later increase in skin thickness of a
DTH response. There was no correlation between post vaccinal antibody optical
density readings and increase in skin thickness in the DTH response. There was also
no significant correlation between the levels of circulating antibodies and the degree
of influx of PMNs into the DTH lesion. When the same serum samples were studied
subjectively in the Western blots, there were no marked differences between the
groups, although there was a slight trend towards higher levels in the MVV
seropositive group, which would suggest a negative correlation between the antibody
level and the degree of PMN influx into and increase in skin thickness in the DTH
response, although this finding requires more detailed investigation.
The small differences in results obtained by the two different methods probably
result from the alterations in antigen characteristics that occur following SDS
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treatment and linearisation, and also reflects the minimal levels of antibodies
circulating in the serum of these sheep either prior to or following BCG vaccination.
This work has confirmed previous investigations in other species (Grange, 1984;
Ivanyi et al. 1988; Fifis et al. 1994), showing that the humoral component of the
immune system plays a relatively minor role in the immune response to BCG
vaccination, as judged by an increase in circulating levels of antibodies to
mycobacterial PPD. The finding of a significant negative correlation between the pre
vaccinal levels of circulating antibodies and the eventual maximal size of the DTH
would provide evidence that antibodies are in fact detrimental to the development of a
DTH response, although the significant correlation was no longer present when the
DTH was initiated following the administration of BCG vaccine. This latter finding
probably reflects the relatively marginal levels of circulating antibodies both pre and
post vaccination. Studies in cattle have also suggested that there is a reciprocal
relationship between the levels of antibodies and development of a PPD initiated DTH
in cattle affected with M. tuberculosis (Plackett et al. 1989). Indeed one study has
suggested that the presence of high levels of antibodies directly suppress the DTH
response (Morikawa et al. 1991). The inverse relationship between antibody levels
and DTH response size and the subjectively higher levels of circulating antibodies
found in sheep seropositive to MVV may indicate an inappropriate stimulation of the
humoral immune system as oppose to the cell mediated immune response in the MVV
sheep. This change of emphasis towards the humoral side of the immune system is
considered to be a feature of the later stages of HIV infection, where it is linked to a
change in the relative population of Thl and Th2 cells, with an increased proportion
of Th2 cells and decreased proportion of Thl cells. This change in turn leads to a
predominantly Th2 type response resulting in a relative increase in antibody
production and lowering of the cell mediated immune response (Meyaard et al. 1993).
Whilst the existence of these two Th subsets is not known in the sheep, it is interesting
to speculate that this mechanism may be involved in the depression of the DTH.
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In conclusion, the experimental work in this chapter has shown that there
appears to be little involvement of the humoral immune system in response to BCG
vaccination, and that there is no significant difference in the level of circulating anti-
PPD antibodies between the MVV seropositive group and the control animals at any
stage in the DTH experiment. There was, however, an inverse relationship between
the levels of prevaccinal antibodies and the development of a gross DTH lesion,
although there was no significant inverse association between the level of circulating
antibody and the recruitment of PMNs to the site of the DTH lesion. These findings
would suggest that antibodies play little part in the recruitment of PMNs to the ovine
DTH lesion, and that the deficiency in this process in sheep seropositive to MVV is
not related to alterations in the levels of such circulating antibodies. These findings
would, however, not rule out the possibility that there is a change of emphasis towards
a humoral response and away from a cell mediated response in the sheep seropositive
to MVV, analogous to the situation in people infected with HIV. Speculatively, this
change in emphasis may be associated with a change in relative levels of Thl/Th2
cells, and with the resultant alteration in cytokine production profiles.
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CHAPTER NINE
COMPARISON OF THE MRNA PRODUCTION
PROFILE IN THE DTH LESION OF MVV
SEROPOSITIVE AND CONTROL SHEEP
9.1 INTRODUCTION
The preceding work has indicated that the defect in PMN and CD4+ cell
migration into a DTH reaction in MVV seropositive sheep appears to be associated
with an alteration in the proinflammatory processes occurring at an early time point in
the reaction. Circulating anti-PPD antibody levels have been shown to be inversely
related to the development of the DTH response, indicating that antibody/antigen
complexes are not involved in the inflammatory process. The finding of a higher level
of circulating antibodies in the MVV infected sheep provided limited evidence that
these sheep have a tendency towards a humoral immune response, and the finding of a
depression in DTH suggested that MVV infected sheep had a tendency for a reduced
cell-mediated immune response. These findings combined would correlate to suggest
a hypothesis of an MVV induced switch from a Thl type response to a Th2 type
response analogous to that found in HIV infection (Meyaard et al. 1993).
Previous studies of inflammatory mediator involvement in PPD induced dermal
DTH responses have indicated that cytokines are crucial to the development of the
lesion. In particular, there is evidence for the production of predominantly Thl type
cytokines, with the specific importance of IFN-y in the ovine model being indicated
by the experimental reduction in DTH size achieved by treatment with an anti-IFN-y
neutralising monoclonal antibody (Emery, Davey, 1995). Further work has confirmed
the abundant presence of IFN-y in the later (post 24 hour) DTH reaction, along with
the other main Thl type cytokine IL-2, and has also indicated an considerable level of
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TNF-a (Chu et al. 1992; Tsicopoulos et al. 1992; Tsicopoulos et al. 1994; Chensue et
al. 1994; Ng et al. 1995). These studies reported a relatively low level of expression of
main Th2 type cytokine IL-4. One investigation reported a high level of expression of
IL-10 mRNA in the DTH (Ng et al. 1995). This cytokine is reported as exerting a
general suppressive effect on Thl type responses and is considered to be involved in
the cross regulation between Thl/Th2 lymphocyte subsets (Mosmann, 1994). IL-10
has also been reported to depress the production of other proinflammatory cytokine
production and reduce dermal swelling when administered immediately prior to
induction of a DTH type response (Li et al. 1994).
This information suggests that there could be an alteration of the cytokine
profile in the DTH response of the MVV seropositive sheep, with either a decrease in
the induced expression of a proinflammatory cytokine(s) or an increase in the
constitutive or induced expression of anti-inflammatory cytokines. It was therefore
important to assess the presence of a range of these cytokines in the early response of
both an MVV seropositive and control group of sheep. Since there was already a
significant difference in the density of inflammatory cells within the lesion by 24
hours post antigen injection, and PMN margination and migration had also been
shown to have commenced by 7 hours, it was decided to assess the cytokine profile in
biopsies taken at 0 and 7 hours post PPD and PBS injection, and compare these with
similar samples taken from control sheep.
Since there were relatively few cells in these early biopsies, a sensitive
technique was required to undertake these investigations, and RT-PCR technology
was therefore employed in order to assess the production of cytokine mRNA in the
DTH lesions (Arnheim, Erlich, 1992). In order to further increase sensitivity and to
show specificity, the PCR products were Southern blotted and probed using
radiolabelled internal sequence oligonucleotide probes. The cytokines whose
expression was investigated were those that had previously been shown to be
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important in both the induction and suppression of DTH responses, concentrating on
those that had been shown to induce dermal migration of PMNs and lymphocytes
when injected intradermally in sheep. IFN-y is a Thl cytokine that has been reported
to be crucial to the development of the DTH lesion (Tsicopoulos et al. 1992;
Tsicopoulos et al. 1994; Chensue et al. 1994; Ohmen et al. 1995; Emery, Davey,
1995; Ng et al. 1995), and has also been shown to induce significant accumulation of
lymphocytes and PMNs when injected dermally in sheep(Colditz, Watson, 1992). IL-
2 is similarly a Thl type cytokine, and is expressed in DTH lesions(Tsicopoulos et al.
1992; Tsicopoulos et al. 1994; Ng et al. 1995). In order to assess the level of IL-2 in
the lesions, the expression of mRNA for the IL-2R was examined, as this receptor
molecule is expressed in response to IL-2 mediated activation. Expression of IL2R is
therefore considered to be a marker for the IL-2 mediated activation of T cells
(Budjoso et al. 1992). TNF-a involvement has also been reported in DTH lesions (Ng
et al. 1995), and has also been shown to induce significant traffic of PMN and
lymphocytes when injected dermally in sheep (Colditz, Watson, 1992) Finally, IL-10
expression was also investigated as it has been shown to occur in DTH responses (Ng
et al. 1995), and may exert a suppressive effect (Li et al. 1994) analogous to the effect
associated with MVV seropositivity. The opportunity was also taken to use RT-PCR
to evaluate the presence of viral RNA in the skin sample in order to see whether there
was a direct correlation between the presence of virus and the suppression ofDTH.
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9.2 MATERIALS AND METHODS
9.2.1 Animals used
Six adult female Texel sheep were selected from the MVV infected flock (2.1,
Table 9.1). All of these sheep had exhibited a persistent serological response to MVV,
as defined using a standard agar gel immunodiffusion test. Six sex and breed matched
control sheep of similar age to the infected ewes were obtained from accredited flocks
(2.1, Table 9.1). These control sheep were clinically normal and serologically free
from MVV infection at the time of challenge.
Table 9.1: Details of the sheep used in this experiment
Sheep Number Status Breed Age (years) Sex
064 MVV +ve TexelX 9 Female
103 MVV +ve Texel >10 Female
155 MVV +ve TexelX 4 Female
168 MVV +ve Texel 4 Female
174 MVV +ve Texel X 4 Female
255 MVV +ve Texel 4 Female
51 Control Texel 2 Female
52 Control Texel 5 Female
54 Control Texel 5 Female
55 Control Texel 4 Female
56 Control Texel 2 Female
57 Control Texel 2 Female
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9.2.2 Initiation, measurement and biopsy of the DTH
The DTH was initiated, measured, and biopsied in the standard manner
described in 2.4 - 2.6. Biopsies were taken initially from untreated skin and from PPD
and PBS injected sites at 7 hours post injection. Biopsies were immediately wrapped
in aluminium foil and snap frozen in liquid nitrogen in order to preserve the integrity
of the RNA. Samples were maintained at -70°C for as short a time as possible before
the RNA was extracted.
9.2.3 Isolation of RNA
RNA was extracted from the tissue using a commercial kit as described in
2.12.2. Reverse transcription was performed as outlined in 2.13.1.
9.2.4 PCR technique
The PCR was performed as described in 2.13.2. Positive control material was
provided using specific plasmid cloned DNA sequences. In order to assess that RNA
isolation and reverse transcription had been performed successfully, the presence of
mRNA for the ubiquitous 'reporter' mRNA ATPase was first verified with the PCR
(Woodall et al. 1994). Samples were then subjected to PCR for specific cytokine
messages. The sequences of the primers and probes used is listed in Appendix 9.2.4.
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9.2.5 Radiolabeled probing
Radiolabeled probing was performed using probes complementary for internal
sequences of the PCR product as described in 2.14.2. Probed blots were left in contact
with X-ray film for variable lengths of time dependent upon the level of radioactivity
detected on the blot using a Geiger-Muller counter. This ranged from 3 hours at room
temperature for blots with high levels of radioactivity to 6 days at -70°C for blots with
minimal levels of radioactivity. Probe sequences are listed in Appendix 9.2.4.
9.3 RESULTS
9.3.1 Skin thickness
In accordance with previous results, increases in skin thicknesses following PPD
injection were maximal at 48-72 hours post injection (Figure 9.1, Appendix 9.3.1).
There was a significant depression in the increase in skin thickness seen in the MVV
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9.3.2 ATPase PCR
ATPase PCR products were detected in all the samples with the exception of
those from the sheep 56 PPD biopsy and the sheep 64 PBS biopsy. This confirmed
that mRNA had been successfully isolated and reverse transcribed from 34 of the 36
biopsy specimens (Appendix 9.3.2 and Figure 9.2).
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9.3.3 Virus PCR
The presence of virus was investigated using primers and probe specific for the
Pol region of the genome. The particular primer set and probe combination had been
shown to reliably detect a large range of virus isolates (Woodall and Ebrahimi,
personal communication). The positive control lanes produced marked bands on the
autoradiographs. All other lanes were negative (Appendix 9.3.2 and Figure 9.3).
9.3.4 IFN-y PCR
The autoradiograph of the probed blot of the IFN-y PCR products exhibited
strong bands in the positive control lanes. Otherwise, IFN-y was rarely detected in any
of the sample lanes, being present as a relatively weak signal in samples from the
following biopsies: 51 control, 54 PBS, 55 control (Appendix 9.3.2 and Figure 9.4).
There was no apparent difference in distribution between the two groups of sheep.
9.3.5 IL-2R PCR
The autoradiograph of the probed blot of the IL2-R PCR products exhibited
strong bands in the positive control lanes. Again, IL2-R was rarely detected in the
sample lanes with a moderate signal present in the sample from biopsy 51 PPD, and
weak signals present in samples from the following biopsies: 52 PBS, 155 PPD,
064PPD, 168 PBS, and 255 PBS (Appendix 9.3.2 and Figure 9.5). There was no
apparent difference in distribution between the two groups of sheep.
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9.3.6 TNF-a PCR
The autoradiograph of the probed blot of the TNF-a PCR products exhibited
only a weak band in the positive control lanes. In the sample lanes,a moderate positive
signal was detected in the sample from 057 PPD, and weak positive signals were
detected in a wide range of samples, including control, PBS and PPD biopsies
(Appendix 9.3.2 and Figure 9.6). There was no apparent difference in distribution
between the two groups of sheep.
9.3.7 IL-IO PCR
The autoradiograph of the probed blot of the IL-10 PCR products exhibited
strong bands in the positive control lanes. In the sample lanes, strong positive signals
were detected in a wide range of samples, including control, PBS and PPD biopsies.
There were no clear distinctions between the groups in the expression of IL-10
mRNA, although there was a trend towards stronger bands in the PPD biopsies of the
MVV group (although it should be stressed that this was not a quantitative
experimental system) (Appendix 9.3.2 and Figure 9.7).
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9.4 DISCUSSION
The results of this study indicate that there is no apparent alteration in the
cytokine mRNA profile in the early DTH reaction in sheep seropositive to MVV that
exhibit depression in the maximal size of the response. Furthermore, MVV specific
RNA was not present in the skin biopsies removed from the MVV group of sheep,
mRNAs coding for the proinflammatory cytokines IFN-y and TNF-a and
proinflammatory indicator IL2-R were not consistently present in the biopsies, with
many samples being negative, and there was a marked expression of IL-10 mRNA in
a large number of the biopsies, with a trend towards stronger banding in the MVV
infected sheep.
Previous studies of the expression of cytokine mRNAs in the PPD initiated
DTH response have utilised murine, rattine, bovine and human subjects; and have
largely concentrated on time points of 24 hours or later. These studies have
consistently reported the presence of IL-2 and IFN-y in the DTH at 24-72 hours using
immunohistochemistry, in situ hybridisation and RT-PCR techniques (Chu et al.
1992; Tsicopoulos et al. 1992; Chensue et al. 1994; Ohmen et al. 1995; Tsicopoulos et
al. 1994; Ng et al. 1995), with one study indicating a positive immunohistochemical
staining for IFN-y at 6 hours (Chu et al. 1992). The present study demonstrated that
expression of IFN-y mRNA was rare in any of the biopsy specimens, with no
indication that PPD induced an upregulation in this cytokine expression at the 7 hour
time point. This result would suggest that IFN-y is not produced at high levels in the
early ovine DTH and is not a major component in the control of the early cell
migration, although previous work would suggest that the infiltrating cells are
important producers of this cytokine. The depression in DTH size reported to occur
following depletion of IFN-y (Emery, Davey, 1995) would indicate a pivotal role for
this cytokine in the development of the DTH response, although this work provides no
indication of the kinetics of the involvement of IFN-y in the reaction. A less probable
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interpretation would be that the IFN-y is being released from storage and functioning
without the need for induction ofmRNA production, although there is no evidence to
support such a theory. A similar situation exists for the expression of mRNAs
encoding for IL-2R, with this experiment indicating that expression rarely occurred in
skin, and that PPD failed to induce an appreciable and consistent signal by 7 hours.
Previous studies have reported the presence of considerable levels of IL-2, but only in
biopsies of later time points (Tsicopoulos et al. 1992; Ohmen et al. 1995; Tsicopoulos
et al. 1994; Ng et al. 1995), although one study reported the expression of IL-2 in
untreated bovine skin (Ng et al. 1995). This would suggest that expression of IL-2,
and hence the expression of it's receptor molecule, occurs later in the reaction and is
probably associated with the presence of the T lymphocytes at this time point. It
would be reasonable to assume that IFN-y and IL-2R would be expressed
simultaneously as they are both primary components of the Thl type response.
The presence of TNF-a in PPD induced DTH responses has also been reported
previously, although once again a majority of biopsies were taken at time points of 24
hours and later (Chu et al. 1992; Ng et al. 1995). Depletion of TNF-a has also been
shown to reduce the DTH response (Chensue et al. 1994). In this study mRNA for
TNF-a was seen at low levels in a significant proportion of the biopsies including
untreated skin, although there was no consistent pattern of expression, as was reported
previously in the bovine DTH (Ng et al. 1995). These findings correlate with a
previous report that indicated the constitutive expression of TNF-a mRNA in
untreated ovine skin at levels which remained unchanged when the skin was
undergoing an inflammatory response (Elhay et al. 1994). Again, this would suggest
that the expression of mRNAs for this cytokine is not specifically upregulated by the
PPD at this early time point, although there is still a possibility that TNF-a may be
playing a significant role at this time point as it has been shown to be stored in an
active form in various cell types and released on stimulation without the requirement
for the production ofmRNAs (Vassalli, 1992). As a major proinflammatory cytokine
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responsible for the induced migration of lymphocytes and PMNs (Colditz, Watson,
1992), it is probable that this cytokine plays a part in the DTH, but it would appear
that the differential expression of this cytokine is not associated with the depression in
DTH response associated with MVV infection. The phenomenon of the release of
preformed TNF-a in the lesion would require a study using techniques such as
monoclonal antibody staining that are not currently available.
The apparent high levels of IL-10 expression in a large number of the biopsies
suggests that there is constitutive expression of this cytokine in the ovine skin. A
previous study of the bovine DTH has indicated that IL-10 is expressed preferentially
in DTH reactions compared to untreated skin (Ng et al. 1995), and IL-10 has been
shown to occur in human tuberculin reactions (Ohmen et al. 1995). IL-10 is generally
considered to be an immunosuppressive agent, and it's production by various cell
types including keratinocytes has been recorded (Luger, Schwarz, 1995). Indeed, it
has been postulated that IL-10 acts as a natural suppressant of cutaneous inflammation
and acts to limit immunopathological damage (Berg et al. 1995), being produced in
response to agents such as ultraviolet light (Luger, Schwarz, 1995). IL-10 is also
involved in the switch between Thl and Th2 subsets, and has been shown to inhibit
DTH reactions (Powrie et al. 1993; Li et al. 1994). It is therefore not surprising that
the mRNA encoding for this cytokine was found in a wide range of biopsies, where
the expression is presumably involved in maintaining an immunological homeostasis
in the skin. There was a suggestion that there may be a greater expression of IL-10 in
the MVV infected sheep, although it should be stressed that the experiment was not
performed in a manner that allows quantification of the results. Upregulation of IL-10
production has been previously reported in macrophages when they are infected with
HIV or stimulated with HIV peptides in vitro (Akridge et al. 1994; Emilie et al. 1994;
Haraguchi et al. 1995), and the operation of an analagous mechanism in MVV
infected sheep could provide an explanation for the suppression of the DTH.
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The lack of detectable viral RNA in the skin of the MVV infected sheep was a
significant finding. This would provide evidence that the depression in early cell
traffic in the DTH response is not as a direct result of the presence of viral particles or
active virus transcription within the lesion, but must be occurring either as a result of
the presence of latent viral DNA in the skin lesion or due to systemic
immunosuppressive effects of viral infection.
In conclusion, this experiment has indicated that the depression in DTH
associated with MVV infection is not associated with the local presence of virus
RNA. There was no clear distinction in cytokine profiles between the MVV infected
and control sheep, indicating that either the induction of these particular cytokines is
not affected by the MVV infection, or that there is a quantitative rather than
qualitative difference in cytokine production. Further studies could have included
broadening the the range of inflammatory mediators studied, with one of the more
promising candidates being the potent macrophage released proinflammatory agent
interleukin-1. Broadening the time course of samples taken would also have been of
great benefit as many mRNAs are only present during relatively short time periods, in
particular the use of later time point biopsies during the maximal response would have




The primary objective of this thesis was to study the in vivo functionality of the
cell mediated immune system in sheep naturally infected with MVV, using the PPD
induced dermal DTH reaction as an experimental model.
There was no previous report of a histological study the ovine PPD induced
dermal DTH response, and the essential first stage of the experimental process was the
characterisation of immunohistological characterisation of the DTH reaction in non-
infected control sheep. The results of this experiment indicated that the gross DTH
lesion consisted of a reddened indurative plaque that was maximal in size at 48-72
hours. Histologically, the response commenced at 7 hours post PPD injection, being
characterised by the margination and perivascular emigration of PMNs. This was
followed, at 24 hours, by the subsequent widespread emigration of large numbers of
PMNs, particularly into the periadnexal area., with a less marked emigration of CD4+
and CD8+ lymphocytes. By 48 hours, the density of PMNs in the lesion had declined
markedly, with an increase in the densities of both CD4+ and CD8+ lymphocytes. The
subsequent 72 hour biopsy had similar characteristics, as did the 96 hour biopsy,
although by this time the densities of inflammatory cells were lower. Fibrin and
oedema were marked features of the post 7 hour reaction. Macrophage density
remained at a relatively static level until 48 hours, at which time there was a marked
reduction in cell numbers which remained low throughout the remainder of the
reaction. The cell count of MHC class II expressing cells was similar to that of the
macrophages, exhibiting similar kinetics, suggesting that these markers were staining
the same cell population. Cell counts of B cells, mast cells and yb T cells remained
relatively low throughout the reaction, suggesting that they played little part in the
development of the lesion. These results constituted the basis of the further studies in
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the thesis, and also has been published (Pyrah & Watt, 1995). In particular, the finding
of a significant presence of PMNs in the early lesion clarifies the conflicting reports in
previous publications. As such, the work has relevance to the general understanding of
the cellular basis of the DTH response in all species.
The next experiment investigated the effect of the presence of natural MVV
infection on the development of a DTH response, and attempted to relate the findings
with the degree of classical maedi lung pathology. There were no previous studies of
the DTH response in naturally infected sheep, although a similar investigation in
experimentally infected sheep had produced some evidence for the depression ofDTH
in experimentally infected sheep (Myer et al. 1988). The results presented here
indicate that natural MVV infection was associated with a significant and variable
depression in the increase in skin thickness in the DTH response, and that this
depression was not associated with the degree of pathological change in the animal.
The former finding is consistent with the results of analogous studies in HIV
infection, although the latter finding is contrary to HIV research that linked the
depression in DTH with the progression of infection, in particular the development of
AIDS.
The preceeding study provided the platform for the immunohistological
assessment of the DTH response in MVV infected sheep. This showed that the
depression in DTH response in MVV infected was associated with a reduction in the
density of PMNs and CD4+ cells in the reaction at 24 hours, and that the density of
cells in the later lesion was not altered. These results suggested that the PMN and
CD4+ cell were essential for the production of the induration, and that MVV infection
resulted in the reduced ability of these cells to enter a DTH lesion. Although there
were many reports of the decline in DTH response in HIV infected individuals, there
were no reports of similar investigations into the histological basis of the alteration in
DTH development. This experiment therefore contributed to a greater understanding
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of the defect in DTH response in MVV infected sheep and also had comparative
interest in the study of the pathogenesis ofHIV infection.
As no specific evidence that the PMN was involved in the development of the
DTH reaction was available, control sheep were subsequently depleted of circulating
PMNs using hydroxyurea. Although this treatment was not successful in all cases,
there was an association between the circulating number of PMNs and the
development of a DTH reaction and degree of CD4+ cell influx into the lesion,
indicating that the PMN played a significant role in the reaction. These findings are of
significance to the study of alterations in the DTH reaction and may contribute to
understanding of the mode of action of the antigen specific cell mediated immune
response.
Once the importance of the PMN in the DTH had been established, it was
logical to study the in vivo performance of this cell and the CD4+ cell in the MVV
infected sheep, in order to ascertain whether the reduction in PMN and CD4+ cell
density in the early DTH lesion was as a result of dysfunction of these particular cells
in the sheep, or whether they were responding normally to an aberrant inflammatory
stimulus. To investigate this phenomenon, a necessarily limited range of
proinflammatory agents that were known to attract significant levels of PMNs and
CD4+ cells were injected intradermally into MVV infected and matched control
sheep. These agents acted via distinct mechanisms, but there was no significant
difference in the level of PMN and CD4+ cell emigration stimulated, and no
correlation between the emigration and the degree of depression of a subsequent DTH
response. This provided evidence that the DTH defect occurred as a result of an
alteration in the balance of inflammatory signal in the early part of the DTH response,
and is the first reported study of the in vivo migratory abilities of inflammatory cells
in sheep infected with MVV.
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These results indicated that the defect in DTH development in the MVV
infected sheep was associated with an alteration in the proinflammatory signal
produced by the early DTH lesion, and which was responsible for the emigration of
primarily PMNs. The fact that the PMN migration occurred at high levels in the early
lesion suggested that antibody/antigen interaction and complement activation may
have been significantly involved in the DTH immune response. A study of circulating
anti-PPD antibodies was therefore undertaken in order to establish whether there was
any difference in the response to BCG vaccination in the MVV infected sheep. This
experiment indicated that there was an insignificant antibody response to BCG
vaccination when compared to hyperimmune serum, confirming that there was a
predominant stimulation of the cell mediated immune system. There was, however,
also limited evidence that there were higher titres of antibodies in MVV infected
sheep, with a negative correlation between antibody titre and increase in skin
thickness of the DTH response. This finding suggested that there might be an MVV
associated shift in immune response from a Thl to a Th2 type response, analogous to
the situation reported in HIV infection.
The indication that antibodies were not involved in the promotion of PMN
migration lead to the investigation of other inflammatory mediators in the developing
DTH. As the lesion was relatively small at the 7 hour time point at which cell
migration had begun, the highly sensitive and highly specific technique of RT-PCR
followed by internal radiolabelled oligonucleotide probing was utilised to investigate
the mRNA production of a range of cytokines. The cytokines chosen for study were
either reported initiators of the DTH response, or had been shown to specifically
depress the DTH response in vivo. This study was the first reported investigation of
the cytokine profile of the developing tuberculin type DTH response, and one of the
few records of cytokine production in the normal skin of the sheep. The study
indicated that there was constitutive expression of TNF-a and IL10 in normal
untreated skin, although there was no specific upregulation of IL2R, IL10, TNF-a,or
185
IFN-y at 7 hours post injection of either PBS or PPD. There was some evidence for a
trend towards higher levels of IL10 expression in MVV infected animals. Most
surprisingly, there was no viral RNA present in any of the skin biopsies examined.
This latter finding indicates that the depression of DTH response is either associated
with a systemic effect of the virus, or that the effect is resultant from the presence of
viral DNA in an inactive or latent form. The author is not aware of any similar study
of virus presence in the DTH lesion ofHIV infected patients.
In conclusion, this thesis has contributed to the understanding of the normal
DTH response and has indicated the immunopathological mechanism by which this
reaction is depressed in sheep naturally infected with MVV.
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APPENDICES TO CHAPTER 2
Appendix 2.9.2
Red blood cell lysis buffer solutions tfreshly prepared immediately prior to
useh
90mls O.I6MNH4CL3
lOmls 017M TRIS (pH 7.65)
The resultant solution adjusted to pH 7.2.
Cell washing buffer
Phosphate Buffered Saline with:




ELISA alkaline phosphatase substrate










SDS PAGE gel solutions
Stacking gel 5% gel 20% gel
30% acrylamide / 0.8% bis 0.5ml 2ml 8.3ml
1M tris / 5mM EDTA pH 8.8 3.8ml 3.8ml
Distilled water 2.5ml 6.25ml
10% SDS 50pl 125pl 125pl
1M tris pH 6.8 0.6ml
*10% Ammonium persulphate(freshly 25pl 30pl 30pl
made up)
*Temed 7.5pl 3pi 3pi
"'ONLYADDED IMMEDIATELYPRIOR TO POURING THE GEL
SDS dissolving buffer

































x5 RT superscript buffer (Gibco BRL) 5pi
Random hexamer primers (Pharmacia Biotech) 1.5pi
20nm dNTPs (Pharmacia Biotech) 2.5pl
O.lmDTT (Gibco BRL) lpl
RNAsin (Pharmacia Biotech) 1 pi
RT superscript (Gibco BRL) 1 pi
RNase free water (Sigma) 3pi
Appendix 2.13.2
PCR reaction mix
PCR buffer [lOOmM Tris HCl,pH 8.3,500mM KC1] (Gibco BRL) 5.0 pi
50mM MgCl2 (Gibco BRL) 2.5 pi
20mM dNTPs (Pharmacia Biotech) 1.0 pi
Primer 1 (25pmol/pl) 1.0 pi
Primer 2 (25pmol/pl) 1.0 pi
cDNA 3.0 pi
RNA water (Sigma) 36.0 pi
Appendix 2.13.3
TAE buffer t0.04M tris-acetate. 0.001M EDTAt
57.1ml glacial acetic acid
100ml 0.5M EDTA (pH 8.0)
Make up to one litre with distilled water.
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Appendix 2.14.1
SSPE buffer (x20 concentrate!
175.3g NaCl 27.6g NaH2PO4-H20 (Equivalent to 31.2g of
NaH2PO4.2H20)
7.4g EDTA
Make up to 800ml with water.
pH to 7.0 with lONNaOH.
Adjust the volume to 1000ml with distilled water and sterilise by autoclaving
Appendix 2.14.2
Hybridisation buffer (per 10 mist
8.46ml distilled H20
1 g dextran sulphate
lml 10% SDS
Incubate for 30 minutes at 65°C, and then add
0.58g NaCl
0.4ml 20xSSPE
Incubate for 15 minutes at 65°C prior to use
TE Buffer
lOmM TRIS-HC1 (pH 7.4)




l.Op.1 oligonucleotide (at a concentration of 50ng/|j.l)
1 4.0jlx1 RNAase free water
2.0ql 32p labelled ATP (equivalent to 20pCi)
1 .Ofj.1 PNK enzyme
Incubate for 30 minutes at 37°C, and then terminate the reaction with
80.0|ul TE buffer
APPENDICES TO CHAPTER 3
Appendix 3.3.1
Table of increase in skin thickness versus time post PPD injection
Sheep Increase in skin thickness (mm) at
number
2 hours 7 hours 24 hours 48 hours 72 hours 96 hours
111 0 0 1 6 8.5 6
114 0 0 3 16 14 6
142 0 0 4 14 16 8
143 0 1 6 14 14 8
144 0 0 5 9 13 8
145 0 0 4 12 14 8
Table of increase in skin thickness versus time post control (PBS) injection
Sheep Increase in skin thickness (mm) at
number
2 hours 7 hours 24 hours 48 hours 72 hours 96 hours
111 0 0 0 0 0 0
114 0 0 0 0 0 0
142 0 0 0 0 0 0
143 0 0 0 0 0 0
144 0 0 0 0 0 0
145 0 0 0 0 0 0
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Appendix 3.3.3
Tables indicating the superficial dermal and periadnexal cell count of PMN
cells at time points following the i/d injection of PPD and PBS in sensitised sheep
Sheep Superficial dermal PMN cell count following PBS injection
number 2 hours 7 hours 24 hours 48 hours 72 hours 96 hours
111 11101
114 8 21 16 2 0 2
142 4 2 3 0 2 0
143 2 8 4 9 8 8
144 6 4 2 8 2 2
145 1 8 0 0 6 0
Superficial dermal PMN cell count following PPD injection
2 hours 7 hours 24 hours 48 hours 72 hours 96 hours
111 59 129 51 112 93 46
114 170 120 154 89 49 8
142 12 2 139 51 67 28
143 5 2 142 157 43 18
144 3 4 132 42 42 7
145 0 12 196 0 100 16
Sheep Periadnexal PMN cell count following PBS injection
number 2 hours 7 hours 24 hours 48 hours 72 hours 96 hours
111 1572 7
114 13 37 19 6 8 11
142 10 4 5 2 8 5
143 4 10 26 9 1 4
144 5 6 5 8 8 6
145 3 2 1 4 8 6
Periadnexal PMN cell count following PPD injection
2 hours 7 hours 24 hours 48 hours 72 hours 96 hours
111 82 140 42 104 56 35
114 177 116 236 79 93 24
142 10 12 199 53 85 69
143 10 8 209 158 74 36
144 6 13 205 64 45 22
145 2 27 216 8 128 36
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Appendix 3.3.4
Tables indicating the superficial dermal and periadnexal cell count of cells
exhibiting positive staining with monoclonal antibody SBU-T4 (CD4+ T cells) at
time points following the i/d injection of PPD and PBS in sensitised sheep
Sheep Superficial dermal CD4 cell count following PBS injection
number 2 hours 7 hours 24 hours 48 hours 72 hours 96 hours
111 4 6 4 1 4 4
114 6 1 39 9 2 4
142 4 0 1 3 4 8
143 2 4 4 4 8 8
144 12 4 10 17 8 4
145 6 1 1 4 2 4
Superficial dermal CD4 cell count following PPD injection
2 hours 7 hours 24 hours 48 hours 72 hours 96 hours
111 6 10 20 52 88 68
114 10 5 8 98 112 72
142 10 4 30 57 102 60
143 10 2 39 64 65 138
144 12 5 19 46 77 74
145 8 8 16 54 64 62
Sheep Periadnexal CD4 cell count following PBS injection
number 2 hours 7 hours 24 hours 48 hours 72 hours 96 hours
111 5 16 17 20 19 16
114 9 16 58 45 21 8
142 6 3 0 4 10 17
143 4 8 8 4 9 10
144 9 4 7 28 9 14
145 10 6 5 8 12 9
Periadnexal CD4 cell count following PPD injection
2 hours 7 hours 24 hours 48 hours 72 hours 96 hours
111 3 56 21 158 205 197
114 27 17 29 181 160 116
142 7 5 34 90 121 172
143 3 9 69 147 152 126
144 12 16 44 83 108 88
145 22 10 50 110 120 106
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Appendix 3.3.5
Tables indicating the superficial dermal and periadnexal cell count of cells
exhibiting positive staining with monoclonal antibody SBU-T8 (CD8+ T cells) at
time points following the i/d injection of PPD and PBS in sensitised sheep
Sheep Superficial dermal CD8 cell count following PBS injection
number 2 hours 7 hours 24 hours 48 hours 72 hours 96 hours
111 3 5 7 7 4 1
114 5 5 8 5 6 5
142 4 7 5 0 1 2
143 0 3 1 3 1 0
144 6 4 6 8 6 4
145 4 1 0 1 1 1
Superficial dermal CD8 cell count following PPD injection
2 hours 7 hours 24 hours 48 hours 72 hours 96 hours
111 5 4 6 49 38 45
114 1 6 29 85 94 76
142 2 2 1 18 22 29
143 3 1 8 17 31 22
144 5 4 33 24 26 19
145 0 3 6 7 11 7
Sheep
number Periadnexal CD8 cell count following PBS injection
2 hours 7 hours 24 hours 48 hours 72 hours 96 hours
111 4 7 17 5 3 6
114 9 8 19 9 16 12
142 2 8 6 4 1 3
143 1 2 1 4 2 2
144 5 2 9 5 1 2
145 4 3 2 2 3 2
Periadnexal CD8 cell count following PPD injection
2 hours 7 hours 24 hours 48 hours 72 hours 96 hours
111 7 7 25 124 112 109
114 12 19 39 187 155 114
142 4 1 4 55 54 69
143 7 4 12 51 33 45
144 6 6 58 50 48 40
145 3 3 9 47 24 34
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Appendix 3.3.6
Tables indicating the superficial dermal and periadnexal cell count of cells
exhibiting positive staining with monoclonal antibody 86D (gamma delta T cells) at
time points following the i/d injection of PPD and PBS in sensitised sheep
Sheep Superficial dermal g/d cell count following PBS injection
number 2 hours 7 hours 24 hours 48 hours 72 hours 96 hours
111 1 11 7 3 2 9
114 4 6 20 7 5 5
142 0 6 14 12 14 5
143 1 1 2 3 4 3
144 9 1 0 13 0 2
145 3 1 2 3 3 2
Superficial dermal g/d cell count following PPD injection
2 hours 7 hours 24 hours 48 hours 72 hours 96 hours
111 5 2 2 15 8 16
114 5 7 14 37 32 13
142 1 1 5 1 5 7
143 1 1 4 2 2 4
144 0 7 9 9 18 6
145 5 1 4 8 12 6
Sheep Periadnexal g/d cell count following PBS injection
number 2 hours 7 hours 24 hours 48 hours 72 hours 96 hours
111 4 16 15 7 10 8
114 14 10 33 11 15 5
142 4 5 5 10 8 4
143 3 2 4 8 4 4
144 13 2 1 3 1 4
145 6 5 6 5 3 6
Periadnexal g/d cell count following PPD injection
2 hours 7 hours 24 hours 48 hours 72 hours 96 hours
111 6 5 11 19 24 33
114 23 27 29 31 39 29
142 1 3 2 3 6 8
143 0 2 8 6 7 8
144 1 6 8 6 12 7
145 7 3 3 8 10 11
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Appendix 3.3.7
Tables indicating the superficial dermal and periadnexal cell count of cells
exhibiting positive staining with monoclonal antibody OM1 (macrophages) at time
points following the i/d injection of PPD and PBS in sensitised sheep
Sheep Superficial dermal OM1 cell count following PBS injection
number 2 hours 7 hours 24 hours 48 hours 72 hours 96 hours
111 5 8 7 6 8 7
114 4 7 5 8 6 5
142 3 4 5 7 5 3
143 3 2 13 21 2 2
144 2 3 2 1 5 4
145 2 10 3 3 3 5
Superficial dermal OM1 cell count following PPD injection
2 hours 7 hours 24 hours 48 hours 72 hours 96 hours
111 5 6 3 4 2 7
114 3 5 2 1 0 2
142 4 5 2 0 0 0
143 5 4 1 0 1 0
144 4 8 0 1 0 0
145 10 8 4 8 1 1
Sheep Periadnexal OM1 cell count following PBS injection
number 2 hours 7 hours 24 hours 48 hours 72 hours 96 hours
111 12 13 14 12 5 7
114 10 11 15 12 9 12
142 5 16 12 17 15 14
143 7 3 7 23 12 1
144 10 10 8 6 7 9
145 23 25 19 13 8 5
Periadnexal OM1 cell count following PPD injection
2 hours 7 hours 24 hours 48 hours 72 hours 96 hours
111 10 12 13 5 6 10
114 9 15 4 3 2 2
142 9 12 4 3 1 1
143 13 21 3 2 1 2
144 13 16 1 0 1 2
145 20 10 12 8 2 0
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Appendix 3.3.8
Tables indicating the superficial dermal and periadnexal cell count of cells
exhibiting positive staining with monoclonal antibody SW73.2 (MHC class II) at
time points following the i/d injection of PPD and PBS in sensitised sheep
Sheep Superficial dermal SW73.2 cell count following PBS injection
number 2 hours 7 hours 24 hours 48 hours 72 hours 96 hours
111 5 4 3 4 2 2
114 4 4 4 3 3 5
142 3 3 5 2 4 4
143 2 6 4 2 4 5
144 6 3 3 3 3 3
145 2 4 2 3 4 3
Superficial dermal SW73.2 cell count following PPD injection
2 hours 7 hours 24 hours 48 hours 72 hours 96 hours
111 5 3 2 0 0 0
114 6 2 1 0 0 0
142 2 3 3 1 0 0
143 2 4 1 0 3 0
144 2 5 2 2 0 0
145 2 4 0 0 1 0
Sheep Periadnexal SW73.2 cell count following PBS injection
number 2 hours 7 hours 24 hours 48 hours 72 hours 96 hours
111 8 7 6 8 7 9
114 10 12 10 8 7 8
142 13 11 10 9 8 9
143 10 13 15 5 12 15
144 11 9 10 11 8 9
145 9 11 9 8 11 9
Periadnexal SW73.2 cell count following PPD injection
2 hours 7 hours 24 hours 48 hours 72 hours 96 hours
111 9 8 0 1 0 0
114 12 14 2 0 0 0
142 11 9 5 0 0 0
143 9 2 0 0 1 0
144 12 2 0 1 0 0
145 12 0 1 2 2 1
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APPENDICES TO CHAPTER 4
Appendix 4.3.1
Table indicating the increase in skin thickness at time points following the i/d
injection of PPD in sensitised sheep
Sheep Increase in skin thickness (mm) at
number
2 hours 7 hours 24 hours 48 hours 72 hours 96 hours
004 0 0 3 5 7 6
10 0 0 0 2 2 2
20 0 0 0 3 2 2
27 0 0 0 16 10 7
57 0 0 0 4 5 3
Table indicating the increase in skin thickness at time points following the i/d
injection of PBS in sensitised sheep
Sheep Increase in skin thickness (mm) at
number
2 hours 7 hours 24 hours 48 hours 72 hours 96 hours
004 0 0 0 0 0 0
10 0 0 0 0 0 0
20 0 0 0 0 0 0
27 0 0 0 0 0 0
57 0 0 0 0 0 0
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Table indicating the value of the Spearman correlation statistic relating the lung
pathology assessment attributed independently by two pathologists and the increase
in skin thickness at time points following i/d PPD injection in sensitised control and
MVV infected sheep. There are no significant correlations.
Increase in skin thickness at
2 hours 7 hours 24 hours 48 hours 72 hours 96 hours
Interstitial 0 -0.509 -0.195 0.195 -0.019 0.048
score 1
Interstitial 0 -0.359 -0.095 0.447 0.179 0.104
score 2








Follicle 0 -0.191 -0.164 0.372 0.006 -0.066
structure
count 1
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10/2/94 +ve +ve +ve +ve +ve +ve -ve -ve ND ND ND
20/6/94 ND ND ND ND ND ND -ve -ve -ve -ve -ve
2/11/94 +ve +ve ND +ve ND +ve -ve -ve -ve -ve -ve
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Appendix 5.2.4
Computer image analysis routine (QUIPS) routine used for cell counting
Expression ( TAG=1 )
For ( TAG = 1 to 6, step 1 )
PauseText ( "Draw around the gland and then press continue or O.K." )
Binary Edit [PAUSE] ( Draw from Detected to Detected, nib Fill, width 2 )
Binary Amend ( Dilate from Detected to Amended, cycles 100 )
Binary Logical ( C = A XOR B : C Amended, A Detected, B Amended )
Expression ( MFLDIMAGE=3 )
Measure field (plane MFLDIMAGE, into FLDRESULTS(l))
Selected parameters: Area
Binary Logical ( copy Amended, inverted to Amended )
Binary Logical ( copy Amended to Accepted )
PauseText ("Indicate the positive cells using the mouse and then press OK or
continue" )
Binary Edit [PAUSE] ( Line from Amended to Amended, nib Circle, width 6 )
Binary Logical ( C = A XOR B : C Accepted, A Amended, B Accepted )
Expression (MINAREA=0 )
Expression (MFEATINPUT=4)
Expression ( FERETS=8 )
Measure feature ( plane MFEATINPUT, FERETS ferets, minimum area:
MINAREA
feature counts into FTRCOUNT(2), results into FTRRESULTS(count,0) )
Selected parameters:
Display Page
Display ( "Area measured around the gland (mmsquare)")
Display (FLDRESULTS(l) )
Display Line




Display ( "Cells per area (cells/mm2)" )
Expression ( AREAPERCELL=FTRCOUNT( 1 )/FLDRESULTS( 1) )
Display ( AREAPERCELL )
Binary Logical ( C = A XOR B : C Detected, A Detected, B Detected )
Binary Logical ( copy Detected to Amended )
Binary Logical ( copy Detected to Accepted )
Next (TAG)
Expression (TAG2=1 )
For ( TAG2 = 1 to 6, step 1 )
PauseText ( "Draw a superficial dermal area ignoring adnexae and lymphatics" )
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Binary Edit [PAUSE] ( Draw from Detected to Detected, nib Fill, width 2 )
Expression ( MFLDIMAGE=2)
Measure field ( plane MFLDIMAGE, into FLDRESULTS(l) )
Selected parameters: Area
Binary Logical ( copy Detected, inverted to Detected )
Binary Logical ( copy Detected to Amended )
PauseText ( "Indicate the positive cells with the mouse" )
Binary Edit [PAUSE] ( Line from Detected to Detected, nib Circle, width 6 )
Binary Logical ( C = A XOR B : C Amended, A Detected, B Amended )
Expression ( MFEATINPUT=3 )
Expression ( MINAREA=0 )
Expression (FERETS=8 )
Measure feature ( plane MFEATINPUT, FERETS ferets, minimum area:
MINAREA
feature counts into FTRCOUNT(2), results into FTRRESULTS(count,0))
Selected parameters:
Display Page
Display ("Area measured (mm2)")





Display ("Cells per mm2")
Display ( FTRCOUNT( 1 )/FLDRESULTS( 1) )
Binary Logical ( C = A XOR B : C Detected, A Detected, B Detected )




Table indicating the increase in skin thickness at time points following the i/d
injection of PPD in sensitised MVV positive and control sheep
Sheep Increase in skin thickness (mm) at
number
2 hours 7 hours 24 hours 48 hours 72 hours 96 hou
Oil 0 0 4 8 7 5.5
025 0 2 5.33 6.5 5.5 2
035 0 0 2.667 4.5 5.5 4
071 0 0.333 2.667 4.5 6 2
076 0 0 1 1 3 2
118 0 0 3.333 8 8.5 2
183 0 1.333 6.667 11.5 10 5
184 0 0.667 5 11.5 10 5
245 0 1.5 10.666 14.5 13 7
246 0 1 10.666 15 11.5 5
247 0 1 8.333 16 13 7
Table indicating the increase in skin thickness at time points following the i/d
injection of PBS in sensitised sheep
Sheep Increase in skin thickness (mm) at
number
2 hours 7 hours 24 hours 48 hours 72 hours 96 hours
011 0 0 0 0 0 0
025 0 0 0 0 0 0
035 0 0 0 0 0 0
071 0 0 0 0 0 0
076 0 0 0 0 0 0
118 0 0 0 0 0 0
183 0 0 0 0 0 0
184 0 0 0 0 0 0
245 0 0 0 0 0 0
246 0 0 0 0 0 0
247 0 0 0 0 0 0
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Table indicating the superficial dermal and periadnexal cell count of PMN cells
at time points following the i/d injection of PBS in sensitised sheep
Sheep Periadnexal count at Superficial dermal count at
nber 0 hours 24 hours 72 hours 0 hours 24 hours 72 hours
11 177 192 188 105 100 85
25 158 194 194 139 113 139
35 188 213 221 78 98 127
71 315 291 177 226 170 134
76 207 186 169 105 102 99
118 215 225 204 78 127 84
183 164 108 187 77 71 91
184 184 183 190 102 100 101
245 184 119 117 74 96 99
246 122 117 154 81 71 74
247 180 96 140 80 72 69
Table indicating the superficial dermal and periadnexal cell count of PMN cells
at time points following the i/d injection of PPD in sensitised sheep
Sheep Periadnexal count at Superficial dermal count at
nber 0 hours 24 hours 72 hours 0 hours 24 hours 72 hours
11 177 2526 696 105 1589 309
25 158 2628 1114 139 1201 274
35 188 3935 671 78 2395 492
71 315 1226 1245 226 1120 778
76 207 979 1317 105 713 577
118 215 2364 1519 78 2030 1183
183 164 5094 2756 77 2841 1877
184 184 4125 2822 102 2621 1942
245 184 5271 1425 74 2513 887
246 122 5111 2118 81 1768 1673
247 180 4561 732 80 1937 490
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Table indicating the superficial dermal and periadnexal cell count of cells
exhibiting positive staining with monoclonal antibody SBU-T4 (CD4+ T cells) at time
points following the i/d injection of PBS in sensitised sheep
Sheep Periadnexal count at Superficial dermal count at
nber 0 hours 24 hours 72 hours 0 hours 24 hours 72 hours
11 239 187 248 105 112 141
25 309 249 270 148 123 141
35 381 187 263 141 124 118
71 174 223 294 133 106 129
76 245 322 183 139 128 92
118 286 215 234 129 123 134
183 310 201 272 142 125 132
184 247 178 183 111 104 121
245 219 251 240 123 156 157
246 227 229 298 126 121 169
247 238 214 263 138 128 132
Table indicating the superficial dermal and periadnexal cell count of cells
exhibiting positive staining with monoclonal antibody SBU-T4 (CD4+ T cells) at time
points following the i/d injection of PPD in sensitised sheep
Sheep Periadnexal count at Superficial dermal count at
nber 0 hours 24 hours 72 hours 0 hours 24 hours 72 hours
11 239 750 1893 105 500 1078
25 309 437 2325 148 362 1625
35 381 1008 2076 141 306 1131
71 174 750 1893 133 500 1078
76 245 859 2303 139 567 1286
118 286 851 1878 129 427 699
183 310 1179 2082 142 740 1091
184 247 1217 2367 111 556 1212
245 219 979 1763 123 601 1084
246 227 1024 1872 126 478 1077
247 238 1305 1834 138 614 1027
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Table indicating the superficial dermal and periadnexal cell count of cells
exhibiting positive staining with monoclonal antibody SBU-T8 (CD8+ T cells) at time
points following the i/d injection ofPBS in sensitised sheep
Sheep Periadnexal count at Superficial dermal count at
nber 0 hours 24 hours 72 hours 0 hours 24 hours 72 hours
11 248 199 275 102 103 143
25 177 215 160 134 126 99
35 232 204 182 115 121 126
71 156 177 197 113 112 100
76 176 207 204 120 101 116
118 203 185 188 116 124 135
183 166 154 174 109 114 112
184 227 224 239 127 132 160
245 96 171 302 100 117 109
246 178 224 217 108 137 108
247 225 250 232 133 147 160
Table indicating the superficial dermal and periadnexal cell count of cells
exhibiting positive staining with monoclonal antibody SBU-T8 (CD8+ T cells) at time
points following the i/d injection of PPD in sensitised sheep
Sheep Periadnexal count at Superficial dermal count at
nber 0 hours 24 hours 72 hours 0 hours 24 hours 72 hours
11 248 260 934 102 182 521
25 177 505 1008 134 281 582
35 232 433 1285 115 201 467
71 156 507 1026 113 291 566
76 176 523 1301 120 292 403
118 203 431 1365 116 213 497
183 166 416 1208 109 256 446
184 227 482 1214 127 305 581
245 96 654 1003 100 363 652
246 178 601 1172 108 354 665
247 225 709 1152 133 430 622
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Table indicating the superficial dermal and periadnexal cell count of cells
exhibiting positive staining with monoclonal antibody 86D (gamma delta T cells) at
time points following the i/d injection ofPBS in sensitised sheep
Sheep Periadnexal count at Superficial dermal count at
nber 0 hours 24 hours 72 hours 0 hours 24 hours 72 hours
11 109 246 184 53 93 88
25 130 460 357 143 172 171
35 245 302 148 67 161 100
71 122 272 227 93 151 139
76 184 265 114 124 117 93
118 213 216 138 79 190 101
183 139 201 206 97 158 120
184 152 102 90 97 57 51
245 150 131 153 87 116 86
246 146 162 68 109 108 89
247 108 170 150 71 86 64
Table indicating the superficial dermal and periadnexal cell count of cells
exhibiting positive staining with monoclonal antibody 86D (gamma delta T cells) at
time points following the i/d injection of PPD in sensitised sheep
Sheep Periadnexal count at Superficial dermal count at
nber 0 hours 24 hours 72 hours 0 hours 24 hours 72 hours
11 109 114 158 53 114 120
25 130 273 187 143 293 215
35 245 138 153 67 80 132
71 122 271 261 93 110 135
76 184 229 457 124 135 94
118 213 221 139 79 120 106
183 139 307 185 97 120 137
184 152 159 173 97 93 137
245 150 192 143 87 144 123
246 146 412 318 109 177 193
247 108 354 341 71 236 139
243
Appendix 5.3.7
Table indicating the superficial dermal and periadnexal cell count of cells
exhibiting positive staining with monoclonal antibody OM1 (macrophages) at time
points following the i/d injection of PBS in sensitised sheep
Sheep Periadnexal count at Superficial dermal count at
liber 0 hours 24 hours 72 hours 0 hours 24 hours 72 hours
11 74 82 88 144 162 126
25 124 112 128 173 175 231
35 181 125 184 140 174 190
71 117 127 161 136 151 127
76 93 155 148 143 172 140
118 65 116 84 94 120 122
183 140 129 178 151 127 167
184 117 143 136 133 163 139
245 125 92 101 106 105 116
246 221 158 161 152 132 114
247 209 169 147 130 242 142
Table indicating the superficial dermal and periadnexal cell count of cells
exhibiting positive staining with monoclonal antibody OM1 (macrophages) at time
points following the i/d injection of PPD in sensitised sheep
Sheep Periadnexal count at Superficial dermal count at
nber 0 hours 24 hours 72 hours 0 hours 24 hours 72 hours
11 74 43 45 144 95 87
25 124 18 13 173 73 65
35 181 70 14 140 138 37
71 117 16 13 136 38 35
76 93 27 101 143 63 125
118 65 19 12 94 20 23
183 140 32 36 151 21 125
184 117 37 21 133 89 50
245 125 117 10 106 132 97
246 221 129 10 152 108 29
247 209 144 10 130 185 50
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Tables indicating the superficial dermal and periadnexal cell count of cells
exhibiting positive staining with monoclonal antibody SW73.2 (MHC class II) at time
points following the i/d injection of PBS in sensitised sheep
Sheep Periadnexal count at Superficial dermal count at
nber 0 hours 24 hours 72 hours 0 hours 24 hours 72 hours
11 557 475 506 450 424 314
25 517 490 483 321 275 298
35 368 429 354 249 227 256
71 596 539 324 416 295 287
76 416 420 398 249 218 273
118 441 420 379 248 266 251
183 367 312 442 234 245 265
184 356 356 353 286 256 237
245 526 518 533 351 381 320
246 611 431 400 354 315 370
247 477 490 383 234 350 241
Table indicating the superficial dermal and periadnexal cell count of cells
exhibiting positive staining with monoclonal antibody SW73.2 (MHC class II) at time
points following the i/d injection of PPD in sensitised sheep
Sheep Periadnexal count at Superficial dermal count at
nber 0 hours 24 hours 72 hours 0 hours 24 hours 72 hours
11 557 987 100 450 375 209
25 517 515 100 321 468 380
35 368 633 100 249 370 232
71 596 659 100 416 400 250
76 416 536 100 249 560 240
118 441 614 100 248 430 286
183 367 852 50 234 550 242
184 356 713 50 286 457 239
245 526 590 50 351 673 341
246 611 721 50 354 274 328
247 477 663 50 234 486 214
245
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Table indicating the total white blood cell count (cells x 10^ 1~1) during the
course of hydroxyurea treatment (25/7/95 - 30/7/95) and subsequent DTH response,
with the PPD injected intradermally on 31/7/95
Sheep no 25/07/95 26/07/95 27/07/95 28/07/95 29/07/95 30/07/95 31/07/95 01/08/95 02/08/95 03/08/95
33 6.5 7.8 7.1 5.9 5.9 4.5 4.8 3.2 3.7 4.7
34 7.1 8.7 8.8 7.9 8.1 5 4.7 5.1 6 6.3
35 7.3 7.1 6.7 7.4 15.2 12.6 10.3 13.9 12.3 15.6
36 27 25.8 23 22 17.7 20.6 20.2 14.1 15 12.6
37 5.8 5.7 6.4 11.2 4.6 3.4 3.1 3.9 10.5 4.7
38 8.4 10.3 9 5.7 16.8 15.5 13.1 13.1 4.3 13.7
Table indicating the segmented PMN cell count (cells x 10^ pi) during the
course of hydroxyurea treatment (25/7/95 - 30/7/95) and subsequent DTH response,
with the PPD injected intradermally on 31/7/95
Sheep no 25/07/95 26/07/95 27/07/95 28/07/95 29/07/95 30/07/95 31/07/95 01/08/95 02/08/95 03/08/95
33 1.69 1.482 1.775 1.298 1.18 0.675 0.24 0.48 0.518 0.517
34 2.201 2.61 3.256 1.975 2.511 0.85 1.14 1.275 0.6 1.134
35 2.92 2.414 1.474 1.702 3.95 3.15 1.957 7.228 4.92 3.432
36 13.77 11.352 8.28 8.14 5.31 8.858 9.292 8.178 6.3 2.52
37 1.508 2.451 1.984 4.48 1.15 0.136 0.279 0.819 2.205 1.833
38 2.856 2.781 2.97 1.254 6.216 4.65 3.668 6.681 1.591 2.74
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Table indicating the lymphocyte cell count (cells x 10^ pi) during the course of
hydroxyurea treatment (25/7/95 - 30/7/95) and subsequent DTH response, with the
PPD injected intradermally on 31/7/95
Sheep no 25/07/95 26/07/95 27/07/95 28/07/95 29/07/95 30/07/95 31/07/95 01/08/95 02/08/95 03/08/95
33 4.095 5.496 4.402 4.012 4.189 3.42 4.32 2.656 2.849 3.76
34 4.189 4.959 4.4 4.898 5.022 4 2.961 3.468 4.92 4.599
35 3.723 4.331 4.489 4.81 10.85 8.316 7.725 6.394 6.396 11.076
36 7.56 8.256 9.89 8.8 8.85 8.446 7.878 5.922 7.8 7.56
37 3.422 2.85 3.84 5.824 3.128 2.992 2.604 2.847 7.56 2.773
38 4.956 9.798 5.49 4.332 10.08 10.385 9.432 6.288 2.408 10.686
Table indicating the eosinophil cell count (cells x 10^ 1~1) during the course of
hydroxyurea treatment (25/7/95 - 30/7/95) and subsequent DTH response, with the
PPD injected intradermally on 31/7/95
Sheep no 25/07/95 26/07/95 27/07/95 28/07/95 29/07/95 30/07/95 31/07/95 01/08/95 02/08/95 03/08/95
33 0.715 0.546 0.852 0.531 0.354 0.27 0.144 0 0.074 0.141
34 0.355 0.783 0.44 0.869 0.243 0.1 0.235 0.357 0.3 0.315
35 0.365 0.284 0.536 0.74 1.368 0.191 0.618 0 0.492 0.312
36 4.86 4.902 4.14 0 3.363 2.678 2.424 0 0.9 2.142
37 0.464 0.228 0.448 0.784 0.184 0.136 0.186 0 0.315 0.047
38 0.084 0.103 0.09 0.057 0.336 0.155 0 0 0.129 0
Table indicating the monocyte cell count (cells x 10^ pi) during the course of
hydroxyurea treatment (25/7/95 - 30/7/95) and subsequent DTH response, with the
PPD injected intradermally on 31/7/95
Sheep no 25/07/95 26/07/95 27/07/95 28/07/95 29/07/95 30/07/95 31/07/95 01/08/95 02/08/95 03/08/95
33 0.065 0.234 0.071 0 0.118 0.09 0.096 0.064 0.185 0.235
34 0.213 0.087 0.44 0.079 0.243 0 0.094 0 0.06 0.252
35 0.292 0 0.201 0 0.304 0.252 0 0.278 0.492 0.78
36 0.81 1.29 0.46 4.84 0.177 0.412 0.202 0 0 0.378
37 0.406 0.171 0.128 0.0112 0.138 0.068 0.031 0.234 0.21 0.047
38 0.252 0.412 0.45 0.057 0.336 0.155 0 0.131 0.172 0.274
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Table indicating the percentages of CD4+ and CD8+ cells prior to and following
treatment with hydroxyurea, with the percentages of lymphocytes flourescing in the
control tubes also indicated.
% of lymphocytes fluorescing
No antibody NMS VPM53 CD4 CD8
Sheep no pre post pre post pre post pre post pre post
33 2.98 1.2 0.67 1.42 0.65 1.34 29.11 36.14 28.36 31.87
34 0.67 1.4 0.79 2.08 0.96 1.45 18.14 20.99 21.44 19.78
35 1.65 2.22 2.84 1.77 1.84 1.72 21.64 26.46 35.29 30.03
36 4.63 1.43 2.96 1.78 2.77 1.3 26.52 33.37 29.16 25.76
37 1.46 2.1 2.16 2.28 1.37 3.88 28.17 31.71 33.23 26.07
38 0.86 1.3 1.69 1.58 0.94 1.09 22.42 17.99 51.53 44.21
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Table indicating the increase in skin thickness at time points following the i/d
injection of PPD in sensitised PMN depleted and control sheep
Sheep Increase in skin thickness (mm) at
number
2 hours 7 hours 24 hours 48 hours 72 hours 96 hours
33 ND ND 2.7 5.5 7 6
34 ND ND 3.7 5 5 4.5
35 ND ND 3.8 6.5 9.5 9
36 ND ND 2.7 6 7.5 7
37 ND ND 4.7 4.5 6 5
38 ND ND 2.7 7 9 10
183 0 1.333 6.7 11.5 10 5
184 0 0.667 5 11.5 10 5
245 0 1.5 10.7 14.5 13 7
246 0 1 10.7 15 11.5 5
247 0 1 8.3 16 13 7
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Table indicating the superficial dermal and periadnexal cell count of PMN cells
at time points following the i/d injection of PBS in sensitised sheep
Sheep Periadnexal count at Superficial dermal count at
nber 0 hours 24 hours 72 hours 0 hours 24 hours 72 hours
33 211 200 164 81 152 86
34 148 176 141 98 113 74
35 149 178 255 118 85 70
36 180 165 183 68 67 73
37 156 335 330 65 134 120
38 307 225 166 145 68 101
183 164 108 187 77 71 91
184 184 183 190 102 100 101
245 184 119 117 74 96 99
246 122 117 154 81 71 74
247 180 96 140 80 72 69
Table indicating the superficial dermal and periadnexal cell count of PMN cells
at time points following the i/d injection of PPD in sensitised sheep
Sheep Periadnexal count at Superficial dermal count at
nber 0 hours 24 hours 72 hours 0 hours 24 hours 72 hours
33 211 2423 191 81 922 47
34 148 3038 487 98 1497 854
35 149 2675 935 118 1511 2065
36 180 580 849 68 1562 1114
37 156 215 546 65 477 207
38 307 5521 549 145 2868 1060
183 164 5094 2756 77 2841 1877
184 184 4125 2822 102 2621 1942
245 184 5271 1425 74 2513 887
246 122 5111 2118 81 1768 1673
247 180 4561 732 80 1937 490
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Table indicating the superficial dermal and periadnexal cell count of cells
exhibiting positive staining with monoclonal antibody SBU-T4 (CD4+ T cells) at time
points following the i/d injection of PBS in sensitised sheep
Sheep Periadnexal count at Superficial dermal count at
nber 0 hours 24 hours 72 hours 0 hours 24 hours 72 hours
33 371 340.5 397.5 162.5 224.5 244.5
34 230.5 209.5 167.5 113.5 132.5 144
35 155.5 323 143 85.5 100 66
36 262 339 217 103.5 315 154
37 240.5 165.5 187.5 139.5 171 165
38 176 160 173.5 168 97 148.5
183 310 201 272 142 125 132
184 247 178 183 111 104 121
245 219 251 240 123 156 157
246 227 229 298 126 121 169
247 238 214 263 138 128 132
Table indicating the superficial dermal and periadnexal cell count of cells
exhibiting positive staining with monoclonal antibody SBU-T4 (CD4+ T cells) at time
points following the i/d injection of PPD in sensitised sheep
Sheep Periadnexal count at Superficial dermal count at
nber 0 hours 24 hours 72 hours 0 hours 24 hours 72 hours
33 371 679 185 162.5 676 68
34 230.5 1030 1018 113.5 280 616
35 155.5 224 587 85.5 141 287
36 262 609 682 103.5 153 440
37 240.5 727.5 1710 139.5 316 185
38 176 205 680 168 367 523
183 310 1179 2082 142 740 1091
184 247 1217 2367 111 556 1212
245 219 979 1763 123 601 1084
246 227 1024 1872 126 478 1077
247 238 1305 1834 138 614 1027
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Table indicating the superficial dermal and periadnexal cell count of cells
exhibiting positive staining with monoclonal antibody SBU-T8 (CD8+ T cells) at time
points following the i/d injection of PBS in sensitised sheep
Sheep Periadnexal count at Superficial dermal count at
nber 0 hours 24 hours 72 hours 0 hours 24 hours 72 hours
33 205 113.5 225 201.5 199.5 70
34 361 344 141.5 127 128 140.5
35 224.5 243 160.5 199.5 234 161.5
36 180 180.5 372 114 68 167
37 208.5 415 227.5 141 253.5 191.5
38 469 303 368 223.5 205 266
183 166 154 174 109 114 112
184 227 224 239 127 132 160
245 96 171 302 100 117 109
246 178 224 217 108 137 108
247 225 250 232 133 147 160
Table indicating the superficial dermal and periadnexal cell count of cells
exhibiting positive staining with monoclonal antibody SBU-T8 (CD8+ T cells) at time
points following the i/d injection of PPD in sensitised sheep
Sheep Periadnexal count at Superficial dermal count at
nber 0 hours 24 hours 72 hours 0 hours 24 hours 72 hours
33 205 1121 734 201.5 469 403
34 361 880 738 127 234 555
35 224.5 301.5 1301 199.5 65 500
36 180 419 1127 114 259 312
37 208.5 812 652 141 352 378
38 469 606.5 1445.5 223.5 262 680
183 166 416 1208 109 256 446
184 227 482 1214 127 305 581
245 96 654 1003 100 363 652
246 178 601 1172 108 354 665
247 225 709 1152 133 430 622
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Table indicating the superficial dermal and periadnexal cell count of cells
exhibiting positive staining with monoclonal antibody 86D (gamma delta T cells) at
time points following the i/d injection ofPBS in sensitised sheep
Sheep Periadnexal count at Superficial dermal count at
nber 0 hours 24 hours 72 hours 0 hours 24 hours 72 hours
33 328.5 744 813 197 234 130.5
34 355.5 211 145 69 64 89
35 315.5 275 162.5 420 195.5 199.5
36 83 415 176.5 156.5 298.5 248
37 177.5 138 136 223 224.5 61.5
38 147 323.5 327 180 112 145.5
183 139 201 206 97 158 120
184 152 102 90 97 57 51
245 150 131 153 87 116 86
246 146 162 68 109 108 89
247 108 170 150 71 86 64
Table indicating the superficial dermal and periadnexal cell count of cells
exhibiting positive staining with monoclonal antibody 86D (gamma delta T cells) at
time points following the i/d injection of PPD in sensitised sheep
Sheep Periadnexal count at Superficial dermal count at
nber 0 hours 24 hours 72 hours 0 hours 24 hours 72 hours
33 328.5 281 682 197 151 440
34 355.5 290 700 69 291 278
35 315.5 184 411 420 252.5 353
36 83 405 161 156.5 135 82
37 177.5 405 407 223 480 211
38 147 273 355 180 226 288
183 139 307 185 97 120 137
184 152 159 173 97 93 137
245 150 192 143 87 144 123
246 146 412 318 109 177 193
247 108 354 341 71 236 139
252
Appendix 6.3.8
Table indicating the superficial dermal and periadnexal cell count of cells
exhibiting positive staining with monoclonal antibody OM1 (macrophages) at time
points following the i/d injection of PBS in sensitised sheep
Sheep Periadnexal count at Superficial dermal count at
nber 0 hours 24 hours 72 hours 0 hours 24 hours 72 hours
33 545.5 228.5 732 140.5 213 274.5
34 137.5 150 178.5 139.5 173 148
35 440 241 387 284 204 122
36 179.5 186 174.5 131 103.5 71
37 159.5 116 250.5 208 138 130
38 180 182 262 302.5 128.5 178
183 140 129 178 151 127 167
184 117 143 136 133 163 139
245 125 92 101 106 105 116
246 221 158 161 152 132 114
247 209 169 147 130 242 142
Table indicating the superficial dermal and periadnexal cell count of cells
exhibiting positive staining with monoclonal antibody OM1 (macrophages) at time
points following the i/d injection of PPD in sensitised sheep
Sheep Periadnexal count at Superficial dermal count at
nber 0 hours 24 hours 72 hours 0 hours 24 hours 72 hours
33 545.5 272 <40 140.5 73.5 <40
34 137.5 175 <40 139.5 71 <40
35 440 245.5 <40 284 178 <40
36 179.5 186 <40 131 68 <40
37 159.5 271 <40 208 120 <40
38 180 359 <40 302.5 167 <40
183 140 32 <40 151 21 <40
184 117 37 <40 133 89 <40
245 125 117 <40 106 132 <40
246 221 129 <40 152 108 <40
247 209 144 <40 130 185 <40
253
Appendix 6.3.9
Tables indicating the superficial dermal and periadnexal cell count of cells
exhibiting positive staining with monoclonal antibody SW73.2 (MHC class II) at time
points following the i/d injection of PBS in sensitised sheep
Sheep Periadnexal count at Superficial dermal count at
nber 0 hours 24 hours 72 hours 0 hours 24 hours 72 hours
33 539 296 154.5 610 200 172
34 234.5 367 291.5 217 209 172.5
35 538.5 421.5 438 296 170 208
36 263 175 300.5 112.5 136 232.5
37 277.5 307 277.5 307 167 145.5
38 225 191 162 161 102 124
183 367 312 442 234 245 265
184 356 356 353 286 256 237
245 526 518 533 351 381 320
246 611 431 400 354 315 370
247 477 490 383 234 350 241
Table indicating the superficial dermal and periadnexal cell count of cells
exhibiting positive staining with monoclonal antibody SW73.2 (MHC class II) at time
points following the i/d injection of PPD in sensitised sheep
Sheep Periadnexal count at Superficial dermal count at
nber 0 hours 24 hours 72 hours 0 hours 24 hours 72 hours
33 539 300 <50 610 193 <50
34 234.5 277 <50 217 397 <50
35 538.5 289 <50 296 263 <50
36 263 612 <50 112.5 254 <50
37 277.5 337 <50 307 272 <50
38 225 454 <50 161 270 <50
183 367 852 <50 234 550 242
184 356 713 <50 286 457 239
245 526 590 <50 351 673 341
246 611 721 <50 354 274 328
247 477 663 <50 234 486 214
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Table indicating the PMN cell count in the superficial and deep dermis for a
control biopsy and at four hours post intradermal injection of the indicated solutions
Sheep no. Superficial dermis Deep dermis
0 hours rhil8 tnf zap saline 0 hours rhil8 tnf zap saline
con RT05 10 416 315 26 3 2 562 685 793 0
con RT135 5 67 564 578 5 2 510 1079 675 58
con RT151 5 100 46 76 2 1 708 524 909 2
con 147 4 114 112 86 4 1 247 519 667 27
con 148 48 162 602 47 85 16 152 866 533 2
con 149 13 61 329 344 5 4 406 670 956 2
mvv 006 2 772 705 110 39 2 562 1370 598 157
mvv 045 3 101 148 44 8 1 370 710 618 2
mvv 065 3 14 278 320 53 2 246 1168 767 248
mvv 075 6 929 361 344 4 2 786 771 657 2
mvv 101 2 1070 889 370 16 2 1082 993 502 1
mvv 115 5 130 5 13 13 2 367 2 471 1
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Appendix 7.3.3
Table indicating the CD4+ cell count in the superficial and deep dermis for a
control biopsy and at four hours post intradermal injection of the indicated solutions
Sheep no. Superficial dermis Deep dermis
0 hours rhil8 tnf zap saline 0 hours rhil8 tnf zap saline
con RT05 54 30 40 20 32 77 43 76 38 108
con RT135 40 37 60 13 15 65 92 165 16 15
con RT151 23 35 73 104 47 14 39 140 93 47
con 147 12 17 128 26 11 12 20 78 48 21
con 148 40 21 71 21 12 16 28 24 19 10
con 149 31 36 58 24 74 29 78 86 59 79
mvv 006 20 36 41 58 69 21 66 71 80 90
mvv 045 16 24 27 20 35 8 12 41 33 8
mvv 065 11 62 123 34 50 9 46 187 76 65
mvv 075 77 44 27 12 66 16 38 18 14 44
mvv 101 3 12 60 16 10 5 21 92 19 12
mvv 115 83 31 93 76 28 38 9 37 20 54
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Appendix 7.3.4
Table indicating the increase in skin thickness at time points following the i/d
injection of PPD in sensitised MVV positive and control sheep
Sheep Increase in skin thickness (mm) at
number
2 hours 7 hours 24 hours 48 hours 72 hours 96 hours
RT 05 0 1.1 4.00 10.0 13.0 6.0
RT 135 0 1.2 4.67 10.0 12.0 5.0
RT 151 0 1.6 6.67 11.5 13.0 8.0
147 0 1.2 5.33 13.0 12.0 7.0
148 0 1.0 6.67 12.0 13.0 7.0
149 0 0.8 4.67 10.0 13.0 6.0
006 0 0.9 4.33 11.0 12.0 8.0
045 0 0.5 3.67 6.0 9.0 6.0
065 0 0.6 4.00 7.0 7.0 5.0
075 0 0.9 4.00 8.0 9.0 5.0
101 0 0.8 4.00 10.5 9.0 6.0
115 0 0.5 3.33 7.0 8.0 5.0
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Appendix 8.3.1
Table indicating the mean optical density readings in an anti-PPD antibody
ELISA test at a serum dilution of 1 in 40 pre and post vaccination for MVV
seropositive and control sheep
Sheep Number Mean OD reading at 1 in Mean OD reading at 1 in
40 prior to BCG 40 following BCG
vaccination vaccination
Con 183 0.190 0.067
Con 184 0.134 0.412
Con 245 0.073 0.466
Con 246 0.424 0.770
Con 247 0.146 0.297
MVV Oil 0.122 0.251
MVV 025 0.313 0.337
MVV 035 0.433 0.428
MVV 071 0.238 0.396
MVV 076 0.535 0.787
MVV 118 0.234 0.723
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APPENDICES TO CHAPTER 9
Appendix 9.2.4
Nucleotide sequences of the primers and probes used in the PCR assays. The
optimum temperature for each assay is listed.






























Table indicating the increase in skin thickness at time points following the i/d
injection of PPD in sensitised MVV positive and control sheep
Sheep Increase in skin thickness (mm) at
number
2 hours 7 hours 24 hours 48 hours 72 hours 96 hours
064 0 1 4 8 8 5
103 0 1 4 3.5 5.5 3
155 0 0.5 3 9.5 8 4.5
168 0 1.5 4.5 6 6 4
174 0 2.5 6 8.5 6.5 5.5
255 0 1 4 6.5 4 2
51 0 2.5 5 13 11 6
52 0 2 5.5 10 10 6
54 3 5.5 8 9.5 7
55 0 4.5 6 13 11.5 6
56 0 3 4 11 11.5 9.5
57 0 3 6 9 10 9
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Appendix 9.3.2
Table indicating the presence of positive bands on autoradiographs of
radiolabeled probing of Southern blots of PCR products derived from skin biopsies
taken from control sheep
mRNA Sheep 51 Sheep 52 Sheep 54 Sheep 55 Sheep 56 Sheep 57
con pbs ppd con pbs ppd con pbs ppd con pbs ppd con pbs ppd con pbs ppc
ATPase 2 3 3 3 3 2 3 1 3 3 3 3 3 3 0 3 3 3
IL-10 1 3 1 1 3 1 3 1 1 3 0 1 0 1 0 3 1 1
TNF 0 0 0 0 0 1 1 0 1 1 0 0 0 1 0 1 1 2
IFN 1 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0
IL2-R 0 0 2 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0
POL 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
key: 0=no band, l=weak band, 2=moderate band, 3=strong band
Table indicating the presence of positive bands on autoradiographs of
radiolabeled probing of Southern blots of PCR products derived from skin biopsies
taken from MVV seropositive sheep
mRNA Sheep 64 Sheep 103 Sheep 155 Sheep 168 Sheep 174 Sheep 255
con pbs ppd con pbs ppd con pbs ppd con pbs ppd con pbs ppd con pbs ppc
ATPase 3 0 3 2 3 3 1 1 3 3 3 1 2 3 3 3 3 3
IL-10 2 0 3 1 2 2 0 3 3 3 3 0 0 1 0 1 1 1
TNF 1 0 0 1 1 1 0 1 0 1 1 1 0 0 1 0 0 1
IFN 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
EL2-R 0 0 1 0 0 0 0 0 1 0 1 0 0 0 0 0 0 1
POL 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
key: 0=no band, l=weak band, 2=moderate band, 3=strong band
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Immunohistological study of the cutaneous delayed
type hypersensitivity reaction in sheep
Ian T.G. Pyrah *, Neil J. Watt
Department of Veterinary Pathology, Royal (Dick) School of Veterinary Studies. The University ofEdinburgh,
Veterinary Field Station, Easter Bush EH25 9RC, UK
The cutaneous delayed type hypersensitivity (DTH) reaction may be experimentally initiated
both as an in-vivo technique for the study of the cell mediated arm of the immune system, and
also as an accurate clinical test of the functional capacity of this part of the immune response. This
study was performed to fully evaluate the immunohistological characteristics of the normal DTH
reaction utilising an ovine model. Six clinically healthy sheep were inoculated with an intradermal
Mycobacterium bovts vaccine. After 21 days, they were challenged with multiple intradermal
injections of a purified protein derivative (PPD) of M. bovis in the hairless skin of the medial
thigh. Simultaneous contralateral injections of sterile diluent were performed to provide control
material. The resulting lesions were measured for increase in skin thickness and biopsied at 2, 7,
24, 48. 72, and 96 h post injection. The biopsies were divided, and stained both histochemically
and with monoclonal antibodies directed against lymphocyte subsets, macrophages, and B cells.
The DTH reaction was maximal at 72 hours post challenge, and was largely characterised by an
initial influx of polymorphonuclear neutrophil (PMN) cells, after which there was an accumulation
of or/3 T cells. The number of macrophages within the lesion declined with the progression of the
reaction. B cells and y<5 T cells did not appear to play a major role in the response. Fibrin was a
marked component of the reaction at later time points.
Keywords: Delayed type hypersensitivity; Sheep; Mycobacterium; Immunology
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polymorphonuclear neutrophil; PPD. purified protein derivative.
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2. Introduction
The classical dermal delayed type hypersensitivity (DTH) reaction is an important
model for studying the mechanisms of action of the cell mediated immune system, that
part of the immune system especially associated with the host response to certain
infections such as fungi and mycobacteria, and also the sole in-vivo measure of the
competence of the cell-mediated immune response (Otto et ah, 1993). There is a
surprising paucity of published material that describes the normal immunohistological
characteristics of the DTH reaction, with no single study fully evaluating the cellular
kinetics of the reaction. Considering the importance of the cell mediated immune
response in the control of mycobacterial infections that are becoming increasingly
clinically prevalent, and the growing importance of the gross DTH reaction as a clinical
measure of cell mediated immune function, especially as a prognostic indicator in
human immunodeficiency virus infection (Ahmed and Blose, 1983; Kniker at ah, 1984;
Bratt et ah, 1986; Borleffs et ah. 1991; Rosentreich, 1993), this lack of basic information
constitutes a serious gap in the understanding of the cell mediated immune response and
prevents the scientific evaluation of any clinically apparent alterations in DTH reaction.
This study was undertaken in order to fully characterise the DTH response and address
this gap in the knowledge of its development, utilising a mycobacterial purified protein
derivative (PPD) challenge in a previously immunised sheep as a model.
The results from this study are particularly useful for future investigations of altered
DTH responses in all species, with particular relevance to the investigation of the
depression in DTH response that has previously been reported to occur in sheep affected
with Maedi-Visna virus (Mver et ah, 1988). but will also aid in the understanding of the
mechanisms of action of the cell-mediated arm of the immune system.
3. Materials and methods
3.1. Animals
Six clinicallv normal adult sheep, two Finn and four Greyface obtained from a
commercial market source, were used in this experiment. A full post-mortem examina¬
tion was undertaken at the conclusion of the experiment to confirm the absence of
intercurrent disease.
3.2. Initiation of the delayed-type hypersensitivity response
The sheep were primed intradermals with five human doses of a Mycobacterium
bovis Bacillus de Calmette Guerin (BCG) vaccine (Evans Medical Ltd., Langhurst. UK)
in the skin of the flank region. After 21 days they were challenged with six separate
intradermal injections of 0.1 ml of an M. borts PPD (Central Veterinary Laboratories.
Weybridge. UK), equivalent to 0.1 mg of protein or 2500 IU of activity, in the hairless
skin of the medial thigh. The site of these injections was standardised via use of a
perspex template and skin marker spray, the precise point of injection being marked
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circumferentially with permanent black ink. A similar set of six control injections of
sterile diluent was made in the contralateral thigh.
3.3. Lesion measurement and biopsy
The increase in skin fold thickness in the lesions was measured using a set of
measuring calipers (Camlab Ltd., Cambridge, UK) at 2, 7, 24, 48, 72, and 96 h post
injection, with the lesional skin fold thickness being compared with that of adjacent
unaffected skin. At the same time point, the measured lesion was anaesthetised using a
perilesional 'ring block' of subcutaneous local anaesthetic (Xylocaine 1%, Astra Phar¬
maceuticals, Kings Langley, UK) and a lesional biopsy taken using an 8 mm disposable
punch (Steifel Laboratories Ltd., Woodburn Green, UK). The samples were immediately
bisected, with one half being placed in 10% neutral buffered formalin and one half being
snap frozen at -70°C in a mixture of dry ice and isopentane. The biopsy sites were
closed using surgical staples (Proximate, Ethicon Ltd., Somerville, NJ, USA).
3.4. Specimen staining and evaluation
The formalin fixed specimens were embedded in paraffin, sectioned at 5 pm and
stained in a standard manner with haematoxylin and eosin, toluidine blue, carbol
chromotrope and Martius scarlet blue. The frozen specimens were sectioned at 6 pm in
a cryostat and mounted on tissue adhesive (Biobond, British Biocell International Ltd..
Cardiff, UK) coated slides. These sections were stained with monoclonal antibodies
directed against the following cell types: CD4 + , CDS + , yd TCR + , B cells and
macrophages (Table I). The monoclonal staining was detected utilising a standard
immunoperoxidase detection system (Vectastain Elite, Vector Labs Ltd., Peterborough.
UK), and sections were subsequently counterstained with haematoxylin. Microscopical
evaluation indicated that the cellular reaction was centred on the adnexal structures. As a
result, quantitative evaluation was performed in the specific periadnexal and superficial
dermal areas using a squared (10 X 10) eyepiece graticule at a magnification of X200,
in a modification of the method described by Bos et al. (1987). The graticule was
Tabic 1
Code name. specificity, dilution and reference of the monoclonal antibodies used
Code name Specificity- Dilution Reference
SBU-T4 Ovine CD4 1:1000 Maddox et al., 1985
SBU-TS Ovine CDS 1:1000 Maddox et al., 1985
86D Ovine y8 T cell 1:1000 Mackay et al., 1989
receptor
OM 1 Ovine CD I lc 1:100 Gupta et al., 1993
VPM63 Ovtne Fey receptor 2 1:100 V.K. Gupta, personal
communication, 1994
VPM65 Ovine CD 14 1: 100 V.K. Gupta, personal
communication, 1994
DU2.87 Ovine B cells I : 100 Gupta. 1994
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Time post challenge (hours)
Fig. 1. Increase in the iesional skin thickness versus time (median and interquartile range indicated).
randomly overlaid over an adnexal structure and the cells of interest in ten random
squares immediately adjacent to the structure were counted. This was repeated four
times, which in most cases was the total number of adnexal structures present. Ten
random squares in four adjacent superficial dermal areas were then counted, this again
usually constituting the total area of the section. The total number of marked cells in the
counted areas was then recorded. A descriptive pathological assessment of the develop¬
ing lesion was also made.
4. Results
4.1. Skin thickness and histopathological assessment
There was a marked increase in skin thickness in the antigen injected sites, which
was maximal at 48-72 h post injection, with no change noted in the control injection
sites (Fig. 1).
Histopathologically, the first change in the skin of the biopsies taken from the antigen
challenged sites was the presence of marginating polymorphonuclear neutrophils (PMNs)
within the dermal blood vessels. These were seen occasionally at the 2 h time, but
invariably present at 7 h, where there was an associated migration of these cells into the
perivascular spaces. By the 24 h time point there was a universal florid reaction
involving largely PMNs, but also some lymphocytes, histiocytes, and fibroblast type
cells. This reaction was centred largely on the periadnexal and superficial dermal areas
(Figs. 2 and 3). At 48 h post challenge, there had been a reduction in the level of the
PMNs and an increase in the numbers of lymphoid type cells, with the marked presence
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Fig. 2. Low power view of the reaction at 24 h. Note the concentration of cells in the periadnexal areas (H &
E. scale bar 200 /cm).
of superficial oedema and fibrin. In several samples PMNs were seen within the lumina
of hypertrophic sweat glands. The distribution of the cells was more widespread, but
was still centred periadnexailv and in the superficial dermis (Figs. 4 and 5). In most
cases there was an overlying epidermal oedema. The reaction remained largely un¬
changed at the 72 h time point, before subsiding in cellularity, but not altering in
character, at the 96 h time point.
The biopsies taken from the control injected sites exhibited an early mild dermal
oedema, with no other significant cellular alteration noticeable.
Fig. 3. High power view of the 24 h reaction exhibiting the presence of large numbers of PMNs (H & E. scale
bar 50 ^m).
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Fig. 4. Low power view of the reaction at 48 h showing the more widespread distribution of cells, although
there is still a concentration of cells in the periadnexal areas (H & E. scale bar 200 yam).
4.2. Cell counts
There was a very strong correlation ( P < 0.01 in all cases) between the cell counts in
the periadnexal and dermal compartments, with the densities of cells being proportion¬
ally lower in the dermal compartment. The kinetics of the cellular response appeared
identical in both areas. The distribution pattern seen probably represents the density of
blood vessels in the separate areas, these being the source of the infiltrating cells.
The numbers of PMNs increased dramatically in the early part of the reaction
between 7 and 24 h (Fig. 6). The numbers then decreased rapidly to half this level by
Fig. 5. High power view of the 48 h reaction indicating the decline in PMN numbers with the high levels of
mononuclear inflammatory cells (H 4c E. scale bar 50 /am).
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Time post challenge (hours)
Fig. ti. Pcrtadncxal PMN cell count versus time (median and interquartile range indicated).
48 h and then remained stable to 72 h before returning to almost baseline levels by 96 h.
The numbers of PMNs in the control lesions remained unchanged throughout the
timecourse of the reaction. The numbers of CD8 + cells in the antigen injected lesion
rose slightly at 24 h before reaching a maximal level at 48 h and then remaining
relatively constant until the end of the time course (Figs. 7, 8 and 9). Again there was no
apparent change in the number of cells in the control lesions.
Time post challenge (hours)
Fie. 3. Penadnexal CDS ceil count versus time (median and interquartile range indicated).
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Fig. 6. CDS + cells in the 48 h reaction (immunoperoxidase. scale bar 1(H) timt
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Time post challenge (hours)
Fig. 10. Pcriadncxal CD4 cell count versus time (median and interquartile range indicated).
There was a similar result with the CD4 4- cells, although the number of CD4 + cells
was significantly higher than CDS + cells. In the antigen challenged skin there was a
slight rise at 24 h. with a larger rise to an almost maximal level at 48 h, although the
Fig. 11. CD4 + cells in the 24 h reaction (immunoperoxidase. scale bar 100 /a.m).
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highest cell density was recorded at 72 h (Figs. 10, 11 and 12). The control biopsies
revealed no significant change in cell counts.
The ratio of CD4 + :CD8 4- cells remained relatively constant at approximately 2.5:1
The yS T cell positive cells appeared numerically unimportant throughout the reaction,
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Fig. 13. OM1 stained macrophages at 7 h (immunopcroxidase. scale bar 50 pmi.
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Fig. 14. OM1 stained section at 24 h exhibiting the depressed numbers of macrophages at this time point
(immunopcroxidase, scale bar 50 fim).
ceils. There appeared, however, to be a slight rise in the numbers of yS + T cells
throughout the time course of the reaction. There was no significant change in the
number of yS + T cells in the control lesions.
Macrophages, as recognised by staining with OM1 monoclonal antibody, rapidly
decreased in number at the 24 h time point, remaining at low levels throughout the rest
of the reaction (Figs. 13 and 14). There was little change noted in the levels of
macrophages present in the control sides.
B cells, as defined by staining with monoclonal antibody DU 2.87 (Table 1), were not
noted in the reaction in any significant numbers.
Mast cells numbers in all biopsies were similarly relatively low, with no apparent
alteration in the antigen reaction.
Fibrin was detected via use of the histochemical stain Martius scarlet blue. It was first
noted in the 24 h biopsy, at which point the positively stained material constituted
approximately 30% of the section as observed microscopically. The level remained
relatively constant to the 72 h time point, before declining slightly at 96 h. Fibrin was
present occasionally in very low levels in the control biopsies.
5. Discussion
The most striking finding of this study was the consistent appearance of high
numbers of PMNs in the earlier biopsies, with PMN cell counts at 24 h being similar to
T lymphocyte counts at 72 h. There have been very few previous histological assess¬
ments of the tuberculin reaction, although the early presence of PMNs has been
occasionally reported both in humans, notably by Konttinen et al. (1983), and in the cat.
by Legendre et al. (1979). The study by Konttinen et al. (1983) suggested that the PMNs
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are only present at relatively low levels in the early reaction, and the work by Legendre
et al. (1979) did not indicate the kinetics of the PMN appearance and was subsequently
challenged by the work of Otto et al. (1993), who considered PMNs to be an uncommon
finding in the feline DTH reaction.
The importance of the PMN in the priming and initiation phase of a DTH type
reaction was studied by Kudo et al. (1993), who utilised a monoclonal antibody to
selectively deplete PMNs from the circulation in a rat/sheep red blood cell model. Thev
discovered that a PMN depletion at both priming and initiation stages of the reaction
markedly lowered the eventual size of the gross lesion and the quantitative level of
migration of mononuclear cells into the DTH reaction site, indicating that the PMNs
have a key role in the initial priming and the subsequent DTH response.
The role of the PMN infiltration in the DTH response is as yet unclear, although their
consistent predominance in the early lesion in this study would support the assertion that
they have major role in the development of the classic DTH lesion, presumably through
their production of proinflammatory mediators.
Another unexpected finding was that the cell counts of macrophages drop to an
almost negligible level during the response. Previous studies examining the levels of
macrophages fail to utilise monoclonal antibodies, and most studies group macrophages
loosely with other mononuclear cells to give a total figure. The absence of macrophage
staining in this study may reflect either the loss of the surface marker upon activation/
involvement in the lesion, or the trafficking of the macrophages out of the lesion,
presumably to the local draining lymph node. The former is unlikely as the authors have
undertaken the staining of macrophages active in other sites which remained strongly
positive, and the biopsy samples were also stained with two other monoclonal antibod¬
ies. VPM63 and VPM65 (Table 1), which produced a similar kinetic pattern of staining.
These factors would support the hypothesis that the cells traffic out of the lesion at an
early point, and it is most likely that they travel to a local lymph node. A strong
macrophage response was noted in a lymph node draining the site of a feline DTH
reaction by Legendre et al. (1979), although the trafficking of cells from the reaction to
the node was not investigated. In this situation the DTH reaction site constitutes a likely
source of these activated macrophages, which could become resident in the local lymph
node.
The presence of large numbers of CD4 + and CDS + T lymphocytes at later time
points was as expected and compares with the work of Poulter et al. (1982) and Gibbs et
al. (1984). The ratio of these cells is similar to that found in peripheral blood, which
suggests that there is no selective mechanism for cellular traffic of these cell types into
the lesion.
The low levels of yS + T cells and their only slight rise in numbers during the
reaction is similar to the findings of Fujita et al. (1993), who considered the y8 -r T cells
to be involved not in the initiation, but in the resolution of the contact allergy DTH type
lesion in human subjects. The tuberculin DTH model in the sheep is considerably
different from this human model, however, in that the ovine has been found to have a
much larger proportion of y8 + T cells in the peripheral circulation (Hein and Mackay.
1991), and the immune response to mycobacterial antigens has been reported to rely
considerably on the y6 + T cell (Janis et al.. 1989). With this in mind, a significant
I.T.G. Pyrah, NJ. Watt/ Veterinary Immunology andImmunopathology 48 (1995) 299-312 311
involvement of y<5 + T cells was expected, and their almost negligible presence through¬
out the reaction was somewhat surprising.
The apparent lack of participation of mast cells and basophils agrees with the work of
Torii et al. (1993), who indicated that the mast cell was not important in the tuberculin
driven DTH reaction, and indicated that the this tuberculin reaction is likely to be
initiated and controlled by the macrophage.
This study has outlined the kinetics and relative numerical contribution of the major
immune cell populations in the tuberculin driven DTH reaction in the sheep. The
significant involvement of the PMN in the early reaction has been discovered, and
constitutes an important finding which deserves further detailed study. The low level of
macrophages in the later lesion was another unexpected observation, and suggests that
these cells may traffic out of the lesion to local lymphoid tissue once the reaction is
initiated locally. The low levels of y8 + T cells found in the DTH lesion was surprising,
and may be relevant in elucidating the functional significance of this particular lympho¬
cyte subset. The high levels of CD4 + and CD8 + cells in the later reaction is as would
be expected in a cell-mediated immune response.
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PREDOMINANT ISOTYPE OF SPECIFIC ANTIBODY-SECRETING
CELLS IN BRONCHOALVEOLAR LAVAGE FLUID OF CALVES
DEPENDS ON THE ROUTE OF INOCULATION USED FOR
PRIMING H. HoucnEsch. S E. Torrccrosn. D. Bone. H Park. K Pnrki
and T L. Bowcrsock Departments of Veterinary Pathobiology and
Pharmacv. Purdue University. West Lafayette. IN 47907.
The concentration of IgGl in secretory fluids of ruminants equals
or exceeds that of IgA. in contrast to most monogastnc species, tn which
IgA is the predominant secretory immunoglobulin. The role of IgGl in
protean:-; aj;nnst microbial pathogens relative to the role of IgA is not
undcrs Jud. It is also not known whether IgGl is induced by mucosal
immunization ;.nd whether the IgGl is locally produced or derived from
scrum. We have examined whether subcutaneous versus oral priming of
calves with ovalbumin (OVA) influences the isotype of anti-OVA
antibodies in the bronchoalvcolar lavage (BAL) fluid alter mtrabronchial
challenge. Calves were inoculated subcutancously with 3 mg of OVA in
incomplete Frcund's adjuvant or orally by inoculation with 5 mg ofOVA
in encapsulated in alginate microspheres on three consecutive days.
Control calves received PBS only. The calves were challenged by
intrabronchial inoculation of 5 mg of OVA in PBS on Day 16. Five days
later, the presence of anti-OVA antibody-secreting cells (ASC) and
antibodies in BAL fluid was measured by ELISPOT assay and ELISA.
respectively Control calves had no detectable antibodies or ASCs. The
subcutaneouslv primed calves had predominantly IgGl-ASCs and IgGl
anti-OVA antibodies, whereas ASCs in orally pnmcd calves were
exclusively IgA. A low level of IgA anti-OVA antibodies was dcteacd in
the BAL. We conclude from these experiments that after subcutaneous
priming IgGl B cells arc induced that home to the lung upon
intmbronchial challenge. After oral inoculation, predominantly IgA B
cells are induced that home to the lung upon challenge. These studies
suppon the existence of a common mucosal immune system in cattle
Supported by USDA 94-37204-0446
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CHARACTERIZATION OF CHICKEN AND TUF.KKY
HETEROPHIL ANTIMICROBIAL PEPTIDES. B.G.
Harmon , E . W. Evans , F . G . Beach,
J.Wunderlich Department of Pathology,
College of Veterinary Medicine, The
University of Georgia, Athens, GA 30602.
Recently, numerous antimicrobial
peptides have been isolated from
leukocytes and mucosal surfaces of
different vertebrate species. These
peptides are believed to be essential for
innate disease resistance. We have
identified five different antimicrobial
peptides in chicken and turkey heterophil
granules. These small cationic peptides
are structurally similar to beta-defensins
found in bovine neutrophils ana bovine
respiratory mucosal cells. Avian peptides
are bacteriocidal for several avian
bacterial pathogens including Mycoplasma
aallisepticum. Staphylococcus aureus. and
Bordetella avium. In v;U9 microbicidal
activity was concentration dependent and
the effective peptide concentration for
some bacteria was as low as 2 fig/ml.
Therefore, these peptides are probably
essential for the microbicidal activity of
avian heterophils.
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INVESTIGATION OF DERMAL DELAYED-TYPE
HYPERSENSITIVITY REACTIONS IN MAEDI-VISNA INFECTED
SHEEP. I.T.G.Pyrah and N.J. Watt. Department of Veterinary
Pathology, Royal (Dick) School of Veterinary Studies. University of
Edinburgh, Easter Bush. Roslin. EH25 9RG.
Six sheep naturally infected with Maedi-Visna virus and six
matched, uninfected, control sheep were vaccinated inrradermallv with
a Mycobacterium bovis B.C.G vaccine, and subsequently challenged
intradermally with a Mycobacterium bovis derived purified protein
derivative in order to eiicit a delayed type hypersensitivity reaction in
the dermis. The lesions produced were measured and biopsied at
several time points up to 96 hours post challenge. The biopsies were
stained histochemicallv. and also with monoclonal antibodies directed
against various ceil markers.
There was a significantly reduced gross reaction in the sheep
infected with Maedi-Visna virus, with a marked variation in size of
reaction within in this group. A significant reduction in the
polymorphonuclear neutrophil and CD4'r cell densities in the early
lesion was noted in the Maedi infected group, with a marked vanbility
within the group. The levels of the neutrophils and CD4"r cells in the
early lesion correlated significantly with the eventual maximal size of
the lesion. The densities of other cell subsets investigated were not
significantly different between the two groups.
This work indicates that there are significant reductions in the
cell-mediated immunity in sheep chronically infected with Maedi-
Visna virus. This reduction is associated with a lowered level of
attraction of neutrophils and CD4^ cells to the site of a delayed-tvpe
hypersensitivity reaction. The possible explanations for this
phenomenon will be discussed.
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IMMUNOHISTOCHEMICAL IDENTIFICATION OF B AND T
LYMPHOCYTES IN FORMALIN-FIXED, PARAFFIN-EMBEDDED
FELINE LYMPHOSARCOMAS: RELATION TO FELINE LEUKEMIA
VIRUS (FeLV) STATUS, TUMOR SITE, AND PATIENT AGE.
M.Jackson. S.Hood. V.Misra, D.Haines. Western
College of Veterinary Medicine, 52 Campus Drive,
Saskatoon, SK, Canada, S7N 5B4
The lymphocyte phenotype of 70 formalin-fixed,
paraffin-embedded feline lymphosarcomas (LSAs) was
determined by immunohistochemistry (IHC) using a T
cell polyclonal antibody and a B cell monoclonal
antibody. Of the 70 LSAs, 67? were T cell, 27? were
B cell, and 6? did not stain with either marker.
FeLV antigen was detected by IHC in 54? of LSAs,
whereas 74? contained FeLV DNA detectable by
polymerase chain reaction (PCR). B cell tumors were
FeLV-positive as frequently as T cell tumors using
either IHC or PCR. Intestinal tumors were more
likely to be B than T cell. The incidence of B and
T cell tumors was not different among young
(<3yr), middle-aged (>3yr to S8yr), and old (»8yr)
cats. However, both B and T cell tumors from old
cats were FeLV-positive more often by PCR than by
IHC.
B cell tumors in cats are generally considered
to be FeLV negative. This study supports a role for
FeLV in B as well as T cell tumors in cats of all
ages, although LSAs in some older cats may be
associated with non-replicating FeLV.
